% $ biblatex auxiliary file $
% $ biblatex bbl format version 3.0 $
% Do not modify the above lines!
%
% This is an auxiliary file used by the 'biblatex' package.
% This file may safely be deleted. It will be recreated as
% required.
%
\begingroup
\makeatletter
\@ifundefined{ver@biblatex.sty}
  {\@latex@error
     {Missing 'biblatex' package}
     {The bibliography requires the 'biblatex' package.}
      \aftergroup\endinput}
  {}
\endgroup

\datalist[entry]{none/global//global/global}
  \entry{Wilson1998}{article}{}
    \name{author}{6}{}{%
      {{hash=WPW}{%
         family={Wilson},
         familyi={W\bibinitperiod},
         given={P\bibnamedelima W},
         giveni={P\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
      {{hash=DRB}{%
         family={D'Agostino},
         familyi={D\bibinitperiod},
         given={R\bibnamedelima B},
         giveni={R\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=LD}{%
         family={Levy},
         familyi={L\bibinitperiod},
         given={D},
         giveni={D},
      }}%
      {{hash=BAM}{%
         family={Belanger},
         familyi={B\bibinitperiod},
         given={A\bibnamedelima M},
         giveni={A\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=SH}{%
         family={Silbershatz},
         familyi={S\bibinitperiod},
         given={H},
         giveni={H},
      }}%
      {{hash=KWB}{%
         family={Kannel},
         familyi={K\bibinitperiod},
         given={W\bibnamedelima B},
         giveni={W\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
    }
    \keyw{Adult; Aged; Algorithms; Blood Pressure; Body Mass Index;
  Cholesterol, blood; Cholesterol, LDL, classification; Cohort Studies;
  Comorbidity; Coronary Disease, epidemiology; Diabetes Mellitus, epidemiology;
  Female; Follow-Up Studies; Humans; Lipids, blood; Male; Middle Aged; National
  Health Programs; Proportional Hazards Models; Risk Factors; Smoking,
  epidemiology}
    \strng{namehash}{WPW+1}
    \strng{fullhash}{WPWDRBLDBAMSHKWB1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    The objective of this study was to examine the association of Joint
  National Committee (JNC-V) blood pressure and National Cholesterol Education
  Program (NCEP) cholesterol categories with coronary heart disease (CHD) risk,
  to incorporate them into coronary prediction algorithms, and to compare the
  discrimination properties of this approach with other noncategorical
  prediction functions. This work was designed as a prospective, single-center
  study in the setting of a community-based cohort. The patients were 2489 men
  and 2856 women 30 to 74 years old at baseline with 12 years of follow-up.
  During the 12 years of follow-up, a total of 383 men and 227 women developed
  CHD, which was significantly associated with categories of blood pressure,
  total cholesterol, LDL cholesterol, and HDL cholesterol (all P<.001).
  Sex-specific prediction equations were formulated to predict CHD risk
  according to age, diabetes, smoking, JNC-V blood pressure categories, and
  NCEP total cholesterol and LDL cholesterol categories. The accuracy of this
  categorical approach was found to be comparable to CHD prediction when the
  continuous variables themselves were used. After adjustment for other
  factors, approximately 28% of CHD events in men and 29% in women were
  attributable to blood pressure levels that exceeded high normal (> or
  =130/85). The corresponding multivariable-adjusted attributable risk percent
  associated with elevated total cholesterol (> or =200 mg/dL) was 27% in men
  and 34% in women. Recommended guidelines of blood pressure, total
  cholesterol, and LDL cholesterol effectively predict CHD risk in a
  middle-aged white population sample. A simple coronary disease prediction
  algorithm was developed using categorical variables, which allows physicians
  to predict multivariate CHD risk in patients without overt CHD.%
    }
    \field{issn}{0009-7322}
    \field{issue}{18}
    \field{pages}{1837\bibrangedash 1847}
    \field{title}{Prediction of coronary heart disease using risk factor
  categories.}
    \field{volume}{97}
    \verb{file}
    \verb :PDFs/wilson1998.pdf:PDF
    \endverb
    \field{journaltitle}{Circulation}
    \field{month}{05}
    \field{year}{1998}
  \endentry

  \entry{Conroy2003}{article}{}
    \name{author}{20}{}{%
      {{hash=CRM}{%
         family={Conroy},
         familyi={C\bibinitperiod},
         given={R\bibnamedelima M},
         giveni={R\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=PK}{%
         family={Pyörälä},
         familyi={P\bibinitperiod},
         given={K},
         giveni={K},
      }}%
      {{hash=FAP}{%
         family={Fitzgerald},
         familyi={F\bibinitperiod},
         given={A\bibnamedelima P},
         giveni={A\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=SS}{%
         family={Sans},
         familyi={S\bibinitperiod},
         given={S},
         giveni={S},
      }}%
      {{hash=MA}{%
         family={Menotti},
         familyi={M\bibinitperiod},
         given={A},
         giveni={A},
      }}%
      {{hash=DBG}{%
         family={De\bibnamedelima Backer},
         familyi={D\bibinitperiod\bibinitdelim B\bibinitperiod},
         given={G},
         giveni={G},
      }}%
      {{hash=DBD}{%
         family={De\bibnamedelima Bacquer},
         familyi={D\bibinitperiod\bibinitdelim B\bibinitperiod},
         given={D},
         giveni={D},
      }}%
      {{hash=DP}{%
         family={Ducimetière},
         familyi={D\bibinitperiod},
         given={P},
         giveni={P},
      }}%
      {{hash=JP}{%
         family={Jousilahti},
         familyi={J\bibinitperiod},
         given={P},
         giveni={P},
      }}%
      {{hash=KU}{%
         family={Keil},
         familyi={K\bibinitperiod},
         given={U},
         giveni={U},
      }}%
      {{hash=NI}{%
         family={Njølstad},
         familyi={N\bibinitperiod},
         given={I},
         giveni={I},
      }}%
      {{hash=ORG}{%
         family={Oganov},
         familyi={O\bibinitperiod},
         given={R\bibnamedelima G},
         giveni={R\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=TT}{%
         family={Thomsen},
         familyi={T\bibinitperiod},
         given={T},
         giveni={T},
      }}%
      {{hash=TPH}{%
         family={Tunstall-Pedoe},
         familyi={T\bibinithyphendelim P\bibinitperiod},
         given={H},
         giveni={H},
      }}%
      {{hash=TA}{%
         family={Tverdal},
         familyi={T\bibinitperiod},
         given={A},
         giveni={A},
      }}%
      {{hash=WH}{%
         family={Wedel},
         familyi={W\bibinitperiod},
         given={H},
         giveni={H},
      }}%
      {{hash=WP}{%
         family={Whincup},
         familyi={W\bibinitperiod},
         given={P},
         giveni={P},
      }}%
      {{hash=WL}{%
         family={Wilhelmsen},
         familyi={W\bibinitperiod},
         given={L},
         giveni={L},
      }}%
      {{hash=GIM}{%
         family={Graham},
         familyi={G\bibinitperiod},
         given={I\bibnamedelima M},
         giveni={I\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=pgS}{%
         prefix={project},
         prefixi={p\bibinitperiod},
         family={group},
         familyi={g\bibinitperiod},
         given={SCORE},
         giveni={S\bibinitperiod},
      }}%
    }
    \keyw{Adult; Age Distribution; Aged; Aged, 80 and over; Cardiovascular
  Diseases, mortality; Coronary Disease, mortality; Diabetic Angiopathies,
  mortality; Epidemiologic Methods; Europe, epidemiology; Humans; Male; Middle
  Aged}
    \strng{namehash}{CRM+1}
    \strng{fullhash}{CRMPKFAPSSMADBGDBDDPJPKUNIORGTTTPHTAWHWPWLGIMgSp1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    The SCORE project was initiated to develop a risk scoring system for use in
  the clinical management of cardiovascular risk in European clinical practice.
  The project assembled a pool of datasets from 12 European cohort studies,
  mainly carried out in general population settings. There were 20,5178 persons
  (88,080 women and 11,7098 men) representing 2.7 million person years of
  follow-up. There were 7934 cardiovascular deaths, of which 5652 were deaths
  from coronary heart disease. Ten-year risk of fatal cardiovascular disease
  was calculated using a Weibull model in which age was used as a measure of
  exposure time to risk rather than as a risk factor. Separate estimation
  equations were calculated for coronary heart disease and for non-coronary
  cardiovascular disease. These were calculated for high-risk and low-risk
  regions of Europe. Two parallel estimation models were developed, one based
  on total cholesterol and the other on total cholesterol/HDL cholesterol
  ratio. The risk estimations are displayed graphically in simple risk charts.
  Predictive value of the risk charts was examined by applying them to persons
  aged 45-64; areas under ROC curves ranged from 0.71 to 0.84. The SCORE risk
  estimation system offers direct estimation of total fatal cardiovascular risk
  in a format suited to the constraints of clinical practice.%
    }
    \field{issn}{0195-668X}
    \field{issue}{11}
    \field{pages}{987\bibrangedash 1003}
    \field{title}{Estimation of ten-year risk of fatal cardiovascular disease
  in Europe: the SCORE project.}
    \field{volume}{24}
    \verb{file}
    \verb :PDFs/conroy2003.pdf:PDF
    \endverb
    \field{journaltitle}{European heart journal}
    \field{month}{06}
    \field{year}{2003}
  \endentry

  \entry{DAgostino2008}{article}{}
    \name{author}{7}{}{%
      {{hash=DRB}{%
         family={D'Agostino},
         familyi={D\bibinitperiod},
         given={Ralph\bibnamedelima B},
         giveni={R\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=VRS}{%
         family={Vasan},
         familyi={V\bibinitperiod},
         given={Ramachandran\bibnamedelima S},
         giveni={R\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=PMJ}{%
         family={Pencina},
         familyi={P\bibinitperiod},
         given={Michael\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=WPA}{%
         family={Wolf},
         familyi={W\bibinitperiod},
         given={Philip\bibnamedelima A},
         giveni={P\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=CM}{%
         family={Cobain},
         familyi={C\bibinitperiod},
         given={Mark},
         giveni={M\bibinitperiod},
      }}%
      {{hash=MJM}{%
         family={Massaro},
         familyi={M\bibinitperiod},
         given={Joseph\bibnamedelima M},
         giveni={J\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=KWB}{%
         family={Kannel},
         familyi={K\bibinitperiod},
         given={William\bibnamedelima B},
         giveni={W\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
    }
    \keyw{Adult; Aged; Algorithms; Cardiovascular Diseases; Female; Humans;
  Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Primary
  Health Care; Proportional Hazards Models; Risk Assessment, methods; Risk
  Factors; Sex Factors}
    \strng{namehash}{DRB+2}
    \strng{fullhash}{DRBVRSPMJWPACMMJMKWB1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Separate multivariable risk algorithms are commonly used to assess risk of
  specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary
  heart disease, cerebrovascular disease, peripheral vascular disease, and
  heart failure. The present report presents a single multivariable risk
  function that predicts risk of developing all CVD and of its constituents. We
  used Cox proportional-hazards regression to evaluate the risk of developing a
  first CVD event in 8491 Framingham study participants (mean age, 49 years;
  4522 women) who attended a routine examination between 30 and 74 years of age
  and were free of CVD. Sex-specific multivariable risk functions ("general
  CVD" algorithms) were derived that incorporated age, total and high-density
  lipoprotein cholesterol, systolic blood pressure, treatment for hypertension,
  smoking, and diabetes status. We assessed the performance of the general CVD
  algorithms for predicting individual CVD events (coronary heart disease,
  stroke, peripheral artery disease, or heart failure). Over 12 years of
  follow-up, 1174 participants (456 women) developed a first CVD event. All
  traditional risk factors evaluated predicted CVD risk (multivariable-adjusted
  P<0.0001). The general CVD algorithm demonstrated good discrimination (C
  statistic, 0.763 [men] and 0.793 [women]) and calibration. Simple adjustments
  to the general CVD risk algorithms allowed estimation of the risks of each
  CVD component. Two simple risk scores are presented, 1 based on all
  traditional risk factors and the other based on non-laboratory-based
  predictors. A sex-specific multivariable risk factor algorithm can be
  conveniently used to assess general CVD risk and risk of individual CVD
  events (coronary, cerebrovascular, and peripheral arterial disease and heart
  failure). The estimated absolute CVD event rates can be used to quantify risk
  and to guide preventive care.%
    }
    \verb{doi}
    \verb 10.1161/CIRCULATIONAHA.107.699579
    \endverb
    \field{issn}{1524-4539}
    \field{issue}{6}
    \field{pages}{743\bibrangedash 753}
    \field{title}{General cardiovascular risk profile for use in primary care:
  the Framingham Heart Study.}
    \field{volume}{117}
    \verb{file}
    \verb :PDFs/dagostino2008.pdf:PDF
    \endverb
    \field{journaltitle}{Circulation}
    \field{month}{02}
    \field{year}{2008}
  \endentry

  \entry{Goff2014}{article}{}
    \name{author}{36}{}{%
      {{hash=GDC}{%
         family={Goff},
         familyi={G\bibinitperiod},
         given={David\bibnamedelima C},
         giveni={D\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=LJDM}{%
         family={Lloyd-Jones},
         familyi={L\bibinithyphendelim J\bibinitperiod},
         given={Donald\bibnamedelima M},
         giveni={D\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=BG}{%
         family={Bennett},
         familyi={B\bibinitperiod},
         given={Glen},
         giveni={G\bibinitperiod},
      }}%
      {{hash=CS}{%
         family={Coady},
         familyi={C\bibinitperiod},
         given={Sean},
         giveni={S\bibinitperiod},
      }}%
      {{hash=DRB}{%
         family={D'Agostino},
         familyi={D\bibinitperiod},
         given={Ralph\bibnamedelima B},
         giveni={R\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=GR}{%
         family={Gibbons},
         familyi={G\bibinitperiod},
         given={Raymond},
         giveni={R\bibinitperiod},
      }}%
      {{hash=GP}{%
         family={Greenland},
         familyi={G\bibinitperiod},
         given={Philip},
         giveni={P\bibinitperiod},
      }}%
      {{hash=LDT}{%
         family={Lackland},
         familyi={L\bibinitperiod},
         given={Daniel\bibnamedelima T},
         giveni={D\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
      {{hash=LD}{%
         family={Levy},
         familyi={L\bibinitperiod},
         given={Daniel},
         giveni={D\bibinitperiod},
      }}%
      {{hash=OCJ}{%
         family={O'Donnell},
         familyi={O\bibinitperiod},
         given={Christopher\bibnamedelima J},
         giveni={C\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=RJG}{%
         family={Robinson},
         familyi={R\bibinitperiod},
         given={Jennifer\bibnamedelima G},
         giveni={J\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=SJS}{%
         family={Schwartz},
         familyi={S\bibinitperiod},
         given={J\bibnamedelima Sanford},
         giveni={J\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=SST}{%
         family={Shero},
         familyi={S\bibinitperiod},
         given={Susan\bibnamedelima T},
         giveni={S\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
      {{hash=SSC}{%
         family={Smith},
         familyi={S\bibinitperiod},
         given={Sidney\bibnamedelima C},
         giveni={S\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=SP}{%
         family={Sorlie},
         familyi={S\bibinitperiod},
         given={Paul},
         giveni={P\bibinitperiod},
      }}%
      {{hash=SNJ}{%
         family={Stone},
         familyi={S\bibinitperiod},
         given={Neil\bibnamedelima J},
         giveni={N\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=WPWF}{%
         family={Wilson},
         familyi={W\bibinitperiod},
         given={Peter W\bibnamedelima F},
         giveni={P\bibinitperiod\bibinitdelim W\bibinitperiod\bibinitdelim
  F\bibinitperiod},
      }}%
      {{hash=JHS}{%
         family={Jordan},
         familyi={J\bibinitperiod},
         given={Harmon\bibnamedelima S},
         giveni={H\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=NL}{%
         family={Nevo},
         familyi={N\bibinitperiod},
         given={Lev},
         giveni={L\bibinitperiod},
      }}%
      {{hash=WJ}{%
         family={Wnek},
         familyi={W\bibinitperiod},
         given={Janusz},
         giveni={J\bibinitperiod},
      }}%
      {{hash=AJL}{%
         family={Anderson},
         familyi={A\bibinitperiod},
         given={Jeffrey\bibnamedelima L},
         giveni={J\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=HJL}{%
         family={Halperin},
         familyi={H\bibinitperiod},
         given={Jonathan\bibnamedelima L},
         giveni={J\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=ANM}{%
         family={Albert},
         familyi={A\bibinitperiod},
         given={Nancy\bibnamedelima M},
         giveni={N\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=BB}{%
         family={Bozkurt},
         familyi={B\bibinitperiod},
         given={Biykem},
         giveni={B\bibinitperiod},
      }}%
      {{hash=BRG}{%
         family={Brindis},
         familyi={B\bibinitperiod},
         given={Ralph\bibnamedelima G},
         giveni={R\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=CLH}{%
         family={Curtis},
         familyi={C\bibinitperiod},
         given={Lesley\bibnamedelima H},
         giveni={L\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=DD}{%
         family={DeMets},
         familyi={D\bibinitperiod},
         given={David},
         giveni={D\bibinitperiod},
      }}%
      {{hash=HJS}{%
         family={Hochman},
         familyi={H\bibinitperiod},
         given={Judith\bibnamedelima S},
         giveni={J\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=KRJ}{%
         family={Kovacs},
         familyi={K\bibinitperiod},
         given={Richard\bibnamedelima J},
         giveni={R\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=OEM}{%
         family={Ohman},
         familyi={O\bibinitperiod},
         given={E\bibnamedelima Magnus},
         giveni={E\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=PSJ}{%
         family={Pressler},
         familyi={P\bibinitperiod},
         given={Susan\bibnamedelima J},
         giveni={S\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=SFW}{%
         family={Sellke},
         familyi={S\bibinitperiod},
         given={Frank\bibnamedelima W},
         giveni={F\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
      {{hash=SWK}{%
         family={Shen},
         familyi={S\bibinitperiod},
         given={Win-Kuang},
         giveni={W\bibinithyphendelim K\bibinitperiod},
      }}%
      {{hash=SSC}{%
         family={Smith},
         familyi={S\bibinitperiod},
         given={Sidney\bibnamedelima C},
         giveni={S\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=TGF}{%
         family={Tomaselli},
         familyi={T\bibinitperiod},
         given={Gordon\bibnamedelima F},
         giveni={G\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=oCHATFoPGAC}{%
         prefix={of\bibnamedelima Cardiology/American Heart Association Task
  Force\bibnamedelima on},
         prefixi={o\bibinitperiod\bibinitdelim C\bibinitperiod\bibinitdelim
  H\bibinitperiod\bibinitdelim A\bibinitperiod\bibinitdelim
  T\bibinitperiod\bibinitdelim F\bibinitperiod\bibinitdelim o\bibinitperiod},
         family={Practice\bibnamedelima Guidelines},
         familyi={P\bibinitperiod\bibinitdelim G\bibinitperiod},
         given={American\bibnamedelima College},
         giveni={A\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
    }
    \keyw{American Heart Association; Cardiovascular Diseases, classification,
  diagnosis, epidemiology; Continental Population Groups; Female; Humans; Male;
  Risk Assessment; Sex Factors; Time Factors; United States; AHA Scientific
  Statements; biomarkers; cardiovascular disease; cholesterol; primary
  prevention; risk assessment; risk reduction behavior}
    \strng{namehash}{GDC+1}
  \strng{fullhash}{GDCLJDMBGCSDRBGRGPLDTLDOCJRJGSJSSSTSSCSPSNJWPWFJHSNLWJAJLHJLANMBBBRGCLHDDHJSKRJOEMPSJSFWSWKSSCTGFPGACoCHATFo1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1161/01.cir.0000437741.48606.98
    \endverb
    \field{issn}{1524-4539}
    \field{issue}{25 Suppl 2}
    \field{pages}{S49\bibrangedash S73}
    \field{title}{2013 ACC/AHA guideline on the assessment of cardiovascular
  risk: a report of the American College of Cardiology/American Heart
  Association Task Force on Practice Guidelines.}
    \field{volume}{129}
    \verb{file}
    \verb :PDFs/goff2013.pdf:PDF
    \endverb
    \field{journaltitle}{Circulation}
    \field{month}{06}
    \field{year}{2014}
  \endentry

  \entry{Graham2007}{article}{}
    \name{author}{30}{}{%
      {{hash=GI}{%
         family={Graham},
         familyi={G\bibinitperiod},
         given={Ian},
         giveni={I\bibinitperiod},
      }}%
      {{hash=AD}{%
         family={Atar},
         familyi={A\bibinitperiod},
         given={Dan},
         giveni={D\bibinitperiod},
      }}%
      {{hash=BJK}{%
         family={Borch-Johnsen},
         familyi={B\bibinithyphendelim J\bibinitperiod},
         given={Knut},
         giveni={K\bibinitperiod},
      }}%
      {{hash=BG}{%
         family={Boysen},
         familyi={B\bibinitperiod},
         given={Gudrun},
         giveni={G\bibinitperiod},
      }}%
      {{hash=BG}{%
         family={Burell},
         familyi={B\bibinitperiod},
         given={Gunilla},
         giveni={G\bibinitperiod},
      }}%
      {{hash=CR}{%
         family={Cifkova},
         familyi={C\bibinitperiod},
         given={Renata},
         giveni={R\bibinitperiod},
      }}%
      {{hash=DJ}{%
         family={Dallongeville},
         familyi={D\bibinitperiod},
         given={Jean},
         giveni={J\bibinitperiod},
      }}%
      {{hash=DBG}{%
         family={De\bibnamedelima Backer},
         familyi={D\bibinitperiod\bibinitdelim B\bibinitperiod},
         given={Guy},
         giveni={G\bibinitperiod},
      }}%
      {{hash=ES}{%
         family={Ebrahim},
         familyi={E\bibinitperiod},
         given={Shah},
         giveni={S\bibinitperiod},
      }}%
      {{hash=GB}{%
         family={Gjelsvik},
         familyi={G\bibinitperiod},
         given={Bjørn},
         giveni={B\bibinitperiod},
      }}%
      {{hash=HLC}{%
         family={Herrmann-Lingen},
         familyi={H\bibinithyphendelim L\bibinitperiod},
         given={Christoph},
         giveni={C\bibinitperiod},
      }}%
      {{hash=HA}{%
         family={Hoes},
         familyi={H\bibinitperiod},
         given={Arno},
         giveni={A\bibinitperiod},
      }}%
      {{hash=HS}{%
         family={Humphries},
         familyi={H\bibinitperiod},
         given={Steve},
         giveni={S\bibinitperiod},
      }}%
      {{hash=KM}{%
         family={Knapton},
         familyi={K\bibinitperiod},
         given={Mike},
         giveni={M\bibinitperiod},
      }}%
      {{hash=PJ}{%
         family={Perk},
         familyi={P\bibinitperiod},
         given={Joep},
         giveni={J\bibinitperiod},
      }}%
      {{hash=PSG}{%
         family={Priori},
         familyi={P\bibinitperiod},
         given={Silvia\bibnamedelima G},
         giveni={S\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=PK}{%
         family={Pyorala},
         familyi={P\bibinitperiod},
         given={Kalevi},
         giveni={K\bibinitperiod},
      }}%
      {{hash=RZ}{%
         family={Reiner},
         familyi={R\bibinitperiod},
         given={Zeljko},
         giveni={Z\bibinitperiod},
      }}%
      {{hash=RL}{%
         family={Ruilope},
         familyi={R\bibinitperiod},
         given={Luis},
         giveni={L\bibinitperiod},
      }}%
      {{hash=SMS}{%
         family={Sans-Menendez},
         familyi={S\bibinithyphendelim M\bibinitperiod},
         given={Susana},
         giveni={S\bibinitperiod},
      }}%
      {{hash=SoRW}{%
         prefix={Scholte\bibnamedelima op},
         prefixi={S\bibinitperiod\bibinitdelim o\bibinitperiod},
         family={Reimer},
         familyi={R\bibinitperiod},
         given={Wilma},
         giveni={W\bibinitperiod},
      }}%
      {{hash=WP}{%
         family={Weissberg},
         familyi={W\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
      {{hash=WD}{%
         family={Wood},
         familyi={W\bibinitperiod},
         given={David},
         giveni={D\bibinitperiod},
      }}%
      {{hash=YJ}{%
         family={Yarnell},
         familyi={Y\bibinitperiod},
         given={John},
         giveni={J\bibinitperiod},
      }}%
      {{hash=ZJL}{%
         family={Zamorano},
         familyi={Z\bibinitperiod},
         given={Jose\bibnamedelima Luis},
         giveni={J\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=WE}{%
         family={Walma},
         familyi={W\bibinitperiod},
         given={Edmond},
         giveni={E\bibinitperiod},
      }}%
      {{hash=FT}{%
         family={Fitzgerald},
         familyi={F\bibinitperiod},
         given={Tony},
         giveni={T\bibinitperiod},
      }}%
      {{hash=CMT}{%
         family={Cooney},
         familyi={C\bibinitperiod},
         given={Marie\bibnamedelima Therese},
         giveni={M\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
      {{hash=DA}{%
         family={Dudina},
         familyi={D\bibinitperiod},
         given={Alexandra},
         giveni={A\bibinitperiod},
      }}%
      {{hash=oCECfPGCES}{%
         prefix={of\bibnamedelima Cardiology (ESC) Committee\bibnamedelima
  for},
         prefixi={o\bibinitperiod\bibinitdelim C\bibinitperiod\bibinitdelim
  E\bibinitperiod\bibinitdelim C\bibinitperiod\bibinitdelim f\bibinitperiod},
         family={Practice Guidelines\bibnamedelima (CPG)},
         familyi={P\bibinitperiod\bibinitdelim G\bibinitperiod\bibinitdelim
  C\bibinitperiod},
         given={European\bibnamedelima Society},
         giveni={E\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
    }
    \keyw{Biomarkers, blood; Blood Pressure, physiology; Body Weight;
  Cardiovascular Agents, therapeutic use; Cardiovascular Diseases, etiology,
  physiopathology, prevention & control; Diabetic Angiopathies, prevention &
  control; Diagnostic Imaging; Europe; Evaluation Studies as Topic;
  Evidence-Based Medicine; Exercise; Health Policy; Heart Rate, physiology;
  Humans; Life Style; Lipids, blood; Metabolic Syndrome, prevention & control;
  Nutritional Status; Obesity, prevention & control; Pedigree; Risk Assessment,
  methods; Sex Factors; Smoking Prevention}
    \strng{namehash}{GI+1}
  \strng{fullhash}{GIADBJKBGBGCRDJDBGESGBHLCHAHSKMPJPSGPKRZRLSMSRWSoWPWDYJZJLWEFTCMTDAPGCESoCECf1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1093/eurheartj/ehm316
    \endverb
    \field{issn}{0195-668X}
    \field{issue}{19}
    \field{pages}{2375\bibrangedash 2414}
    \field{title}{European guidelines on cardiovascular disease prevention in
  clinical practice: executive summary: Fourth Joint Task Force of the European
  Society of Cardiology and Other Societies on Cardiovascular Disease
  Prevention in Clinical Practice (Constituted by representatives of nine
  societies and by invited experts).}
    \field{volume}{28}
    \verb{file}
    \verb :PDFs/graham2007.pdf:PDF
    \endverb
    \field{journaltitle}{European heart journal}
    \field{month}{10}
    \field{year}{2007}
  \endentry

  \entry{Koton2014}{article}{}
    \name{author}{7}{}{%
      {{hash=KS}{%
         family={Koton},
         familyi={K\bibinitperiod},
         given={Silvia},
         giveni={S\bibinitperiod},
      }}%
      {{hash=SALC}{%
         family={Schneider},
         familyi={S\bibinitperiod},
         given={Andrea L\bibnamedelima C},
         giveni={A\bibinitperiod\bibinitdelim L\bibinitperiod\bibinitdelim
  C\bibinitperiod},
      }}%
      {{hash=RWD}{%
         family={Rosamond},
         familyi={R\bibinitperiod},
         given={Wayne\bibnamedelima D},
         giveni={W\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=SE}{%
         family={Shahar},
         familyi={S\bibinitperiod},
         given={Eyal},
         giveni={E\bibinitperiod},
      }}%
      {{hash=SY}{%
         family={Sang},
         familyi={S\bibinitperiod},
         given={Yingying},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=GRF}{%
         family={Gottesman},
         familyi={G\bibinitperiod},
         given={Rebecca\bibnamedelima F},
         giveni={R\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=CJ}{%
         family={Coresh},
         familyi={C\bibinitperiod},
         given={Josef},
         giveni={J\bibinitperiod},
      }}%
    }
    \keyw{African Continental Ancestry Group, statistics & numerical data;
  Aged; Brain Ischemia, complications, ethnology, mortality; Cardiovascular
  Diseases, epidemiology; Cerebral Hemorrhage, ethnology, mortality; Cohort
  Studies; European Continental Ancestry Group, statistics & numerical data;
  Female; Hospitalization, statistics & numerical data; Humans; Incidence;
  Male; Middle Aged; Mortality, trends; Risk Factors; Sex Factors; Stroke,
  ethnology, mortality; United States, epidemiology}
    \strng{namehash}{KS+1}
    \strng{fullhash}{KSSALCRWDSESYGRFCJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Prior studies have shown decreases in stroke mortality over time, but data
  on validated stroke incidence and long-term trends by race are limited. To
  study trends in stroke incidence and subsequent mortality among black and
  white adults in the Atherosclerosis Risk in Communities (ARIC) cohort from
  1987 to 2011. Prospective cohort study of 14,357 participants (282,097
  person-years) free of stroke at baseline was facilitated in 4 different US
  communities. Participants were recruited for the purpose of studying all
  stroke hospitalizations and deaths and for collection of baseline information
  on cardiovascular risk factors (via interviews and physical examinations) in
  1987-1989. Participants were followed up (via examinations, annual phone
  interviews, active surveillance of discharges from local hospitals, and
  linkage with the National Death Index) through December 31, 2011. The study
  physician reviewers adjudicated all possible strokes and classified them as
  definite or probable ischemic or hemorrhagic events. Trends in rates of
  first-ever stroke per 10 years of calendar time were estimated using Poisson
  regression incidence rate ratios (IRRs), with subsequent mortality analyzed
  using Cox proportional hazards regression models and hazard ratios (HRs)
  overall and by race, sex, and age divided at 65 years. Among 1051 (7%)
  participants with incident stroke, there were 929 with incident ischemic
  stroke and 140 with incident hemorrhagic stroke (18 participants had both
  during the study period). Crude incidence rates were 3.73 (95% CI, 3.51-3.96)
  per 1000 person-years for total stroke, 3.29 (95% CI, 3.08-3.50) per 1000
  person-years for ischemic stroke, and 0.49 (95% CI, 0.41-0.57) per 1000
  person-years for hemorrhagic stroke. Stroke incidence decreased over time in
  white and black participants (age-adjusted IRRs per 10-year period, 0.76 [95%
  CI, 0.66-0.87]; absolute decrease of 0.93 per 1000 person-years overall). The
  decrease in age-adjusted incidence was evident in participants age 65 years
  and older (age-adjusted IRR per 10-year period, 0.69 [95% CI, 0.59-0.81];
  absolute decrease of 1.35 per 1000 person-years) but not evident in
  participants younger than 65 years (age-adjusted IRR per 10-year period, 0.97
  [95% CI, 0.76-1.25]; absolute decrease of 0.09 per 1000 person-years)
  (P = .02 for interaction). The decrease in incidence was similar by sex.
  Of participants with incident stroke, 614 (58%) died through 2011. The
  mortality rate was higher for hemorrhagic stroke (68%) than for ischemic
  stroke (57%). Overall, mortality after stroke decreased over time (hazard
  ratio [HR], 0.80 [95% CI, 0.66-0.98]; absolute decrease of 8.09 per 100
  strokes after 10 years [per 10-year period]). The decrease in mortality was
  mostly accounted for by the decrease at younger than age 65 years (HR, 0.65
  [95% CI, 0.46-0.93]; absolute decrease of 14.19 per 100 strokes after 10
  years [per 10-year period]), but was similar across race and sex. In a
  multicenter cohort of black and white adults in US communities, stroke
  incidence and mortality rates decreased from 1987 to 2011. The decreases
  varied across age groups, but were similar across sex and race, showing that
  improvements in stroke incidence and outcome continued to 2011.%
    }
    \verb{doi}
    \verb 10.1001/jama.2014.7692
    \endverb
    \field{issn}{1538-3598}
    \field{issue}{3}
    \field{pages}{259\bibrangedash 268}
    \field{title}{Stroke incidence and mortality trends in US communities, 1987
  to 2011.}
    \field{volume}{312}
    \verb{file}
    \verb :PDFs/kroton2014.pdf:PDF
    \endverb
    \field{journaltitle}{JAMA}
    \field{month}{07}
    \field{year}{2014}
  \endentry

  \entry{Vangen-Loenne2017}{article}{}
    \name{author}{6}{}{%
      {{hash=VLAM}{%
         family={Vangen-Lønne},
         familyi={V\bibinithyphendelim L\bibinitperiod},
         given={Anne\bibnamedelima M},
         giveni={A\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=WT}{%
         family={Wilsgaard},
         familyi={W\bibinitperiod},
         given={Tom},
         giveni={T\bibinitperiod},
      }}%
      {{hash=JSH}{%
         family={Johnsen},
         familyi={J\bibinitperiod},
         given={Stein\bibnamedelima Harald},
         giveni={S\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=LML}{%
         family={Løchen},
         familyi={L\bibinitperiod},
         given={Maja-Lisa},
         giveni={M\bibinithyphendelim L\bibinitperiod},
      }}%
      {{hash=NI}{%
         family={Njølstad},
         familyi={N\bibinitperiod},
         given={Inger},
         giveni={I\bibinitperiod},
      }}%
      {{hash=MEB}{%
         family={Mathiesen},
         familyi={M\bibinitperiod},
         given={Ellisiv\bibnamedelima B},
         giveni={E\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
    }
    \keyw{Adult; Aged; Brain Ischemia, epidemiology; Diabetes Mellitus,
  epidemiology; Dyslipidemias, epidemiology; Female; Follow-Up Studies; Humans;
  Hypertension, epidemiology; Incidence; Male; Middle Aged; Norway,
  epidemiology; Obesity, epidemiology; Prevalence; Risk Factors; Smoking,
  epidemiology; Stroke, epidemiology; cohort study; epidemiology; ischemic
  stroke; risk factors; time trends}
    \strng{namehash}{VLAM+1}
    \strng{fullhash}{VLAMWTJSHLMLNIMEB1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    It is proposed that 20% to 40% of the decline in first-ever stroke
  incidence is attributed to the improvement of risk factor control. We
  estimated the impact of modifiable cardiovascular risk factors on the
  changing incidence of ischemic stroke (IS) between 1995 and 2012, using
  individual person data from repeated surveys in a general population. The
  proportion of the IS incidence decline explained by change in each risk
  factor over time was estimated from 1995 to 2012 by Poisson regression among
  26 329 participants who attended the fourth Tromsø survey in 1994 to 1995.
  Hazard ratios for IS were estimated with Cox proportional hazards regression
  among 27 936 participants who attended at least 1 of the Tromsø surveys in
  1994 to 1995, 2001, or 2007 to 2008. Age- and sex-adjusted means or
  prevalences of risk factors over time were estimated by generalized
  estimating equations. There were 1226 first-ever IS during 367 636
  person-years of follow-up. Changes in cardiovascular risk factors accounted
  for 57% of the decrease in IS incidence from 1995 to 2012. The most important
  contributors were decreasing mean systolic blood pressure and smoking
  prevalence, accounting for 26% and 17% of the observed decline, respectively.
  Conversely, increasing diabetes mellitus prevalence contributed negatively to
  the declining IS incidence. Changes in cardiovascular risk factors explained
  57% of the decrease in IS incidence from 1995 to 2012. Reduction in systolic
  blood pressure and prevalence of smoking were the most important
  contributors.%
    }
    \verb{doi}
    \verb 10.1161/STROKEAHA.116.014377
    \endverb
    \field{issn}{1524-4628}
    \field{issue}{3}
    \field{pages}{544\bibrangedash 550}
    \field{title}{Declining Incidence of Ischemic Stroke: What Is the Impact of
  Changing Risk Factors? The Tromsø Study 1995 to 2012.}
    \field{volume}{48}
    \verb{file}
    \verb :PDFs/544.full.pdf:PDF
    \endverb
    \field{journaltitle}{Stroke}
    \field{month}{03}
    \field{year}{2017}
  \endentry

  \entry{ODonnell2016}{article}{}
    \name{author}{47}{}{%
      {{hash=OMJ}{%
         family={O'Donnell},
         familyi={O\bibinitperiod},
         given={Martin\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=CSL}{%
         family={Chin},
         familyi={C\bibinitperiod},
         given={Siu\bibnamedelima Lim},
         giveni={S\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=RS}{%
         family={Rangarajan},
         familyi={R\bibinitperiod},
         given={Sumathy},
         giveni={S\bibinitperiod},
      }}%
      {{hash=XD}{%
         family={Xavier},
         familyi={X\bibinitperiod},
         given={Denis},
         giveni={D\bibinitperiod},
      }}%
      {{hash=LL}{%
         family={Liu},
         familyi={L\bibinitperiod},
         given={Lisheng},
         giveni={L\bibinitperiod},
      }}%
      {{hash=ZH}{%
         family={Zhang},
         familyi={Z\bibinitperiod},
         given={Hongye},
         giveni={H\bibinitperiod},
      }}%
      {{hash=RMP}{%
         family={Rao-Melacini},
         familyi={R\bibinithyphendelim M\bibinitperiod},
         given={Purnima},
         giveni={P\bibinitperiod},
      }}%
      {{hash=ZX}{%
         family={Zhang},
         familyi={Z\bibinitperiod},
         given={Xiaohe},
         giveni={X\bibinitperiod},
      }}%
      {{hash=PP}{%
         family={Pais},
         familyi={P\bibinitperiod},
         given={Prem},
         giveni={P\bibinitperiod},
      }}%
      {{hash=AS}{%
         family={Agapay},
         familyi={A\bibinitperiod},
         given={Steven},
         giveni={S\bibinitperiod},
      }}%
      {{hash=LJP}{%
         family={Lopez-Jaramillo},
         familyi={L\bibinithyphendelim J\bibinitperiod},
         given={Patricio},
         giveni={P\bibinitperiod},
      }}%
      {{hash=DA}{%
         family={Damasceno},
         familyi={D\bibinitperiod},
         given={Albertino},
         giveni={A\bibinitperiod},
      }}%
      {{hash=LP}{%
         family={Langhorne},
         familyi={L\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
      {{hash=MMJ}{%
         family={McQueen},
         familyi={M\bibinitperiod},
         given={Matthew\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=RA}{%
         family={Rosengren},
         familyi={R\bibinitperiod},
         given={Annika},
         giveni={A\bibinitperiod},
      }}%
      {{hash=DM}{%
         family={Dehghan},
         familyi={D\bibinitperiod},
         given={Mahshid},
         giveni={M\bibinitperiod},
      }}%
      {{hash=HGJ}{%
         family={Hankey},
         familyi={H\bibinitperiod},
         given={Graeme\bibnamedelima J},
         giveni={G\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=DAL}{%
         family={Dans},
         familyi={D\bibinitperiod},
         given={Antonio\bibnamedelima L},
         giveni={A\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=EA}{%
         family={Elsayed},
         familyi={E\bibinitperiod},
         given={Ahmed},
         giveni={A\bibinitperiod},
      }}%
      {{hash=AA}{%
         family={Avezum},
         familyi={A\bibinitperiod},
         given={Alvaro},
         giveni={A\bibinitperiod},
      }}%
      {{hash=MC}{%
         family={Mondo},
         familyi={M\bibinitperiod},
         given={Charles},
         giveni={C\bibinitperiod},
      }}%
      {{hash=DHC}{%
         family={Diener},
         familyi={D\bibinitperiod},
         given={Hans-Christoph},
         giveni={H\bibinithyphendelim C\bibinitperiod},
      }}%
      {{hash=RD}{%
         family={Ryglewicz},
         familyi={R\bibinitperiod},
         given={Danuta},
         giveni={D\bibinitperiod},
      }}%
      {{hash=CA}{%
         family={Czlonkowska},
         familyi={C\bibinitperiod},
         given={Anna},
         giveni={A\bibinitperiod},
      }}%
      {{hash=PN}{%
         family={Pogosova},
         familyi={P\bibinitperiod},
         given={Nana},
         giveni={N\bibinitperiod},
      }}%
      {{hash=WC}{%
         family={Weimar},
         familyi={W\bibinitperiod},
         given={Christian},
         giveni={C\bibinitperiod},
      }}%
      {{hash=IR}{%
         family={Iqbal},
         familyi={I\bibinitperiod},
         given={Romaina},
         giveni={R\bibinitperiod},
      }}%
      {{hash=DR}{%
         family={Diaz},
         familyi={D\bibinitperiod},
         given={Rafael},
         giveni={R\bibinitperiod},
      }}%
      {{hash=YK}{%
         family={Yusoff},
         familyi={Y\bibinitperiod},
         given={Khalid},
         giveni={K\bibinitperiod},
      }}%
      {{hash=YA}{%
         family={Yusufali},
         familyi={Y\bibinitperiod},
         given={Afzalhussein},
         giveni={A\bibinitperiod},
      }}%
      {{hash=OA}{%
         family={Oguz},
         familyi={O\bibinitperiod},
         given={Aytekin},
         giveni={A\bibinitperiod},
      }}%
      {{hash=WX}{%
         family={Wang},
         familyi={W\bibinitperiod},
         given={Xingyu},
         giveni={X\bibinitperiod},
      }}%
      {{hash=PE}{%
         family={Penaherrera},
         familyi={P\bibinitperiod},
         given={Ernesto},
         giveni={E\bibinitperiod},
      }}%
      {{hash=LF}{%
         family={Lanas},
         familyi={L\bibinitperiod},
         given={Fernando},
         giveni={F\bibinitperiod},
      }}%
      {{hash=OOS}{%
         family={Ogah},
         familyi={O\bibinitperiod},
         given={Okechukwu\bibnamedelima S},
         giveni={O\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=OA}{%
         family={Ogunniyi},
         familyi={O\bibinitperiod},
         given={Adesola},
         giveni={A\bibinitperiod},
      }}%
      {{hash=IHK}{%
         family={Iversen},
         familyi={I\bibinitperiod},
         given={Helle\bibnamedelima K},
         giveni={H\bibinitperiod\bibinitdelim K\bibinitperiod},
      }}%
      {{hash=MG}{%
         family={Malaga},
         familyi={M\bibinitperiod},
         given={German},
         giveni={G\bibinitperiod},
      }}%
      {{hash=RZ}{%
         family={Rumboldt},
         familyi={R\bibinitperiod},
         given={Zvonko},
         giveni={Z\bibinitperiod},
      }}%
      {{hash=OS}{%
         family={Oveisgharan},
         familyi={O\bibinitperiod},
         given={Shahram},
         giveni={S\bibinitperiod},
      }}%
      {{hash=AHF}{%
         family={Al\bibnamedelima Hussain},
         familyi={A\bibinitperiod\bibinitdelim H\bibinitperiod},
         given={Fawaz},
         giveni={F\bibinitperiod},
      }}%
      {{hash=MD}{%
         family={Magazi},
         familyi={M\bibinitperiod},
         given={Daliwonga},
         giveni={D\bibinitperiod},
      }}%
      {{hash=NY}{%
         family={Nilanont},
         familyi={N\bibinitperiod},
         given={Yongchai},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=FJ}{%
         family={Ferguson},
         familyi={F\bibinitperiod},
         given={John},
         giveni={J\bibinitperiod},
      }}%
      {{hash=PG}{%
         family={Pare},
         familyi={P\bibinitperiod},
         given={Guillaume},
         giveni={G\bibinitperiod},
      }}%
      {{hash=YS}{%
         family={Yusuf},
         familyi={Y\bibinitperiod},
         given={Salim},
         giveni={S\bibinitperiod},
      }}%
      {{hash=iI}{%
         family={investigators},
         familyi={i\bibinitperiod},
         given={INTERSTROKE},
         giveni={I\bibinitperiod},
      }}%
    }
    \keyw{Adult; Africa, epidemiology; Aged; Alcohol Drinking, adverse effects,
  epidemiology; Apolipoprotein A-I, blood; Apolipoproteins B, blood; Asia,
  epidemiology; Atrial Fibrillation, complications, epidemiology; Australia,
  epidemiology; Biomarkers, blood; Brain Ischemia, blood, complications,
  epidemiology; Case-Control Studies; Cerebral Hemorrhage, blood,
  complications, epidemiology; China, epidemiology; Diabetes Complications,
  epidemiology, prevention & control; Europe, epidemiology; Evidence-Based
  Medicine; Feeding Behavior; Female; Health Behavior; Humans; Hypertension,
  blood, complications, epidemiology; International Cooperation; Male; Middle
  Aged; Middle East, epidemiology; Motor Activity; Obesity, Abdominal,
  complications, epidemiology; Odds Ratio; Risk Factors; Risk Reduction
  Behavior; Self Report; Smoking, adverse effects, epidemiology; Stroke, blood,
  epidemiology, etiology, pathology, prevention & control; Waist-Hip Ratio}
    \strng{namehash}{OMJ+1}
  \strng{fullhash}{OMJCSLRSXDLLZHRMPZXPPASLJPDALPMMJRADMHGJDALEAAAMCDHCRDCAPNWCIRDRYKYAOAWXPELFOOSOAIHKMGRZOSAHFMDNYFJPGYSiI1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Stroke is a leading cause of death and disability, especially in low-income
  and middle-income countries. We sought to quantify the importance of
  potentially modifiable risk factors for stroke in different regions of the
  world, and in key populations and primary pathological subtypes of stroke. We
  completed a standardised international case-control study in 32 countries in
  Asia, America, Europe, Australia, the Middle East, and Africa. Cases were
  patients with acute first stroke (within 5 days of symptom onset and 72 h of
  hospital admission). Controls were hospital-based or community-based
  individuals with no history of stroke, and were matched with cases, recruited
  in a 1:1 ratio, for age and sex. All participants completed a clinical
  assessment and were requested to provide blood and urine samples. Odds ratios
  (OR) and their population attributable risks (PARs) were calculated, with 99%
  confidence intervals. Between Jan 11, 2007, and Aug 8, 2015, 26 919
  participants were recruited from 32 countries (13 447 cases [10 388 with
  ischaemic stroke and 3059 intracerebral haemorrhage] and 13 472 controls).
  Previous history of hypertension or blood pressure of 140/90 mm Hg or higher
  (OR 2·98, 99% CI 2·72-3·28; PAR 47·9%, 99% CI 45·1-50·6), regular
  physical activity (0·60, 0·52-0·70; 35·8%, 27·7-44·7), apolipoprotein
  (Apo)B/ApoA1 ratio (1·84, 1·65-2·06 for highest vs lowest tertile; 26·8%,
  22·2-31·9 for top two tertiles vs lowest tertile), diet (0·60, 0·53-0·67
  for highest vs lowest tertile of modified Alternative Healthy Eating Index
  [mAHEI]; 23·2%, 18·2-28·9 for lowest two tertiles vs highest tertile of
  mAHEI), waist-to-hip ratio (1·44, 1·27-1·64 for highest vs lowest tertile;
  18·6%, 13·3-25·3 for top two tertiles vs lowest), psychosocial factors
  (2·20, 1·78-2·72; 17·4%, 13·1-22·6), current smoking (1·67,
  1·49-1·87; 12·4%, 10·2-14·9), cardiac causes (3·17, 2·68-3·75; 9·1%,
  8·0-10·2), alcohol consumption (2·09, 1·64-2·67 for high or heavy
  episodic intake vs never or former drinker; 5·8%, 3·4-9·7 for current
  alcohol drinker vs never or former drinker), and diabetes mellitus (1·16,
  1·05-1·30; 3·9%, 1·9-7·6) were associated with all stroke. Collectively,
  these risk factors accounted for 90·7% of the PAR for all stroke worldwide
  (91·5% for ischaemic stroke, 87·1% for intracerebral haemorrhage), and were
  consistent across regions (ranging from 82·7% in Africa to 97·4% in
  southeast Asia), sex (90·6% in men and in women), and age groups (92·2% in
  patients aged ≤55 years, 90·0% in patients aged >55 years). We observed
  regional variations in the importance of individual risk factors, which were
  related to variations in the magnitude of ORs (rather than direction, which
  we observed for diet) and differences in prevalence of risk factors among
  regions. Hypertension was more associated with intracerebral haemorrhage than
  with ischaemic stroke, whereas current smoking, diabetes, apolipoproteins,
  and cardiac causes were more associated with ischaemic stroke (p<0·0001).
  Ten potentially modifiable risk factors are collectively associated with
  about 90% of the PAR of stroke in each major region of the world, among
  ethnic groups, in men and women, and in all ages. However, we found important
  regional variations in the relative importance of most individual risk
  factors for stroke, which could contribute to worldwide variations in
  frequency and case-mix of stroke. Our findings support developing both global
  and region-specific programmes to prevent stroke. Canadian Institutes of
  Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke
  Network, Health Research Board Ireland, Swedish Research Council, Swedish
  Heart and Lung Foundation, The Health & Medical Care Committee of the
  Regional Executive Board, Region Västra Götaland (Sweden), AstraZeneca,
  Boehringer Ingelheim (Canada), Pfizer (Canada), MSD, Chest, Heart and Stroke
  Scotland, and The Stroke Association, with support from The UK Stroke
  Research Network.%
    }
    \verb{doi}
    \verb 10.1016/S0140-6736(16)30506-2
    \endverb
    \field{issn}{1474-547X}
    \field{issue}{10046}
    \field{pages}{761\bibrangedash 775}
    \field{title}{Global and regional effects of potentially modifiable risk
  factors associated with acute stroke in 32 countries (INTERSTROKE): a
  case-control study.}
    \field{volume}{388}
    \verb{file}
    \verb :PDFs/odonnell2016.pdf:PDF
    \endverb
    \field{journaltitle}{Lancet (London, England)}
    \field{month}{08}
    \field{year}{2016}
  \endentry

  \entry{Moons2012}{article}{}
    \name{author}{7}{}{%
      {{hash=MKGM}{%
         family={Moons},
         familyi={M\bibinitperiod},
         given={Karel G\bibnamedelima M},
         giveni={K\bibinitperiod\bibinitdelim G\bibinitperiod\bibinitdelim
  M\bibinitperiod},
      }}%
      {{hash=KAP}{%
         family={Kengne},
         familyi={K\bibinitperiod},
         given={Andre\bibnamedelima Pascal},
         giveni={A\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=GDE}{%
         family={Grobbee},
         familyi={G\bibinitperiod},
         given={Diederick\bibnamedelima E},
         giveni={D\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=RP}{%
         family={Royston},
         familyi={R\bibinitperiod},
         given={Patrick},
         giveni={P\bibinitperiod},
      }}%
      {{hash=VY}{%
         family={Vergouwe},
         familyi={V\bibinitperiod},
         given={Yvonne},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=ADG}{%
         family={Altman},
         familyi={A\bibinitperiod},
         given={Douglas\bibnamedelima G},
         giveni={D\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=WM}{%
         family={Woodward},
         familyi={W\bibinitperiod},
         given={Mark},
         giveni={M\bibinitperiod},
      }}%
    }
    \keyw{Cardiovascular Diseases, diagnosis, epidemiology, therapy; Decision
  Making; Delivery of Health Care, organization & administration; Humans;
  Models, Theoretical; Prognosis; Reproducibility of Results; Risk Assessment,
  methods}
    \strng{namehash}{MKGM+1}
    \strng{fullhash}{MKGMKAPGDERPVYADGWM1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Clinical prediction models are increasingly used to complement clinical
  reasoning and decision-making in modern medicine, in general, and in the
  cardiovascular domain, in particular. To these ends, developed models first
  and foremost need to provide accurate and (internally and externally)
  validated estimates of probabilities of specific health conditions or
  outcomes in the targeted individuals. Subsequently, the adoption of such
  models by professionals must guide their decision-making, and improve patient
  outcomes and the cost-effectiveness of care. In the first paper of this
  series of two companion papers, issues relating to prediction model
  development, their internal validation, and estimating the added value of a
  new (bio)marker to existing predictors were discussed. In this second paper,
  an overview is provided of the consecutive steps for the assessment of the
  model's predictive performance in new individuals (external validation
  studies), how to adjust or update existing models to local circumstances or
  with new predictors, and how to investigate the impact of the uptake of
  prediction models on clinical decision-making and patient outcomes (impact
  studies). Each step is illustrated with empirical examples from the
  cardiovascular field.%
    }
    \verb{doi}
    \verb 10.1136/heartjnl-2011-301247
    \endverb
    \field{issn}{1468-201X}
    \field{issue}{9}
    \field{pages}{691\bibrangedash 698}
    \field{title}{Risk prediction models: II. External validation, model
  updating, and impact assessment.}
    \field{volume}{98}
    \verb{file}
    \verb :PDFs/moons2012.pdf:PDF
    \endverb
    \field{journaltitle}{Heart (British Cardiac Society)}
    \field{month}{05}
    \field{year}{2012}
  \endentry

  \entry{Collins2015}{article}{}
    \name{author}{4}{}{%
      {{hash=CGS}{%
         family={Collins},
         familyi={C\bibinitperiod},
         given={Gary\bibnamedelima S},
         giveni={G\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=RJB}{%
         family={Reitsma},
         familyi={R\bibinitperiod},
         given={Johannes\bibnamedelima B},
         giveni={J\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=ADG}{%
         family={Altman},
         familyi={A\bibinitperiod},
         given={Douglas\bibnamedelima G},
         giveni={D\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=MKGM}{%
         family={Moons},
         familyi={M\bibinitperiod},
         given={Karel G\bibnamedelima M},
         giveni={K\bibinitperiod\bibinitdelim G\bibinitperiod\bibinitdelim
  M\bibinitperiod},
      }}%
    }
    \keyw{Checklist; Decision Support Techniques; Humans; Information
  Dissemination; Models, Statistical; Multivariate Analysis; Practice
  Guidelines as Topic; Prognosis; Publishing, standards, statistics & numerical
  data; Diagnostic; model development; model validation; predictions models;
  prognostic; reporting}
    \strng{namehash}{CGS+1}
    \strng{fullhash}{CGSRJBADGMKGM1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Prediction models are developed to aid healthcare providers in estimating
  the probability or risk that a specific disease or condition is present
  (diagnostic models) or that a specific event will occur in the future
  (prognostic models), to inform their decision-making. However, the
  overwhelming evidence shows that the quality of reporting of prediction model
  studies is poor. Only with full and clear reporting of information on all
  aspects of a prediction model can risk of bias and potential usefulness of
  prediction models be adequately assessed. The Transparent Reporting of a
  multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)
  initiative developed a set of recommendations for the reporting of studies
  developing, validating or updating a prediction model, whether for diagnostic
  or prognostic purposes. This article describes how the TRIPOD Statement was
  developed. An extensive list of items based on a review of the literature was
  created, which was reduced after a Web-based survey and revised during a
  3-day meeting in June 2011 with methodologists, healthcare professionals and
  journal editors. The list was refined during several meetings of the steering
  group and in e-mail discussions with the wider group of TRIPOD contributors.
  The resulting TRIPOD Statement is a checklist of 22 items, deemed essential
  for transparent reporting of a prediction model study. The TRIPOD Statement
  aims to improve the transparency of the reporting of a prediction model study
  regardless of the study methods used. The TRIPOD Statement is best used in
  conjunction with the TRIPOD explanation and elaboration document. To aid the
  editorial process and readers of prediction model studies, it is recommended
  that authors include a completed checklist in their submission (also
  available at www.tripod-statement.org).%
    }
    \verb{doi}
    \verb 10.1111/eci.12376
    \endverb
    \field{issn}{1365-2362}
    \field{issue}{2}
    \field{pages}{204\bibrangedash 214}
    \field{title}{Transparent reporting of a multivariable prediction model for
  individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.}
    \field{volume}{45}
    \verb{file}
    \verb :PDFs/collins2015.pdf:PDF
    \endverb
    \field{journaltitle}{European journal of clinical investigation}
    \field{month}{02}
    \field{year}{2015}
  \endentry

  \entry{Weng2017}{article}{}
    \name{author}{5}{}{%
      {{hash=WSF}{%
         family={Weng},
         familyi={W\bibinitperiod},
         given={Stephen\bibnamedelima F.},
         giveni={S\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=RJ}{%
         family={Reps},
         familyi={R\bibinitperiod},
         given={Jenna},
         giveni={J\bibinitperiod},
      }}%
      {{hash=KJ}{%
         family={Kai},
         familyi={K\bibinitperiod},
         given={Joe},
         giveni={J\bibinitperiod},
      }}%
      {{hash=GJM}{%
         family={Garibaldi},
         familyi={G\bibinitperiod},
         given={Jonathan\bibnamedelima M.},
         giveni={J\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=QN}{%
         family={Qureshi},
         familyi={Q\bibinitperiod},
         given={Nadeem},
         giveni={N\bibinitperiod},
      }}%
    }
    \name{editor}{1}{}{%
      {{hash=LB}{%
         family={Liu},
         familyi={L\bibinitperiod},
         given={Bin},
         giveni={B\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Public Library of Science ({PLoS})}%
    }
    \strng{namehash}{WSF+1}
    \strng{fullhash}{WSFRJKJGJMQN1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1371/journal.pone.0174944
    \endverb
    \field{number}{4}
    \field{pages}{e0174944}
    \field{title}{Can machine-learning improve cardiovascular risk prediction
  using routine clinical data?}
    \field{volume}{12}
    \verb{file}
    \verb :bibtex/PDFs/weng2017.pdf:PDF
    \endverb
    \field{journaltitle}{{PLOS} {ONE}}
    \field{year}{2017}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Nelder1972}{article}{}
    \name{author}{2}{}{%
      {{hash=NJA}{%
         family={Nelder},
         familyi={N\bibinitperiod},
         given={J.\bibnamedelima A.},
         giveni={J\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=WRWM}{%
         family={Wedderburn},
         familyi={W\bibinitperiod},
         given={R.\bibnamedelima W.\bibnamedelima M.},
         giveni={R\bibinitperiod\bibinitdelim W\bibinitperiod\bibinitdelim
  M\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {{JSTOR}}%
    }
    \strng{namehash}{NJAWRWM1}
    \strng{fullhash}{NJAWRWM1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.2307/2344614
    \endverb
    \field{number}{3}
    \field{pages}{370}
    \field{title}{Generalized Linear Models}
    \field{volume}{135}
    \verb{file}
    \verb :PDFs/Nelder1972.pdf:PDF
    \endverb
    \field{journaltitle}{Journal of the Royal Statistical Society. Series A
  (General)}
    \field{year}{1972}
  \endentry

  \entry{Cox1972}{article}{}
    \name{author}{1}{}{%
      {{hash=CD}{%
         family={Cox},
         familyi={C\bibinitperiod},
         given={David},
         giveni={D\bibinitperiod},
      }}%
    }
    \strng{namehash}{CD1}
    \strng{fullhash}{CD1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{title}{Regression Models and Life-Tables}
    \verb{file}
    \verb :PDFs/Cox1972.pdf:PDF
    \endverb
    \field{journaltitle}{Journal of the royal statistical society}
    \field{year}{1972}
  \endentry

  \entry{Russell2002}{book}{}
    \name{author}{2}{}{%
      {{hash=RS}{%
         family={Russell},
         familyi={R\bibinitperiod},
         given={Stuart},
         giveni={S\bibinitperiod},
      }}%
      {{hash=NP}{%
         family={Norvig},
         familyi={N\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Prentice Hall}%
    }
    \strng{namehash}{RSNP1}
    \strng{fullhash}{RSNP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{isbn}{0137903952}
    \field{title}{Artificial Intelligence: A Modern Approach (2nd Edition)}
    \verb{url}
    \verb https://www.amazon.com/Artificial-Intelligence-Modern-Approach-2nd/dp
    \verb /0137903952?SubscriptionId=0JYN1NVW651KCA56C102&tag=techkie-20&linkCo
    \verb de=xm2&camp=2025&creative=165953&creativeASIN=0137903952
    \endverb
    \field{year}{2002}
  \endentry

  \entry{Obermeyer2016}{article}{}
    \name{author}{2}{}{%
      {{hash=OZ}{%
         family={Obermeyer},
         familyi={O\bibinitperiod},
         given={Ziad},
         giveni={Z\bibinitperiod},
      }}%
      {{hash=EEJ}{%
         family={Emanuel},
         familyi={E\bibinitperiod},
         given={Ezekiel\bibnamedelima J},
         giveni={E\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
    }
    \keyw{Algorithms; Clinical Medicine; Computational Biology; Diagnosis;
  Expert Systems; Machine Learning; Prognosis}
    \strng{namehash}{OZEEJ1}
    \strng{fullhash}{OZEEJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1056/NEJMp1606181
    \endverb
    \field{issn}{1533-4406}
    \field{issue}{13}
    \field{pages}{1216\bibrangedash 1219}
    \field{title}{Predicting the Future - Big Data, Machine Learning, and
  Clinical Medicine.}
    \field{volume}{375}
    \verb{file}
    \verb :bibtex/PDFs/obermeyer2016.pdf:PDF
    \endverb
    \field{journaltitle}{The New England journal of medicine}
    \field{month}{09}
    \field{year}{2016}
  \endentry

  \entry{Shalev-Shwartz2014}{book}{}
    \name{author}{2}{}{%
      {{hash=SSS}{%
         family={Shalev-Shwartz},
         familyi={S\bibinithyphendelim S\bibinitperiod},
         given={Shai},
         giveni={S\bibinitperiod},
      }}%
      {{hash=BDS}{%
         family={Ben-David},
         familyi={B\bibinithyphendelim D\bibinitperiod},
         given={Shai},
         giveni={S\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Cambridge University Press}%
    }
    \strng{namehash}{SSSBDS1}
    \strng{fullhash}{SSSBDS1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{isbn}{978-1107057135}
    \field{title}{Understanding Machine Learning: From Theory to Algorithms}
    \verb{url}
    \verb https://www.amazon.com/Understanding-Machine-Learning-Theory-Algorith
    \verb ms/dp/1107057132?SubscriptionId=0JYN1NVW651KCA56C102&tag=techkie-20&l
    \verb inkCode=xm2&camp=2025&creative=165953&creativeASIN=1107057132
    \endverb
    \verb{file}
    \verb :PDFs/shaishalev2014.pdf:PDF
    \endverb
    \field{year}{2014}
  \endentry

  \entry{Deo2015}{article}{}
    \name{author}{1}{}{%
      {{hash=DRC}{%
         family={Deo},
         familyi={D\bibinitperiod},
         given={Rahul\bibnamedelima C},
         giveni={R\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
    }
    \keyw{Algorithms; Humans; Machine Learning, trends; Medicine, trends;
  artificial intelligence; computers; prognosis; risk factors; statistics}
    \strng{namehash}{DRC1}
    \strng{fullhash}{DRC1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Spurred by advances in processing power, memory, storage, and an
  unprecedented wealth of data, computers are being asked to tackle
  increasingly complex learning tasks, often with astonishing success.
  Computers have now mastered a popular variant of poker, learned the laws of
  physics from experimental data, and become experts in video games - tasks
  that would have been deemed impossible not too long ago. In parallel, the
  number of companies centered on applying complex data analysis to varying
  industries has exploded, and it is thus unsurprising that some analytic
  companies are turning attention to problems in health care. The purpose of
  this review is to explore what problems in medicine might benefit from such
  learning approaches and use examples from the literature to introduce basic
  concepts in machine learning. It is important to note that seemingly large
  enough medical data sets and adequate learning algorithms have been available
  for many decades, and yet, although there are thousands of papers applying
  machine learning algorithms to medical data, very few have contributed
  meaningfully to clinical care. This lack of impact stands in stark contrast
  to the enormous relevance of machine learning to many other industries. Thus,
  part of my effort will be to identify what obstacles there may be to changing
  the practice of medicine through statistical learning approaches, and discuss
  how these might be overcome.%
    }
    \verb{doi}
    \verb 10.1161/CIRCULATIONAHA.115.001593
    \endverb
    \field{issn}{1524-4539}
    \field{issue}{20}
    \field{pages}{1920\bibrangedash 1930}
    \field{title}{Machine Learning in Medicine.}
    \field{volume}{132}
    \verb{file}
    \verb :PDFs/Deo2015.pdf:PDF
    \endverb
    \field{journaltitle}{Circulation}
    \field{month}{11}
    \field{year}{2015}
  \endentry

  \entry{Price2015}{article}{}
    \name{author}{1}{}{%
      {{hash=PN}{%
         family={Price},
         familyi={P\bibinitperiod},
         given={Nicholas},
         giveni={N\bibinitperiod},
      }}%
    }
    \strng{namehash}{PN1}
    \strng{fullhash}{PN1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{number}{2}
    \field{pages}{420\bibrangedash 454}
    \field{title}{Black-Box Medicine}
    \field{volume}{28}
    \verb{file}
    \verb :PDFs/Price2015.pdf:PDF
    \endverb
    \field{journaltitle}{Harvard Journal of Law \& Technology}
    \field{year}{2015}
  \endentry

  \entry{Hebert-Johnson2017}{article}{}
    \name{author}{4}{}{%
      {{hash=HJ}{%
         prefix={Úrsula},
         prefixi={\bibinitperiod},
         family={Hébert-Johnson},
         familyi={H\bibinithyphendelim J\bibinitperiod},
      }}%
      {{hash=KMP}{%
         family={Kim},
         familyi={K\bibinitperiod},
         given={Michael\bibnamedelima P.},
         giveni={M\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=RO}{%
         family={Reingold},
         familyi={R\bibinitperiod},
         given={Omer},
         giveni={O\bibinitperiod},
      }}%
      {{hash=RGN}{%
         family={Rothblum},
         familyi={R\bibinitperiod},
         given={Guy\bibnamedelima N.},
         giveni={G\bibinitperiod\bibinitdelim N\bibinitperiod},
      }}%
    }
    \keyw{cs.LG, cs.DS, stat.ML}
    \strng{namehash}{HJ+1}
    \strng{fullhash}{HJKMPRORGN1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    As algorithms increasingly inform and influence decisions made about
  individuals, it becomes increasingly important to address concerns that these
  algorithms might be discriminatory. The output of an algorithm can be
  discriminatory for many reasons, most notably: (1) the data used to train the
  algorithm might be biased (in various ways) to favor certain populations over
  others; (2) the analysis of this training data might inadvertently or
  maliciously introduce biases that are not borne out in the data. This work
  focuses on the latter concern. We develop and study multicalbration -- a new
  measure of algorithmic fairness that aims to mitigate concerns about
  discrimination that is introduced in the process of learning a predictor from
  data. Multicalibration guarantees accurate (calibrated) predictions for every
  subpopulation that can be identified within a specified class of
  computations. We think of the class as being quite rich; in particular, it
  can contain many overlapping subgroups of a protected group. We show that in
  many settings this strong notion of protection from discrimination is both
  attainable and aligned with the goal of obtaining accurate predictions. Along
  the way, we present new algorithms for learning a multicalibrated predictor,
  study the computational complexity of this task, and draw new connections to
  computational learning models such as agnostic learning.%
    }
    \verb{eprint}
    \verb 1711.08513v2
    \endverb
    \field{title}{Calibration for the (Computationally-Identifiable) Masses}
    \verb{file}
    \verb online:http\://arxiv.org/pdf/1711.08513v2:PDF
    \endverb
    \field{eprinttype}{arXiv}
    \field{eprintclass}{cs.LG}
    \field{day}{22}
    \field{month}{11}
    \field{year}{2017}
  \endentry

  \entry{Corbett-Davies2017}{article}{}
    \name{author}{5}{}{%
      {{hash=CDS}{%
         family={Corbett-Davies},
         familyi={C\bibinithyphendelim D\bibinitperiod},
         given={Sam},
         giveni={S\bibinitperiod},
      }}%
      {{hash=PE}{%
         family={Pierson},
         familyi={P\bibinitperiod},
         given={Emma},
         giveni={E\bibinitperiod},
      }}%
      {{hash=FA}{%
         family={Feller},
         familyi={F\bibinitperiod},
         given={Avi},
         giveni={A\bibinitperiod},
      }}%
      {{hash=GS}{%
         family={Goel},
         familyi={G\bibinitperiod},
         given={Sharad},
         giveni={S\bibinitperiod},
      }}%
      {{hash=HA}{%
         family={Huq},
         familyi={H\bibinitperiod},
         given={Aziz},
         giveni={A\bibinitperiod},
      }}%
    }
    \keyw{cs.CY, stat.AP}
    \strng{namehash}{CDS+1}
    \strng{fullhash}{CDSPEFAGSHA1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Algorithms are now regularly used to decide whether defendants awaiting
  trial are too dangerous to be released back into the community. In some
  cases, black defendants are substantially more likely than white defendants
  to be incorrectly classified as high risk. To mitigate such disparities,
  several techniques recently have been proposed to achieve algorithmic
  fairness. Here we reformulate algorithmic fairness as constrained
  optimization: the objective is to maximize public safety while satisfying
  formal fairness constraints designed to reduce racial disparities. We show
  that for several past definitions of fairness, the optimal algorithms that
  result require detaining defendants above race-specific risk thresholds. We
  further show that the optimal unconstrained algorithm requires applying a
  single, uniform threshold to all defendants. The unconstrained algorithm thus
  maximizes public safety while also satisfying one important understanding of
  equality: that all individuals are held to the same standard, irrespective of
  race. Because the optimal constrained and unconstrained algorithms generally
  differ, there is tension between improving public safety and satisfying
  prevailing notions of algorithmic fairness. By examining data from Broward
  County, Florida, we show that this trade-off can be large in practice. We
  focus on algorithms for pretrial release decisions, but the principles we
  discuss apply to other domains, and also to human decision makers carrying
  out structured decision rules.%
    }
    \verb{doi}
    \verb 10.1145/3097983.309809
    \endverb
    \verb{eprint}
    \verb 1701.08230v4
    \endverb
    \field{title}{Algorithmic decision making and the cost of fairness}
    \verb{file}
    \verb online:http\://arxiv.org/pdf/1701.08230v4:PDF
    \endverb
    \field{eprinttype}{arXiv}
    \field{eprintclass}{cs.CY}
    \field{day}{28}
    \field{month}{01}
    \field{year}{2017}
  \endentry

  \entry{Goldstein2016}{article}{}
    \name{author}{3}{}{%
      {{hash=GBA}{%
         family={Goldstein},
         familyi={G\bibinitperiod},
         given={Benjamin\bibnamedelima A},
         giveni={B\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=NAM}{%
         family={Navar},
         familyi={N\bibinitperiod},
         given={Ann\bibnamedelima Marie},
         giveni={A\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=PMJ}{%
         family={Pencina},
         familyi={P\bibinitperiod},
         given={Michael\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
    }
    \strng{namehash}{GBANAMPMJ1}
    \strng{fullhash}{GBANAMPMJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1001/jamacardio.2016.3826
    \endverb
    \field{issn}{2380-6591}
    \field{issue}{9}
    \field{pages}{976\bibrangedash 977}
    \field{title}{Risk Prediction With Electronic Health Records: The
  Importance of Model Validation and Clinical Context.}
    \field{volume}{1}
    \verb{file}
    \verb :PDFs/goldstein2016.pdf:PDF
    \endverb
    \field{journaltitle}{JAMA cardiology}
    \field{month}{12}
    \field{year}{2016}
  \endentry

  \entry{Lovis2015}{article}{}
    \name{author}{2}{}{%
      {{hash=LC}{%
         family={Lovis},
         familyi={L\bibinitperiod},
         given={Christian},
         giveni={C\bibinitperiod},
      }}%
      {{hash=GR}{%
         family={Gamzu},
         familyi={G\bibinitperiod},
         given={Ronni},
         giveni={R\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Springer Nature}%
    }
    \strng{namehash}{LCGR1}
    \strng{fullhash}{LCGR1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1186/s13584-015-0057-0
    \endverb
    \field{number}{1}
    \field{title}{Big Data in Israeli healthcare: hopes and challenges report
  of an international workshop}
    \field{volume}{4}
    \verb{file}
    \verb :PDFs/lovis2015.pdf:PDF
    \endverb
    \field{journaltitle}{Israel Journal of Health Policy Research}
    \field{year}{2015}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Goldstein2017}{article}{}
    \name{author}{4}{}{%
      {{hash=GBA}{%
         family={Goldstein},
         familyi={G\bibinitperiod},
         given={Benjamin\bibnamedelima A},
         giveni={B\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=NAM}{%
         family={Navar},
         familyi={N\bibinitperiod},
         given={Ann\bibnamedelima Marie},
         giveni={A\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=PMJ}{%
         family={Pencina},
         familyi={P\bibinitperiod},
         given={Michael\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=IJPA}{%
         family={Ioannidis},
         familyi={I\bibinitperiod},
         given={John P\bibnamedelima A},
         giveni={J\bibinitperiod\bibinitdelim P\bibinitperiod\bibinitdelim
  A\bibinitperiod},
      }}%
    }
    \keyw{Electronic Health Records; Humans; Models, Statistical; Risk
  Assessment, methods; Electronic Medical Record; Review; Risk Assessment}
    \strng{namehash}{GBA+1}
    \strng{fullhash}{GBANAMPMJIJPA1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Electronic health records (EHRs) are an increasingly common data source for
  clinical risk prediction, presenting both unique analytic opportunities and
  challenges. We sought to evaluate the current state of EHR based risk
  prediction modeling through a systematic review of clinical prediction
  studies using EHR data. We searched PubMed for articles that reported on the
  use of an EHR to develop a risk prediction model from 2009 to 2014. Articles
  were extracted by two reviewers, and we abstracted information on study
  design, use of EHR data, model building, and performance from each
  publication and supplementary documentation. We identified 107 articles from
  15 different countries. Studies were generally very large (median sample
  size = 26 100) and utilized a diverse array of predictors. Most used
  validation techniques (n = 94 of 107) and reported model coefficients for
  reproducibility (n = 83). However, studies did not fully leverage the
  breadth of EHR data, as they uncommonly used longitudinal information
  (n = 37) and employed relatively few predictor variables (median = 27
  variables). Less than half of the studies were multicenter (n = 50) and
  only 26 performed validation across sites. Many studies did not fully address
  biases of EHR data such as missing data or loss to follow-up. Average
  c-statistics for different outcomes were: mortality (0.84), clinical
  prediction (0.83), hospitalization (0.71), and service utilization (0.71).
  EHR data present both opportunities and challenges for clinical risk
  prediction. There is room for improvement in designing such studies.%
    }
    \verb{doi}
    \verb 10.1093/jamia/ocw042
    \endverb
    \field{issn}{1527-974X}
    \field{issue}{1}
    \field{pages}{198\bibrangedash 208}
    \field{title}{Opportunities and challenges in developing risk prediction
  models with electronic health records data: a systematic review.}
    \field{volume}{24}
    \verb{file}
    \verb :PDFs/goldstein2017.pdf:PDF
    \endverb
    \field{journaltitle}{Journal of the American Medical Informatics
  Association : JAMIA}
    \field{month}{01}
    \field{year}{2017}
  \endentry

  \entry{WHO2017}{online}{}
    \name{author}{1}{}{%
      {{hash=W}{%
         family={WHO},
         familyi={W\bibinitperiod},
      }}%
    }
    \strng{namehash}{W1}
    \strng{fullhash}{W1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{title}{Cardiovascular Disease fact sheet}
    \verb{url}
    \verb http://www.who.int/mediacentre/factsheets/fs317/en/
    \endverb
    \field{year}{2017}
    \warn{\item Invalid format of field 'date' \item Invalid format of field
  'date'}
  \endentry

  \entry{Rapsomaniki2014}{article}{}
    \name{author}{13}{}{%
      {{hash=RE}{%
         family={Rapsomaniki},
         familyi={R\bibinitperiod},
         given={Eleni},
         giveni={E\bibinitperiod},
      }}%
      {{hash=TA}{%
         family={Timmis},
         familyi={T\bibinitperiod},
         given={Adam},
         giveni={A\bibinitperiod},
      }}%
      {{hash=GJ}{%
         family={George},
         familyi={G\bibinitperiod},
         given={Julie},
         giveni={J\bibinitperiod},
      }}%
      {{hash=PRM}{%
         family={Pujades-Rodriguez},
         familyi={P\bibinithyphendelim R\bibinitperiod},
         given={Mar},
         giveni={M\bibinitperiod},
      }}%
      {{hash=SAD}{%
         family={Shah},
         familyi={S\bibinitperiod},
         given={Anoop\bibnamedelima D},
         giveni={A\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=DS}{%
         family={Denaxas},
         familyi={D\bibinitperiod},
         given={Spiros},
         giveni={S\bibinitperiod},
      }}%
      {{hash=WIR}{%
         family={White},
         familyi={W\bibinitperiod},
         given={Ian\bibnamedelima R},
         giveni={I\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=CMJ}{%
         family={Caulfield},
         familyi={C\bibinitperiod},
         given={Mark\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=DJE}{%
         family={Deanfield},
         familyi={D\bibinitperiod},
         given={John\bibnamedelima E},
         giveni={J\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=SL}{%
         family={Smeeth},
         familyi={S\bibinitperiod},
         given={Liam},
         giveni={L\bibinitperiod},
      }}%
      {{hash=WB}{%
         family={Williams},
         familyi={W\bibinitperiod},
         given={Bryan},
         giveni={B\bibinitperiod},
      }}%
      {{hash=HA}{%
         family={Hingorani},
         familyi={H\bibinitperiod},
         given={Aroon},
         giveni={A\bibinitperiod},
      }}%
      {{hash=HH}{%
         family={Hemingway},
         familyi={H\bibinitperiod},
         given={Harry},
         giveni={H\bibinitperiod},
      }}%
    }
    \keyw{Acute Disease; Adult; Age Distribution; Aged; Aged, 80 and over;
  Angina Pectoris, epidemiology, etiology; Antihypertensive Agents, therapeutic
  use; Aortic Aneurysm, Abdominal, epidemiology, etiology; Blood Pressure,
  physiology; Cardiovascular Diseases, epidemiology, etiology, physiopathology;
  Chronic Disease; England, epidemiology; Female; Follow-Up Studies; Humans;
  Hypertension, complications, drug therapy, epidemiology; Incidence;
  Intracranial Hemorrhage, Hypertensive, epidemiology; Male; Medical Record
  Linkage; Middle Aged; Risk Assessment, methods; Subarachnoid Hemorrhage,
  epidemiology, etiology}
    \strng{namehash}{RE+1}
    \strng{fullhash}{RETAGJPRMSADDSWIRCMJDJESLWBHAHH1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    The associations of blood pressure with the different manifestations of
  incident cardiovascular disease in a contemporary population have not been
  compared. In this study, we aimed to analyse the associations of blood
  pressure with 12 different presentations of cardiovascular disease. We used
  linked electronic health records from 1997 to 2010 in the CALIBER
  (CArdiovascular research using LInked Bespoke studies and Electronic health
  Records) programme to assemble a cohort of 1·25 million patients, 30 years
  of age or older and initially free from cardiovascular disease, a fifth of
  whom received blood pressure-lowering treatments. We studied the
  heterogeneity in the age-specific associations of clinically measured blood
  pressure with 12 acute and chronic cardiovascular diseases, and estimated the
  lifetime risks (up to 95 years of age) and cardiovascular disease-free
  life-years lost adjusted for other risk factors at index ages 30, 60, and 80
  years. This study is registered at ClinicalTrials.gov, number NCT01164371.
  During 5·2 years median follow-up, we recorded 83,098 initial cardiovascular
  disease presentations. In each age group, the lowest risk for cardiovascular
  disease was in people with systolic blood pressure of 90-114 mm Hg and
  diastolic blood pressure of 60-74 mm Hg, with no evidence of a J-shaped
  increased risk at lower blood pressures. The effect of high blood pressure
  varied by cardiovascular disease endpoint, from strongly positive to no
  effect. Associations with high systolic blood pressure were strongest for
  intracerebral haemorrhage (hazard ratio 1·44 [95% CI 1·32-1·58]),
  subarachnoid haemorrhage (1·43 [1·25-1·63]), and stable angina (1·41
  [1·36-1·46]), and weakest for abdominal aortic aneurysm (1·08
  [1·00-1·17]). Compared with diastolic blood pressure, raised systolic blood
  pressure had a greater effect on angina, myocardial infarction, and
  peripheral arterial disease, whereas raised diastolic blood pressure had a
  greater effect on abdominal aortic aneurysm than did raised systolic
  pressure. Pulse pressure associations were inverse for abdominal aortic
  aneurysm (HR per 10 mm Hg 0·91 [95% CI 0·86-0·98]) and strongest for
  peripheral arterial disease (1·23 [1·20-1·27]). People with hypertension
  (blood pressure ≥140/90 mm Hg or those receiving blood pressure-lowering
  drugs) had a lifetime risk of overall cardiovascular disease at 30 years of
  age of 63·3% (95% CI 62·9-63·8) compared with 46·1% (45·5-46·8) for
  those with normal blood pressure, and developed cardiovascular disease 5·0
  years earlier (95% CI 4·8-5·2). Stable and unstable angina accounted for
  most (43%) of the cardiovascular disease-free years of life lost associated
  with hypertension from index age 30 years, whereas heart failure and stable
  angina accounted for the largest proportion (19% each) of years of life lost
  from index age 80 years. The widely held assumptions that blood pressure has
  strong associations with the occurrence of all cardiovascular diseases across
  a wide age range, and that diastolic and systolic associations are
  concordant, are not supported by the findings of this high-resolution study.
  Despite modern treatments, the lifetime burden of hypertension is
  substantial. These findings emphasise the need for new blood
  pressure-lowering strategies, and will help to inform the design of
  randomised trials to assess them. Medical Research Council, National
  Institute for Health Research, and Wellcome Trust.%
    }
    \verb{doi}
    \verb 10.1016/S0140-6736(14)60685-1
    \endverb
    \field{issn}{1474-547X}
    \field{issue}{9932}
    \field{pages}{1899\bibrangedash 1911}
    \field{title}{Blood pressure and incidence of twelve cardiovascular
  diseases: lifetime risks, healthy life-years lost, and age-specific
  associations in 1·25 million people.}
    \field{volume}{383}
    \verb{file}
    \verb :PDFs/Rapsomaniki2014.pdf:PDF
    \endverb
    \field{journaltitle}{Lancet (London, England)}
    \field{month}{05}
    \field{year}{2014}
  \endentry

  \entry{Benjamin2017}{article}{}
    \name{author}{47}{}{%
      {{hash=BEJ}{%
         family={Benjamin},
         familyi={B\bibinitperiod},
         given={Emelia\bibnamedelima J},
         giveni={E\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=BMJ}{%
         family={Blaha},
         familyi={B\bibinitperiod},
         given={Michael\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=CSE}{%
         family={Chiuve},
         familyi={C\bibinitperiod},
         given={Stephanie\bibnamedelima E},
         giveni={S\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=CM}{%
         family={Cushman},
         familyi={C\bibinitperiod},
         given={Mary},
         giveni={M\bibinitperiod},
      }}%
      {{hash=DSR}{%
         family={Das},
         familyi={D\bibinitperiod},
         given={Sandeep\bibnamedelima R},
         giveni={S\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=DR}{%
         family={Deo},
         familyi={D\bibinitperiod},
         given={Rajat},
         giveni={R\bibinitperiod},
      }}%
      {{hash=dFSD}{%
         prefix={de},
         prefixi={d\bibinitperiod},
         family={Ferranti},
         familyi={F\bibinitperiod},
         given={Sarah\bibnamedelima D},
         giveni={S\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=FJ}{%
         family={Floyd},
         familyi={F\bibinitperiod},
         given={James},
         giveni={J\bibinitperiod},
      }}%
      {{hash=FM}{%
         family={Fornage},
         familyi={F\bibinitperiod},
         given={Myriam},
         giveni={M\bibinitperiod},
      }}%
      {{hash=GC}{%
         family={Gillespie},
         familyi={G\bibinitperiod},
         given={Cathleen},
         giveni={C\bibinitperiod},
      }}%
      {{hash=ICR}{%
         family={Isasi},
         familyi={I\bibinitperiod},
         given={Carmen\bibnamedelima R},
         giveni={C\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=JMC}{%
         family={Jiménez},
         familyi={J\bibinitperiod},
         given={Monik\bibnamedelima C},
         giveni={M\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=JLC}{%
         family={Jordan},
         familyi={J\bibinitperiod},
         given={Lori\bibnamedelima Chaffin},
         giveni={L\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=JSE}{%
         family={Judd},
         familyi={J\bibinitperiod},
         given={Suzanne\bibnamedelima E},
         giveni={S\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=LD}{%
         family={Lackland},
         familyi={L\bibinitperiod},
         given={Daniel},
         giveni={D\bibinitperiod},
      }}%
      {{hash=LJH}{%
         family={Lichtman},
         familyi={L\bibinitperiod},
         given={Judith\bibnamedelima H},
         giveni={J\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=LL}{%
         family={Lisabeth},
         familyi={L\bibinitperiod},
         given={Lynda},
         giveni={L\bibinitperiod},
      }}%
      {{hash=LS}{%
         family={Liu},
         familyi={L\bibinitperiod},
         given={Simin},
         giveni={S\bibinitperiod},
      }}%
      {{hash=LCT}{%
         family={Longenecker},
         familyi={L\bibinitperiod},
         given={Chris\bibnamedelima T},
         giveni={C\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
      {{hash=MRH}{%
         family={Mackey},
         familyi={M\bibinitperiod},
         given={Rachel\bibnamedelima H},
         giveni={R\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=MK}{%
         family={Matsushita},
         familyi={M\bibinitperiod},
         given={Kunihiro},
         giveni={K\bibinitperiod},
      }}%
      {{hash=MD}{%
         family={Mozaffarian},
         familyi={M\bibinitperiod},
         given={Dariush},
         giveni={D\bibinitperiod},
      }}%
      {{hash=MME}{%
         family={Mussolino},
         familyi={M\bibinitperiod},
         given={Michael\bibnamedelima E},
         giveni={M\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=NK}{%
         family={Nasir},
         familyi={N\bibinitperiod},
         given={Khurram},
         giveni={K\bibinitperiod},
      }}%
      {{hash=NRW}{%
         family={Neumar},
         familyi={N\bibinitperiod},
         given={Robert\bibnamedelima W},
         giveni={R\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
      {{hash=PL}{%
         family={Palaniappan},
         familyi={P\bibinitperiod},
         given={Latha},
         giveni={L\bibinitperiod},
      }}%
      {{hash=PDK}{%
         family={Pandey},
         familyi={P\bibinitperiod},
         given={Dilip\bibnamedelima K},
         giveni={D\bibinitperiod\bibinitdelim K\bibinitperiod},
      }}%
      {{hash=TRR}{%
         family={Thiagarajan},
         familyi={T\bibinitperiod},
         given={Ravi\bibnamedelima R},
         giveni={R\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=RMJ}{%
         family={Reeves},
         familyi={R\bibinitperiod},
         given={Mathew\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=RM}{%
         family={Ritchey},
         familyi={R\bibinitperiod},
         given={Matthew},
         giveni={M\bibinitperiod},
      }}%
      {{hash=RCJ}{%
         family={Rodriguez},
         familyi={R\bibinitperiod},
         given={Carlos\bibnamedelima J},
         giveni={C\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=RGA}{%
         family={Roth},
         familyi={R\bibinitperiod},
         given={Gregory\bibnamedelima A},
         giveni={G\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=RWD}{%
         family={Rosamond},
         familyi={R\bibinitperiod},
         given={Wayne\bibnamedelima D},
         giveni={W\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=SC}{%
         family={Sasson},
         familyi={S\bibinitperiod},
         given={Comilla},
         giveni={C\bibinitperiod},
      }}%
      {{hash=TA}{%
         family={Towfighi},
         familyi={T\bibinitperiod},
         given={Amytis},
         giveni={A\bibinitperiod},
      }}%
      {{hash=TCW}{%
         family={Tsao},
         familyi={T\bibinitperiod},
         given={Connie\bibnamedelima W},
         giveni={C\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
      {{hash=TMB}{%
         family={Turner},
         familyi={T\bibinitperiod},
         given={Melanie\bibnamedelima B},
         giveni={M\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=VSS}{%
         family={Virani},
         familyi={V\bibinitperiod},
         given={Salim\bibnamedelima S},
         giveni={S\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=VJH}{%
         family={Voeks},
         familyi={V\bibinitperiod},
         given={Jenifer\bibnamedelima H},
         giveni={J\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=WJZ}{%
         family={Willey},
         familyi={W\bibinitperiod},
         given={Joshua\bibnamedelima Z},
         giveni={J\bibinitperiod\bibinitdelim Z\bibinitperiod},
      }}%
      {{hash=WJT}{%
         family={Wilkins},
         familyi={W\bibinitperiod},
         given={John\bibnamedelima T},
         giveni={J\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
      {{hash=WJH}{%
         family={Wu},
         familyi={W\bibinitperiod},
         given={Jason\bibnamedelima Hy},
         giveni={J\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=AHM}{%
         family={Alger},
         familyi={A\bibinitperiod},
         given={Heather\bibnamedelima M},
         giveni={H\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=WSS}{%
         family={Wong},
         familyi={W\bibinitperiod},
         given={Sally\bibnamedelima S},
         giveni={S\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=MP}{%
         family={Muntner},
         familyi={M\bibinitperiod},
         given={Paul},
         giveni={P\bibinitperiod},
      }}%
      {{hash=CAHAS}{%
         family={Committee},
         familyi={C\bibinitperiod},
         given={American Heart Association\bibnamedelima Statistics},
         giveni={A\bibinitperiod\bibinitdelim H\bibinitperiod\bibinitdelim
  A\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=SSS}{%
         family={Subcommittee},
         familyi={S\bibinitperiod},
         given={Stroke\bibnamedelima Statistics},
         giveni={S\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
    }
    \keyw{AHA Scientific Statements; cardiovascular diseases; epidemiology;
  risk factors; statistics; stroke}
    \strng{namehash}{BEJ+1}
  \strng{fullhash}{BEJBMJCSECMDSRDRFSDdFJFMGCICRJMCJLCJSELDLJHLLLSLCTMRHMKMDMMENKNRWPLPDKTRRRMJRMRCJRGARWDSCTATCWTMBVSSVJHWJZWJTWJHAHMWSSMPCAHASSSS1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1161/CIR.0000000000000485
    \endverb
    \field{issn}{1524-4539}
    \field{issue}{10}
    \field{pages}{e146\bibrangedash e603}
    \field{title}{Heart Disease and Stroke Statistics-2017 Update: A Report
  From the American Heart Association.}
    \field{volume}{135}
    \verb{file}
    \verb :PDFs/Benjamin2017.pdf:PDF
    \endverb
    \field{journaltitle}{Circulation}
    \field{month}{03}
    \field{year}{2017}
  \endentry

  \entry{Lozano2012}{article}{}
    \name{author}{191}{}{%
      {{hash=LR}{%
         family={Lozano},
         familyi={L\bibinitperiod},
         given={Rafael},
         giveni={R\bibinitperiod},
      }}%
      {{hash=NM}{%
         family={Naghavi},
         familyi={N\bibinitperiod},
         given={Mohsen},
         giveni={M\bibinitperiod},
      }}%
      {{hash=FK}{%
         family={Foreman},
         familyi={F\bibinitperiod},
         given={Kyle},
         giveni={K\bibinitperiod},
      }}%
      {{hash=LS}{%
         family={Lim},
         familyi={L\bibinitperiod},
         given={Stephen},
         giveni={S\bibinitperiod},
      }}%
      {{hash=SK}{%
         family={Shibuya},
         familyi={S\bibinitperiod},
         given={Kenji},
         giveni={K\bibinitperiod},
      }}%
      {{hash=AV}{%
         family={Aboyans},
         familyi={A\bibinitperiod},
         given={Victor},
         giveni={V\bibinitperiod},
      }}%
      {{hash=AJ}{%
         family={Abraham},
         familyi={A\bibinitperiod},
         given={Jerry},
         giveni={J\bibinitperiod},
      }}%
      {{hash=AT}{%
         family={Adair},
         familyi={A\bibinitperiod},
         given={Timothy},
         giveni={T\bibinitperiod},
      }}%
      {{hash=AR}{%
         family={Aggarwal},
         familyi={A\bibinitperiod},
         given={Rakesh},
         giveni={R\bibinitperiod},
      }}%
      {{hash=ASY}{%
         family={Ahn},
         familyi={A\bibinitperiod},
         given={Stephanie\bibnamedelima Y},
         giveni={S\bibinitperiod\bibinitdelim Y\bibinitperiod},
      }}%
      {{hash=AM}{%
         family={Alvarado},
         familyi={A\bibinitperiod},
         given={Miriam},
         giveni={M\bibinitperiod},
      }}%
      {{hash=AHR}{%
         family={Anderson},
         familyi={A\bibinitperiod},
         given={H\bibnamedelima Ross},
         giveni={H\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=ALM}{%
         family={Anderson},
         familyi={A\bibinitperiod},
         given={Laurie\bibnamedelima M},
         giveni={L\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=AKG}{%
         family={Andrews},
         familyi={A\bibinitperiod},
         given={Kathryn\bibnamedelima G},
         giveni={K\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=AC}{%
         family={Atkinson},
         familyi={A\bibinitperiod},
         given={Charles},
         giveni={C\bibinitperiod},
      }}%
      {{hash=BLM}{%
         family={Baddour},
         familyi={B\bibinitperiod},
         given={Larry\bibnamedelima M},
         giveni={L\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=BCS}{%
         family={Barker-Collo},
         familyi={B\bibinithyphendelim C\bibinitperiod},
         given={Suzanne},
         giveni={S\bibinitperiod},
      }}%
      {{hash=BDH}{%
         family={Bartels},
         familyi={B\bibinitperiod},
         given={David\bibnamedelima H},
         giveni={D\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=BML}{%
         family={Bell},
         familyi={B\bibinitperiod},
         given={Michelle\bibnamedelima L},
         giveni={M\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=BEJ}{%
         family={Benjamin},
         familyi={B\bibinitperiod},
         given={Emelia\bibnamedelima J},
         giveni={E\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=BD}{%
         family={Bennett},
         familyi={B\bibinitperiod},
         given={Derrick},
         giveni={D\bibinitperiod},
      }}%
      {{hash=BK}{%
         family={Bhalla},
         familyi={B\bibinitperiod},
         given={Kavi},
         giveni={K\bibinitperiod},
      }}%
      {{hash=BB}{%
         family={Bikbov},
         familyi={B\bibinitperiod},
         given={Boris},
         giveni={B\bibinitperiod},
      }}%
      {{hash=BAA}{%
         family={Bin\bibnamedelima Abdulhak},
         familyi={B\bibinitperiod\bibinitdelim A\bibinitperiod},
         given={Aref},
         giveni={A\bibinitperiod},
      }}%
      {{hash=BG}{%
         family={Birbeck},
         familyi={B\bibinitperiod},
         given={Gretchen},
         giveni={G\bibinitperiod},
      }}%
      {{hash=BF}{%
         family={Blyth},
         familyi={B\bibinitperiod},
         given={Fiona},
         giveni={F\bibinitperiod},
      }}%
      {{hash=BI}{%
         family={Bolliger},
         familyi={B\bibinitperiod},
         given={Ian},
         giveni={I\bibinitperiod},
      }}%
      {{hash=BS}{%
         family={Boufous},
         familyi={B\bibinitperiod},
         given={Soufiane},
         giveni={S\bibinitperiod},
      }}%
      {{hash=BC}{%
         family={Bucello},
         familyi={B\bibinitperiod},
         given={Chiara},
         giveni={C\bibinitperiod},
      }}%
      {{hash=BM}{%
         family={Burch},
         familyi={B\bibinitperiod},
         given={Michael},
         giveni={M\bibinitperiod},
      }}%
      {{hash=BP}{%
         family={Burney},
         familyi={B\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
      {{hash=CJ}{%
         family={Carapetis},
         familyi={C\bibinitperiod},
         given={Jonathan},
         giveni={J\bibinitperiod},
      }}%
      {{hash=CH}{%
         family={Chen},
         familyi={C\bibinitperiod},
         given={Honglei},
         giveni={H\bibinitperiod},
      }}%
      {{hash=CD}{%
         family={Chou},
         familyi={C\bibinitperiod},
         given={David},
         giveni={D\bibinitperiod},
      }}%
      {{hash=CSS}{%
         family={Chugh},
         familyi={C\bibinitperiod},
         given={Sumeet\bibnamedelima S},
         giveni={S\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=CLE}{%
         family={Coffeng},
         familyi={C\bibinitperiod},
         given={Luc\bibnamedelima E},
         giveni={L\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=CSD}{%
         family={Colan},
         familyi={C\bibinitperiod},
         given={Steven\bibnamedelima D},
         giveni={S\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=CS}{%
         family={Colquhoun},
         familyi={C\bibinitperiod},
         given={Samantha},
         giveni={S\bibinitperiod},
      }}%
      {{hash=CKE}{%
         family={Colson},
         familyi={C\bibinitperiod},
         given={K\bibnamedelima Ellicott},
         giveni={K\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=CJ}{%
         family={Condon},
         familyi={C\bibinitperiod},
         given={John},
         giveni={J\bibinitperiod},
      }}%
      {{hash=CMD}{%
         family={Connor},
         familyi={C\bibinitperiod},
         given={Myles\bibnamedelima D},
         giveni={M\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=CLT}{%
         family={Cooper},
         familyi={C\bibinitperiod},
         given={Leslie\bibnamedelima T},
         giveni={L\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
      {{hash=CM}{%
         family={Corriere},
         familyi={C\bibinitperiod},
         given={Matthew},
         giveni={M\bibinitperiod},
      }}%
      {{hash=CM}{%
         family={Cortinovis},
         familyi={C\bibinitperiod},
         given={Monica},
         giveni={M\bibinitperiod},
      }}%
      {{hash=dVKC}{%
         prefix={de},
         prefixi={d\bibinitperiod},
         family={Vaccaro},
         familyi={V\bibinitperiod},
         given={Karen\bibnamedelima Courville},
         giveni={K\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=CW}{%
         family={Couser},
         familyi={C\bibinitperiod},
         given={William},
         giveni={W\bibinitperiod},
      }}%
      {{hash=CBC}{%
         family={Cowie},
         familyi={C\bibinitperiod},
         given={Benjamin\bibnamedelima C},
         giveni={B\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=CMH}{%
         family={Criqui},
         familyi={C\bibinitperiod},
         given={Michael\bibnamedelima H},
         giveni={M\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=CM}{%
         family={Cross},
         familyi={C\bibinitperiod},
         given={Marita},
         giveni={M\bibinitperiod},
      }}%
      {{hash=DKC}{%
         family={Dabhadkar},
         familyi={D\bibinitperiod},
         given={Kaustubh\bibnamedelima C},
         giveni={K\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=DN}{%
         family={Dahodwala},
         familyi={D\bibinitperiod},
         given={Nabila},
         giveni={N\bibinitperiod},
      }}%
      {{hash=DLD}{%
         family={De\bibnamedelima Leo},
         familyi={D\bibinitperiod\bibinitdelim L\bibinitperiod},
         given={Diego},
         giveni={D\bibinitperiod},
      }}%
      {{hash=DL}{%
         family={Degenhardt},
         familyi={D\bibinitperiod},
         given={Louisa},
         giveni={L\bibinitperiod},
      }}%
      {{hash=DA}{%
         family={Delossantos},
         familyi={D\bibinitperiod},
         given={Allyne},
         giveni={A\bibinitperiod},
      }}%
      {{hash=DJ}{%
         family={Denenberg},
         familyi={D\bibinitperiod},
         given={Julie},
         giveni={J\bibinitperiod},
      }}%
      {{hash=DJDC}{%
         family={Des\bibnamedelima Jarlais},
         familyi={D\bibinitperiod\bibinitdelim J\bibinitperiod},
         given={Don\bibnamedelima C},
         giveni={D\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=DSD}{%
         family={Dharmaratne},
         familyi={D\bibinitperiod},
         given={Samath\bibnamedelima D},
         giveni={S\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=DER}{%
         family={Dorsey},
         familyi={D\bibinitperiod},
         given={E\bibnamedelima Ray},
         giveni={E\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=DT}{%
         family={Driscoll},
         familyi={D\bibinitperiod},
         given={Tim},
         giveni={T\bibinitperiod},
      }}%
      {{hash=DH}{%
         family={Duber},
         familyi={D\bibinitperiod},
         given={Herbert},
         giveni={H\bibinitperiod},
      }}%
      {{hash=EB}{%
         family={Ebel},
         familyi={E\bibinitperiod},
         given={Beth},
         giveni={B\bibinitperiod},
      }}%
      {{hash=EPJ}{%
         family={Erwin},
         familyi={E\bibinitperiod},
         given={Patricia\bibnamedelima J},
         giveni={P\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=EP}{%
         family={Espindola},
         familyi={E\bibinitperiod},
         given={Patricia},
         giveni={P\bibinitperiod},
      }}%
      {{hash=EM}{%
         family={Ezzati},
         familyi={E\bibinitperiod},
         given={Majid},
         giveni={M\bibinitperiod},
      }}%
      {{hash=FV}{%
         family={Feigin},
         familyi={F\bibinitperiod},
         given={Valery},
         giveni={V\bibinitperiod},
      }}%
      {{hash=FAD}{%
         family={Flaxman},
         familyi={F\bibinitperiod},
         given={Abraham\bibnamedelima D},
         giveni={A\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=FMH}{%
         family={Forouzanfar},
         familyi={F\bibinitperiod},
         given={Mohammad\bibnamedelima H},
         giveni={M\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=FFGR}{%
         family={Fowkes},
         familyi={F\bibinitperiod},
         given={Francis Gerry\bibnamedelima R},
         giveni={F\bibinitperiod\bibinitdelim G\bibinitperiod\bibinitdelim
  R\bibinitperiod},
      }}%
      {{hash=FR}{%
         family={Franklin},
         familyi={F\bibinitperiod},
         given={Richard},
         giveni={R\bibinitperiod},
      }}%
      {{hash=FM}{%
         family={Fransen},
         familyi={F\bibinitperiod},
         given={Marlene},
         giveni={M\bibinitperiod},
      }}%
      {{hash=FMK}{%
         family={Freeman},
         familyi={F\bibinitperiod},
         given={Michael\bibnamedelima K},
         giveni={M\bibinitperiod\bibinitdelim K\bibinitperiod},
      }}%
      {{hash=GSE}{%
         family={Gabriel},
         familyi={G\bibinitperiod},
         given={Sherine\bibnamedelima E},
         giveni={S\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=GE}{%
         family={Gakidou},
         familyi={G\bibinitperiod},
         given={Emmanuela},
         giveni={E\bibinitperiod},
      }}%
      {{hash=GF}{%
         family={Gaspari},
         familyi={G\bibinitperiod},
         given={Flavio},
         giveni={F\bibinitperiod},
      }}%
      {{hash=GRF}{%
         family={Gillum},
         familyi={G\bibinitperiod},
         given={Richard\bibnamedelima F},
         giveni={R\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=GMD}{%
         family={Gonzalez-Medina},
         familyi={G\bibinithyphendelim M\bibinitperiod},
         given={Diego},
         giveni={D\bibinitperiod},
      }}%
      {{hash=HYA}{%
         family={Halasa},
         familyi={H\bibinitperiod},
         given={Yara\bibnamedelima A},
         giveni={Y\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=HD}{%
         family={Haring},
         familyi={H\bibinitperiod},
         given={Diana},
         giveni={D\bibinitperiod},
      }}%
      {{hash=HJE}{%
         family={Harrison},
         familyi={H\bibinitperiod},
         given={James\bibnamedelima E},
         giveni={J\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=HR}{%
         family={Havmoeller},
         familyi={H\bibinitperiod},
         given={Rasmus},
         giveni={R\bibinitperiod},
      }}%
      {{hash=HRJ}{%
         family={Hay},
         familyi={H\bibinitperiod},
         given={Roderick\bibnamedelima J},
         giveni={R\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=HB}{%
         family={Hoen},
         familyi={H\bibinitperiod},
         given={Bruno},
         giveni={B\bibinitperiod},
      }}%
      {{hash=HPJ}{%
         family={Hotez},
         familyi={H\bibinitperiod},
         given={Peter\bibnamedelima J},
         giveni={P\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=HD}{%
         family={Hoy},
         familyi={H\bibinitperiod},
         given={Damian},
         giveni={D\bibinitperiod},
      }}%
      {{hash=JKH}{%
         family={Jacobsen},
         familyi={J\bibinitperiod},
         given={Kathryn\bibnamedelima H},
         giveni={K\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=JSL}{%
         family={James},
         familyi={J\bibinitperiod},
         given={Spencer\bibnamedelima L},
         giveni={S\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=JR}{%
         family={Jasrasaria},
         familyi={J\bibinitperiod},
         given={Rashmi},
         giveni={R\bibinitperiod},
      }}%
      {{hash=JS}{%
         family={Jayaraman},
         familyi={J\bibinitperiod},
         given={Sudha},
         giveni={S\bibinitperiod},
      }}%
      {{hash=JN}{%
         family={Johns},
         familyi={J\bibinitperiod},
         given={Nicole},
         giveni={N\bibinitperiod},
      }}%
      {{hash=KG}{%
         family={Karthikeyan},
         familyi={K\bibinitperiod},
         given={Ganesan},
         giveni={G\bibinitperiod},
      }}%
      {{hash=KN}{%
         family={Kassebaum},
         familyi={K\bibinitperiod},
         given={Nicholas},
         giveni={N\bibinitperiod},
      }}%
      {{hash=KA}{%
         family={Keren},
         familyi={K\bibinitperiod},
         given={Andre},
         giveni={A\bibinitperiod},
      }}%
      {{hash=KJP}{%
         family={Khoo},
         familyi={K\bibinitperiod},
         given={Jon-Paul},
         giveni={J\bibinithyphendelim P\bibinitperiod},
      }}%
      {{hash=KLM}{%
         family={Knowlton},
         familyi={K\bibinitperiod},
         given={Lisa\bibnamedelima Marie},
         giveni={L\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=KO}{%
         family={Kobusingye},
         familyi={K\bibinitperiod},
         given={Olive},
         giveni={O\bibinitperiod},
      }}%
      {{hash=KA}{%
         family={Koranteng},
         familyi={K\bibinitperiod},
         given={Adofo},
         giveni={A\bibinitperiod},
      }}%
      {{hash=KR}{%
         family={Krishnamurthi},
         familyi={K\bibinitperiod},
         given={Rita},
         giveni={R\bibinitperiod},
      }}%
      {{hash=LM}{%
         family={Lipnick},
         familyi={L\bibinitperiod},
         given={Michael},
         giveni={M\bibinitperiod},
      }}%
      {{hash=LSE}{%
         family={Lipshultz},
         familyi={L\bibinitperiod},
         given={Steven\bibnamedelima E},
         giveni={S\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=OSL}{%
         family={Ohno},
         familyi={O\bibinitperiod},
         given={Summer\bibnamedelima Lockett},
         giveni={S\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=MJ}{%
         family={Mabweijano},
         familyi={M\bibinitperiod},
         given={Jacqueline},
         giveni={J\bibinitperiod},
      }}%
      {{hash=MMF}{%
         family={MacIntyre},
         familyi={M\bibinitperiod},
         given={Michael\bibnamedelima F},
         giveni={M\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=ML}{%
         family={Mallinger},
         familyi={M\bibinitperiod},
         given={Leslie},
         giveni={L\bibinitperiod},
      }}%
      {{hash=ML}{%
         family={March},
         familyi={M\bibinitperiod},
         given={Lyn},
         giveni={L\bibinitperiod},
      }}%
      {{hash=MGB}{%
         family={Marks},
         familyi={M\bibinitperiod},
         given={Guy\bibnamedelima B},
         giveni={G\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=MR}{%
         family={Marks},
         familyi={M\bibinitperiod},
         given={Robin},
         giveni={R\bibinitperiod},
      }}%
      {{hash=MA}{%
         family={Matsumori},
         familyi={M\bibinitperiod},
         given={Akira},
         giveni={A\bibinitperiod},
      }}%
      {{hash=MR}{%
         family={Matzopoulos},
         familyi={M\bibinitperiod},
         given={Richard},
         giveni={R\bibinitperiod},
      }}%
      {{hash=MBM}{%
         family={Mayosi},
         familyi={M\bibinitperiod},
         given={Bongani\bibnamedelima M},
         giveni={B\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=MJH}{%
         family={McAnulty},
         familyi={M\bibinitperiod},
         given={John\bibnamedelima H},
         giveni={J\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=MMM}{%
         family={McDermott},
         familyi={M\bibinitperiod},
         given={Mary\bibnamedelima M},
         giveni={M\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=MJ}{%
         family={McGrath},
         familyi={M\bibinitperiod},
         given={John},
         giveni={J\bibinitperiod},
      }}%
      {{hash=MGA}{%
         family={Mensah},
         familyi={M\bibinitperiod},
         given={George\bibnamedelima A},
         giveni={G\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=MTR}{%
         family={Merriman},
         familyi={M\bibinitperiod},
         given={Tony\bibnamedelima R},
         giveni={T\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=MC}{%
         family={Michaud},
         familyi={M\bibinitperiod},
         given={Catherine},
         giveni={C\bibinitperiod},
      }}%
      {{hash=MM}{%
         family={Miller},
         familyi={M\bibinitperiod},
         given={Matthew},
         giveni={M\bibinitperiod},
      }}%
      {{hash=MTR}{%
         family={Miller},
         familyi={M\bibinitperiod},
         given={Ted\bibnamedelima R},
         giveni={T\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=MC}{%
         family={Mock},
         familyi={M\bibinitperiod},
         given={Charles},
         giveni={C\bibinitperiod},
      }}%
      {{hash=MAO}{%
         family={Mocumbi},
         familyi={M\bibinitperiod},
         given={Ana\bibnamedelima Olga},
         giveni={A\bibinitperiod\bibinitdelim O\bibinitperiod},
      }}%
      {{hash=MAA}{%
         family={Mokdad},
         familyi={M\bibinitperiod},
         given={Ali\bibnamedelima A},
         giveni={A\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=MA}{%
         family={Moran},
         familyi={M\bibinitperiod},
         given={Andrew},
         giveni={A\bibinitperiod},
      }}%
      {{hash=MK}{%
         family={Mulholland},
         familyi={M\bibinitperiod},
         given={Kim},
         giveni={K\bibinitperiod},
      }}%
      {{hash=NMN}{%
         family={Nair},
         familyi={N\bibinitperiod},
         given={M\bibnamedelima Nathan},
         giveni={M\bibinitperiod\bibinitdelim N\bibinitperiod},
      }}%
      {{hash=NL}{%
         family={Naldi},
         familyi={N\bibinitperiod},
         given={Luigi},
         giveni={L\bibinitperiod},
      }}%
      {{hash=NKMV}{%
         family={Narayan},
         familyi={N\bibinitperiod},
         given={K\bibnamedelima M\bibnamedelima Venkat},
         giveni={K\bibinitperiod\bibinitdelim M\bibinitperiod\bibinitdelim
  V\bibinitperiod},
      }}%
      {{hash=NK}{%
         family={Nasseri},
         familyi={N\bibinitperiod},
         given={Kiumarss},
         giveni={K\bibinitperiod},
      }}%
      {{hash=NP}{%
         family={Norman},
         familyi={N\bibinitperiod},
         given={Paul},
         giveni={P\bibinitperiod},
      }}%
      {{hash=OM}{%
         family={O'Donnell},
         familyi={O\bibinitperiod},
         given={Martin},
         giveni={M\bibinitperiod},
      }}%
      {{hash=OSB}{%
         family={Omer},
         familyi={O\bibinitperiod},
         given={Saad\bibnamedelima B},
         giveni={S\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=OK}{%
         family={Ortblad},
         familyi={O\bibinitperiod},
         given={Katrina},
         giveni={K\bibinitperiod},
      }}%
      {{hash=OR}{%
         family={Osborne},
         familyi={O\bibinitperiod},
         given={Richard},
         giveni={R\bibinitperiod},
      }}%
      {{hash=OD}{%
         family={Ozgediz},
         familyi={O\bibinitperiod},
         given={Doruk},
         giveni={D\bibinitperiod},
      }}%
      {{hash=PB}{%
         family={Pahari},
         familyi={P\bibinitperiod},
         given={Bishnu},
         giveni={B\bibinitperiod},
      }}%
      {{hash=PJD}{%
         family={Pandian},
         familyi={P\bibinitperiod},
         given={Jeyaraj\bibnamedelima Durai},
         giveni={J\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=RAP}{%
         family={Rivero},
         familyi={R\bibinitperiod},
         given={Andrea\bibnamedelima Panozo},
         giveni={A\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=PRP}{%
         family={Padilla},
         familyi={P\bibinitperiod},
         given={Rogelio\bibnamedelima Perez},
         giveni={R\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=PRF}{%
         family={Perez-Ruiz},
         familyi={P\bibinithyphendelim R\bibinitperiod},
         given={Fernando},
         giveni={F\bibinitperiod},
      }}%
      {{hash=PN}{%
         family={Perico},
         familyi={P\bibinitperiod},
         given={Norberto},
         giveni={N\bibinitperiod},
      }}%
      {{hash=PD}{%
         family={Phillips},
         familyi={P\bibinitperiod},
         given={David},
         giveni={D\bibinitperiod},
      }}%
      {{hash=PK}{%
         family={Pierce},
         familyi={P\bibinitperiod},
         given={Kelsey},
         giveni={K\bibinitperiod},
      }}%
      {{hash=PCA}{%
         family={Pope},
         familyi={P\bibinitperiod},
         given={C\bibnamedelima Arden},
         giveni={C\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=PE}{%
         family={Porrini},
         familyi={P\bibinitperiod},
         given={Esteban},
         giveni={E\bibinitperiod},
      }}%
      {{hash=PF}{%
         family={Pourmalek},
         familyi={P\bibinitperiod},
         given={Farshad},
         giveni={F\bibinitperiod},
      }}%
      {{hash=RM}{%
         family={Raju},
         familyi={R\bibinitperiod},
         given={Murugesan},
         giveni={M\bibinitperiod},
      }}%
      {{hash=RD}{%
         family={Ranganathan},
         familyi={R\bibinitperiod},
         given={Dharani},
         giveni={D\bibinitperiod},
      }}%
      {{hash=RJT}{%
         family={Rehm},
         familyi={R\bibinitperiod},
         given={Jürgen\bibnamedelima T},
         giveni={J\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
      {{hash=RDB}{%
         family={Rein},
         familyi={R\bibinitperiod},
         given={David\bibnamedelima B},
         giveni={D\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=RG}{%
         family={Remuzzi},
         familyi={R\bibinitperiod},
         given={Guiseppe},
         giveni={G\bibinitperiod},
      }}%
      {{hash=RFP}{%
         family={Rivara},
         familyi={R\bibinitperiod},
         given={Frederick\bibnamedelima P},
         giveni={F\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=RT}{%
         family={Roberts},
         familyi={R\bibinitperiod},
         given={Thomas},
         giveni={T\bibinitperiod},
      }}%
      {{hash=DLFR}{%
         family={De\bibnamedelima León},
         familyi={D\bibinitperiod\bibinitdelim L\bibinitperiod},
         given={Felipe\bibnamedelima Rodriguez},
         giveni={F\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=RLC}{%
         family={Rosenfeld},
         familyi={R\bibinitperiod},
         given={Lisa\bibnamedelima C},
         giveni={L\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=RL}{%
         family={Rushton},
         familyi={R\bibinitperiod},
         given={Lesley},
         giveni={L\bibinitperiod},
      }}%
      {{hash=SRL}{%
         family={Sacco},
         familyi={S\bibinitperiod},
         given={Ralph\bibnamedelima L},
         giveni={R\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=SJA}{%
         family={Salomon},
         familyi={S\bibinitperiod},
         given={Joshua\bibnamedelima A},
         giveni={J\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=SU}{%
         family={Sampson},
         familyi={S\bibinitperiod},
         given={Uchechukwu},
         giveni={U\bibinitperiod},
      }}%
      {{hash=SE}{%
         family={Sanman},
         familyi={S\bibinitperiod},
         given={Ella},
         giveni={E\bibinitperiod},
      }}%
      {{hash=SDC}{%
         family={Schwebel},
         familyi={S\bibinitperiod},
         given={David\bibnamedelima C},
         giveni={D\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=SGM}{%
         family={Segui-Gomez},
         familyi={S\bibinithyphendelim G\bibinitperiod},
         given={Maria},
         giveni={M\bibinitperiod},
      }}%
      {{hash=SDS}{%
         family={Shepard},
         familyi={S\bibinitperiod},
         given={Donald\bibnamedelima S},
         giveni={D\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=SD}{%
         family={Singh},
         familyi={S\bibinitperiod},
         given={David},
         giveni={D\bibinitperiod},
      }}%
      {{hash=SJ}{%
         family={Singleton},
         familyi={S\bibinitperiod},
         given={Jessica},
         giveni={J\bibinitperiod},
      }}%
      {{hash=SK}{%
         family={Sliwa},
         familyi={S\bibinitperiod},
         given={Karen},
         giveni={K\bibinitperiod},
      }}%
      {{hash=SE}{%
         family={Smith},
         familyi={S\bibinitperiod},
         given={Emma},
         giveni={E\bibinitperiod},
      }}%
      {{hash=SA}{%
         family={Steer},
         familyi={S\bibinitperiod},
         given={Andrew},
         giveni={A\bibinitperiod},
      }}%
      {{hash=TJA}{%
         family={Taylor},
         familyi={T\bibinitperiod},
         given={Jennifer\bibnamedelima A},
         giveni={J\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=TB}{%
         family={Thomas},
         familyi={T\bibinitperiod},
         given={Bernadette},
         giveni={B\bibinitperiod},
      }}%
      {{hash=TIM}{%
         family={Tleyjeh},
         familyi={T\bibinitperiod},
         given={Imad\bibnamedelima M},
         giveni={I\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=TJA}{%
         family={Towbin},
         familyi={T\bibinitperiod},
         given={Jeffrey\bibnamedelima A},
         giveni={J\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=TT}{%
         family={Truelsen},
         familyi={T\bibinitperiod},
         given={Thomas},
         giveni={T\bibinitperiod},
      }}%
      {{hash=UEA}{%
         family={Undurraga},
         familyi={U\bibinitperiod},
         given={Eduardo\bibnamedelima A},
         giveni={E\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=VN}{%
         family={Venketasubramanian},
         familyi={V\bibinitperiod},
         given={N},
         giveni={N},
      }}%
      {{hash=VL}{%
         family={Vijayakumar},
         familyi={V\bibinitperiod},
         given={Lakshmi},
         giveni={L\bibinitperiod},
      }}%
      {{hash=VT}{%
         family={Vos},
         familyi={V\bibinitperiod},
         given={Theo},
         giveni={T\bibinitperiod},
      }}%
      {{hash=WGR}{%
         family={Wagner},
         familyi={W\bibinitperiod},
         given={Gregory\bibnamedelima R},
         giveni={G\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=WM}{%
         family={Wang},
         familyi={W\bibinitperiod},
         given={Mengru},
         giveni={M\bibinitperiod},
      }}%
      {{hash=WW}{%
         family={Wang},
         familyi={W\bibinitperiod},
         given={Wenzhi},
         giveni={W\bibinitperiod},
      }}%
      {{hash=WK}{%
         family={Watt},
         familyi={W\bibinitperiod},
         given={Kerrianne},
         giveni={K\bibinitperiod},
      }}%
      {{hash=WMA}{%
         family={Weinstock},
         familyi={W\bibinitperiod},
         given={Martin\bibnamedelima A},
         giveni={M\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=WR}{%
         family={Weintraub},
         familyi={W\bibinitperiod},
         given={Robert},
         giveni={R\bibinitperiod},
      }}%
      {{hash=WJD}{%
         family={Wilkinson},
         familyi={W\bibinitperiod},
         given={James\bibnamedelima D},
         giveni={J\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=WAD}{%
         family={Woolf},
         familyi={W\bibinitperiod},
         given={Anthony\bibnamedelima D},
         giveni={A\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=WS}{%
         family={Wulf},
         familyi={W\bibinitperiod},
         given={Sarah},
         giveni={S\bibinitperiod},
      }}%
      {{hash=YPH}{%
         family={Yeh},
         familyi={Y\bibinitperiod},
         given={Pon-Hsiu},
         giveni={P\bibinithyphendelim H\bibinitperiod},
      }}%
      {{hash=YP}{%
         family={Yip},
         familyi={Y\bibinitperiod},
         given={Paul},
         giveni={P\bibinitperiod},
      }}%
      {{hash=ZA}{%
         family={Zabetian},
         familyi={Z\bibinitperiod},
         given={Azadeh},
         giveni={A\bibinitperiod},
      }}%
      {{hash=ZZJ}{%
         family={Zheng},
         familyi={Z\bibinitperiod},
         given={Zhi-Jie},
         giveni={Z\bibinithyphendelim J\bibinitperiod},
      }}%
      {{hash=LAD}{%
         family={Lopez},
         familyi={L\bibinitperiod},
         given={Alan\bibnamedelima D},
         giveni={A\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=MCJL}{%
         family={Murray},
         familyi={M\bibinitperiod},
         given={Christopher J\bibnamedelima L},
         giveni={C\bibinitperiod\bibinitdelim J\bibinitperiod\bibinitdelim
  L\bibinitperiod},
      }}%
      {{hash=AMA}{%
         family={AlMazroa},
         familyi={A\bibinitperiod},
         given={Mohammad\bibnamedelima A},
         giveni={M\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=MZA}{%
         family={Memish},
         familyi={M\bibinitperiod},
         given={Ziad\bibnamedelima A},
         giveni={Z\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
    }
    \keyw{Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cause of
  Death, trends; Child; Child, Preschool; Female; Global Health, statistics &
  numerical data; Humans; Infant; Infant, Newborn; Male; Middle Aged;
  Mortality, trends; Sex Factors; Young Adult}
    \strng{namehash}{LR+1}
  \strng{fullhash}{LRNMFKLSSKAVAJATARASYAMAHRALMAKGACBLMBCSBDHBMLBEJBDBKBBBAABGBFBIBSBCBMBPCJCHCDCSSCLECSDCSCKECJCMDCLTCMCMVKCdCWCBCCMHCMDKCDNDLDDLDADJDJDCDSDDERDTDHEBEPJEPEMFVFADFMHFFGRFRFMFMKGSEGEGFGRFGMDHYAHDHJEHRHRJHBHPJHDJKHJSLJRJSJNKGKNKAKJPKLMKOKAKRLMLSEOSLMJMMF}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Reliable and timely information on the leading causes of death in
  populations, and how these are changing, is a crucial input into health
  policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors
  Study 2010 (GBD 2010), we aimed to estimate annual deaths for the world and
  21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals
  (UIs), separately by age and sex. We attempted to identify all available data
  on causes of death for 187 countries from 1980 to 2010 from vital
  registration, verbal autopsy, mortality surveillance, censuses, surveys,
  hospitals, police records, and mortuaries. We assessed data quality for
  completeness, diagnostic accuracy, missing data, stochastic variations, and
  probable causes of death. We applied six different modelling strategies to
  estimate cause-specific mortality trends depending on the strength of the
  data. For 133 causes and three special aggregates we used the Cause of Death
  Ensemble model (CODEm) approach, which uses four families of statistical
  models testing a large set of different models using different permutations
  of covariates. Model ensembles were developed from these component models. We
  assessed model performance with rigorous out-of-sample testing of prediction
  error and the validity of 95% UIs. For 13 causes with low observed numbers of
  deaths, we developed negative binomial models with plausible covariates. For
  27 causes for which death is rare, we modelled the higher level cause in the
  cause hierarchy of the GBD 2010 and then allocated deaths across component
  causes proportionately, estimated from all available data in the database.
  For selected causes (African trypanosomiasis, congenital syphilis, whooping
  cough, measles, typhoid and parathyroid, leishmaniasis, acute hepatitis E,
  and HIV/AIDS), we used natural history models based on information on
  incidence, prevalence, and case-fatality. We separately estimated cause
  fractions by aetiology for diarrhoea, lower respiratory infections, and
  meningitis, as well as disaggregations by subcause for chronic kidney
  disease, maternal disorders, cirrhosis, and liver cancer. For deaths due to
  collective violence and natural disasters, we used mortality shock
  regressions. For every cause, we estimated 95% UIs that captured both
  parameter estimation uncertainty and uncertainty due to model specification
  where CODEm was used. We constrained cause-specific fractions within every
  age-sex group to sum to total mortality based on draws from the uncertainty
  distributions. In 2010, there were 52·8 million deaths globally. At the most
  aggregate level, communicable, maternal, neonatal, and nutritional causes
  were 24·9% of deaths worldwide in 2010, down from 15·9 million (34·1%) of
  46·5 million in 1990. This decrease was largely due to decreases in
  mortality from diarrhoeal disease (from 2·5 to 1·4 million), lower
  respiratory infections (from 3·4 to 2·8 million), neonatal disorders (from
  3·1 to 2·2 million), measles (from 0·63 to 0·13 million), and tetanus
  (from 0·27 to 0·06 million). Deaths from HIV/AIDS increased from 0·30
  million in 1990 to 1·5 million in 2010, reaching a peak of 1·7 million in
  2006. Malaria mortality also rose by an estimated 19·9% since 1990 to 1·17
  million deaths in 2010. Tuberculosis killed 1·2 million people in 2010.
  Deaths from non-communicable diseases rose by just under 8 million between
  1990 and 2010, accounting for two of every three deaths (34·5 million)
  worldwide by 2010. 8 million people died from cancer in 2010, 38% more than
  two decades ago; of these, 1·5 million (19%) were from trachea, bronchus,
  and lung cancer. Ischaemic heart disease and stroke collectively killed 12·9
  million people in 2010, or one in four deaths worldwide, compared with one in
  five in 1990; 1·3 million deaths were due to diabetes, twice as many as in
  1990. The fraction of global deaths due to injuries (5·1 million deaths) was
  marginally higher in 2010 (9·6%) compared with two decades earlier (8·8%).
  This was driven by a 46% rise in deaths worldwide due to road traffic
  accidents (1·3 million in 2010) and a rise in deaths from falls. Ischaemic
  heart disease, stroke, chronic obstructive pulmonary disease (COPD), lower
  respiratory infections, lung cancer, and HIV/AIDS were the leading causes of
  death in 2010. Ischaemic heart disease, lower respiratory infections, stroke,
  diarrhoeal disease, malaria, and HIV/AIDS were the leading causes of years of
  life lost due to premature mortality (YLLs) in 2010, similar to what was
  estimated for 1990, except for HIV/AIDS and preterm birth complications. YLLs
  from lower respiratory infections and diarrhoea decreased by 45-54% since
  1990; ischaemic heart disease and stroke YLLs increased by 17-28%. Regional
  variations in leading causes of death were substantial. Communicable,
  maternal, neonatal, and nutritional causes still accounted for 76% of
  premature mortality in sub-Saharan Africa in 2010. Age standardised death
  rates from some key disorders rose (HIV/AIDS, Alzheimer's disease, diabetes
  mellitus, and chronic kidney disease in particular), but for most diseases,
  death rates fell in the past two decades; including major vascular diseases,
  COPD, most forms of cancer, liver cirrhosis, and maternal disorders. For
  other conditions, notably malaria, prostate cancer, and injuries, little
  change was noted. Population growth, increased average age of the world's
  population, and largely decreasing age-specific, sex-specific, and
  cause-specific death rates combine to drive a broad shift from communicable,
  maternal, neonatal, and nutritional causes towards non-communicable diseases.
  Nevertheless, communicable, maternal, neonatal, and nutritional causes remain
  the dominant causes of YLLs in sub-Saharan Africa. Overlaid on this general
  pattern of the epidemiological transition, marked regional variation exists
  in many causes, such as interpersonal violence, suicide, liver cancer,
  diabetes, cirrhosis, Chagas disease, African trypanosomiasis, melanoma, and
  others. Regional heterogeneity highlights the importance of sound
  epidemiological assessments of the causes of death on a regular basis. Bill &
  Melinda Gates Foundation.%
    }
    \verb{doi}
    \verb 10.1016/S0140-6736(12)61728-0
    \endverb
    \field{issn}{1474-547X}
    \field{issue}{9859}
    \field{pages}{2095\bibrangedash 2128}
    \field{title}{Global and regional mortality from 235 causes of death for 20
  age groups in 1990 and 2010: a systematic analysis for the Global Burden of
  Disease Study 2010.}
    \field{volume}{380}
    \verb{file}
    \verb :PDFs/lozano2012.pdf:PDF
    \endverb
    \field{journaltitle}{Lancet (London, England)}
    \field{month}{12}
    \field{year}{2012}
  \endentry

  \entry{ICDC2017}{online}{}
    \name{author}{1}{}{%
      {{hash=fDCIC}{%
         prefix={for},
         prefixi={f\bibinitperiod},
         family={Disease\bibnamedelima Control},
         familyi={D\bibinitperiod\bibinitdelim C\bibinitperiod},
         given={Israeli\bibnamedelima Center},
         giveni={I\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
    }
    \name{editor}{1}{}{%
      {{hash=ZI}{%
         family={Zucker},
         familyi={Z\bibinitperiod},
         given={Inbar},
         giveni={I\bibinitperiod},
      }}%
    }
    \strng{namehash}{DCICf1}
    \strng{fullhash}{DCICf1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{title}{National Stroke Registry in Israel, 2014-2015}
    \verb{url}
    \verb https://www.health.gov.il/publicationsfiles/stroke_registry_report_20
    \verb 14-2015.pdf
    \endverb
    \verb{file}
    \verb :bibtex/PDFs/ICDC2017.pdf:PDF
    \endverb
    \field{year}{2017}
    \warn{\item Invalid format of field 'date' \item Invalid format of field
  'date'}
  \endentry

  \entry{Yusuf2004}{article}{}
    \name{author}{12}{}{%
      {{hash=YS}{%
         family={Yusuf},
         familyi={Y\bibinitperiod},
         given={Salim},
         giveni={S\bibinitperiod},
      }}%
      {{hash=HS}{%
         family={Hawken},
         familyi={H\bibinitperiod},
         given={Steven},
         giveni={S\bibinitperiod},
      }}%
      {{hash=OS}{%
         family={Ounpuu},
         familyi={O\bibinitperiod},
         given={Stephanie},
         giveni={S\bibinitperiod},
      }}%
      {{hash=DT}{%
         family={Dans},
         familyi={D\bibinitperiod},
         given={Tony},
         giveni={T\bibinitperiod},
      }}%
      {{hash=AA}{%
         family={Avezum},
         familyi={A\bibinitperiod},
         given={Alvaro},
         giveni={A\bibinitperiod},
      }}%
      {{hash=LF}{%
         family={Lanas},
         familyi={L\bibinitperiod},
         given={Fernando},
         giveni={F\bibinitperiod},
      }}%
      {{hash=MM}{%
         family={McQueen},
         familyi={M\bibinitperiod},
         given={Matthew},
         giveni={M\bibinitperiod},
      }}%
      {{hash=BA}{%
         family={Budaj},
         familyi={B\bibinitperiod},
         given={Andrzej},
         giveni={A\bibinitperiod},
      }}%
      {{hash=PP}{%
         family={Pais},
         familyi={P\bibinitperiod},
         given={Prem},
         giveni={P\bibinitperiod},
      }}%
      {{hash=VJ}{%
         family={Varigos},
         familyi={V\bibinitperiod},
         given={John},
         giveni={J\bibinitperiod},
      }}%
      {{hash=LL}{%
         family={Lisheng},
         familyi={L\bibinitperiod},
         given={Liu},
         giveni={L\bibinitperiod},
      }}%
      {{hash=IIS}{%
         family={Investigators},
         familyi={I\bibinitperiod},
         given={INTERHEART\bibnamedelima Study},
         giveni={I\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
    }
    \keyw{Alcohol Drinking; Apolipoproteins, blood; Body Constitution;
  Case-Control Studies; Cross-Cultural Comparison; Diabetes Complications;
  Diet; Exercise; Female; Global Health; Humans; Hypertension, complications;
  Male; Myocardial Infarction, epidemiology, etiology, prevention & control;
  Obesity, complications; Odds Ratio; Risk Factors; Smoking, adverse effects;
  Socioeconomic Factors}
    \strng{namehash}{YS+1}
    \strng{fullhash}{YSHSOSDTAALFMMBAPPVJLLIIS1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Although more than 80% of the global burden of cardiovascular disease
  occurs in low-income and middle-income countries, knowledge of the importance
  of risk factors is largely derived from developed countries. Therefore, the
  effect of such factors on risk of coronary heart disease in most regions of
  the world is unknown. We established a standardised case-control study of
  acute myocardial infarction in 52 countries, representing every inhabited
  continent. 15152 cases and 14820 controls were enrolled. The relation of
  smoking, history of hypertension or diabetes, waist/hip ratio, dietary
  patterns, physical activity, consumption of alcohol, blood apolipoproteins
  (Apo), and psychosocial factors to myocardial infarction are reported here.
  Odds ratios and their 99% CIs for the association of risk factors to
  myocardial infarction and their population attributable risks (PAR) were
  calculated. Smoking (odds ratio 2.87 for current vs never, PAR 35.7% for
  current and former vs never), raised ApoB/ApoA1 ratio (3.25 for top vs lowest
  quintile, PAR 49.2% for top four quintiles vs lowest quintile), history of
  hypertension (1.91, PAR 17.9%), diabetes (2.37, PAR 9.9%), abdominal obesity
  (1.12 for top vs lowest tertile and 1.62 for middle vs lowest tertile, PAR
  20.1% for top two tertiles vs lowest tertile), psychosocial factors (2.67,
  PAR 32.5%), daily consumption of fruits and vegetables (0.70, PAR 13.7% for
  lack of daily consumption), regular alcohol consumption (0.91, PAR 6.7%), and
  regular physical activity (0.86, PAR 12.2%), were all significantly related
  to acute myocardial infarction (p<0.0001 for all risk factors and p=0.03 for
  alcohol). These associations were noted in men and women, old and young, and
  in all regions of the world. Collectively, these nine risk factors accounted
  for 90% of the PAR in men and 94% in women. Abnormal lipids, smoking,
  hypertension, diabetes, abdominal obesity, psychosocial factors, consumption
  of fruits, vegetables, and alcohol, and regular physical activity account for
  most of the risk of myocardial infarction worldwide in both sexes and at all
  ages in all regions. This finding suggests that approaches to prevention can
  be based on similar principles worldwide and have the potential to prevent
  most premature cases of myocardial infarction.%
    }
    \verb{doi}
    \verb 10.1016/S0140-6736(04)17018-9
    \endverb
    \field{issn}{1474-547X}
    \field{issue}{9438}
    \field{pages}{937\bibrangedash 952}
    \field{title}{Effect of potentially modifiable risk factors associated with
  myocardial infarction in 52 countries (the INTERHEART study): case-control
  study.}
    \field{volume}{364}
    \verb{file}
    \verb :PDFs/yusuf2004.pdf:PDF
    \endverb
    \field{journaltitle}{Lancet (London, England)}
    \field{year}{2004}
  \endentry

  \entry{NationalCholesterolEducationProgramNCEPExpertPanelonDetection2002}{article}{}
    \name{author}{1}{}{%
      {{hash=N}{%
         family={{National Cholesterol Education Program (NCEP) Expert Panel on
  Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
  (Adult Treatment Panel III)}},
         familyi={N\bibinitperiod},
      }}%
    }
    \keyw{Adult; Cholesterol, blood; Cholesterol, HDL, blood; Cholesterol, LDL,
  blood; Coronary Disease, prevention & control; Diet; Diet Therapy; Disease
  Management; Drug Therapy; Female; Health Education; Humans;
  Hypercholesterolemia, blood, diagnosis, ethnology, therapy; Hyperlipidemias,
  blood, diagnosis, therapy; Life Style; Male; Nutrition Surveys; Reference
  Values; Risk Assessment; Risk Reduction Behavior; Triglycerides, blood}
    \strng{namehash}{N1}
    \strng{fullhash}{N1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{issn}{1524-4539}
    \field{issue}{25}
    \field{pages}{3143\bibrangedash 3421}
    \field{title}{Third Report of the National Cholesterol Education Program
  (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood
  Cholesterol in Adults (Adult Treatment Panel III) final report.}
    \field{volume}{106}
    \verb{file}
    \verb :PDFs/NCEP2002.pdf:PDF
    \endverb
    \field{journaltitle}{Circulation}
    \field{month}{12}
    \field{year}{2002}
  \endentry

  \entry{Hippisley-Cox2007}{article}{}
    \name{author}{6}{}{%
      {{hash=HCJ}{%
         family={Hippisley-Cox},
         familyi={H\bibinithyphendelim C\bibinitperiod},
         given={Julia},
         giveni={J\bibinitperiod},
      }}%
      {{hash=CC}{%
         family={Coupland},
         familyi={C\bibinitperiod},
         given={Carol},
         giveni={C\bibinitperiod},
      }}%
      {{hash=VY}{%
         family={Vinogradova},
         familyi={V\bibinitperiod},
         given={Yana},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=RJ}{%
         family={Robson},
         familyi={R\bibinitperiod},
         given={John},
         giveni={J\bibinitperiod},
      }}%
      {{hash=MM}{%
         family={May},
         familyi={M\bibinitperiod},
         given={Margaret},
         giveni={M\bibinitperiod},
      }}%
      {{hash=BP}{%
         family={Brindle},
         familyi={B\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
    }
    \keyw{Adult; Aged; Algorithms; Cardiovascular Diseases, etiology,
  mortality, prevention & control; Cohort Studies; Female; Humans; Male; Middle
  Aged; Prospective Studies; Risk Assessment; Risk Factors; United Kingdom,
  epidemiology}
    \strng{namehash}{HCJ+1}
    \strng{fullhash}{HCJCCVYRJMMBP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    To derive a new cardiovascular disease risk score (QRISK) for the United
  Kingdom and to validate its performance against the established Framingham
  cardiovascular disease algorithm and a newly developed Scottish score
  (ASSIGN). Prospective open cohort study using routinely collected data from
  general practice. UK practices contributing to the QRESEARCH database. The
  derivation cohort consisted of 1.28 million patients, aged 35-74 years,
  registered at 318 practices between 1 January 1995 and 1 April 2007 and who
  were free of diabetes and existing cardiovascular disease. The validation
  cohort consisted of 0.61 million patients from 160 practices. First recorded
  diagnosis of cardiovascular disease (incident diagnosis between 1 January
  1995 and 1 April 2007): myocardial infarction, coronary heart disease,
  stroke, and transient ischaemic attacks. Risk factors were age, sex, smoking
  status, systolic blood pressure, ratio of total serum cholesterol to high
  density lipoprotein, body mass index, family history of coronary heart
  disease in first degree relative aged less than 60, area measure of
  deprivation, and existing treatment with antihypertensive agent. A
  cardiovascular disease risk algorithm (QRISK) was developed in the derivation
  cohort. In the validation cohort the observed 10 year risk of a
  cardiovascular event was 6.60% (95% confidence interval 6.48% to 6.72%) in
  women and 9.28% (9.14% to 9.43%) in men. Overall the Framingham algorithm
  over-predicted cardiovascular disease risk at 10 years by 35%, ASSIGN by 36%,
  and QRISK by 0.4%. Measures of discrimination tended to be higher for QRISK
  than for the Framingham algorithm and it was better calibrated to the UK
  population than either the Framingham or ASSIGN models. Using QRISK 8.5% of
  patients aged 35-74 are at high risk (20% risk or higher over 10 years)
  compared with 13% when using the Framingham algorithm and 14% when using
  ASSIGN. Using QRISK 34% of women and 73% of men aged 64-75 would be at high
  risk compared with 24% and 86% according to the Framingham algorithm. UK
  estimates for 2005 based on QRISK give 3.2 million patients aged 35-74 at
  high risk, with the Framingham algorithm predicting 4.7 million and ASSIGN
  5.1 million. Overall, 53 668 patients in the validation dataset (9% of the
  total) would be reclassified from high to low risk or vice versa using QRISK
  compared with the Framingham algorithm. QRISK performed at least as well as
  the Framingham model for discrimination and was better calibrated to the UK
  population than either the Framingham model or ASSIGN. QRISK is likely to
  provide more appropriate risk estimates to help identify high risk patients
  on the basis of age, sex, and social deprivation. It is therefore likely to
  be a more equitable tool to inform management decisions and help ensure
  treatments are directed towards those most likely to benefit. It includes
  additional variables which improve risk estimates for patients with a
  positive family history or those on antihypertensive treatment. However,
  since the validation was performed in a similar population to the population
  from which the algorithm was derived, it potentially has a "home advantage."
  Further validation in other populations is therefore required.%
    }
    \verb{doi}
    \verb 10.1136/bmj.39261.471806.55
    \endverb
    \field{issn}{1756-1833}
    \field{issue}{7611}
    \field{pages}{136}
    \field{title}{Derivation and validation of QRISK, a new cardiovascular
  disease risk score for the United Kingdom: prospective open cohort study.}
    \field{volume}{335}
    \verb{file}
    \verb :PDFs/hippisley-cox2007.pdf:PDF
    \endverb
    \field{journaltitle}{BMJ (Clinical research ed.)}
    \field{month}{07}
    \field{year}{2007}
  \endentry

  \entry{Hippisley-Cox2008}{article}{}
    \name{author}{7}{}{%
      {{hash=HCJ}{%
         family={Hippisley-Cox},
         familyi={H\bibinithyphendelim C\bibinitperiod},
         given={Julia},
         giveni={J\bibinitperiod},
      }}%
      {{hash=CC}{%
         family={Coupland},
         familyi={C\bibinitperiod},
         given={Carol},
         giveni={C\bibinitperiod},
      }}%
      {{hash=VY}{%
         family={Vinogradova},
         familyi={V\bibinitperiod},
         given={Yana},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=RJ}{%
         family={Robson},
         familyi={R\bibinitperiod},
         given={John},
         giveni={J\bibinitperiod},
      }}%
      {{hash=MR}{%
         family={Minhas},
         familyi={M\bibinitperiod},
         given={Rubin},
         giveni={R\bibinitperiod},
      }}%
      {{hash=SA}{%
         family={Sheikh},
         familyi={S\bibinitperiod},
         given={Aziz},
         giveni={A\bibinitperiod},
      }}%
      {{hash=BP}{%
         family={Brindle},
         familyi={B\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
    }
    \keyw{Adult; Age Distribution; Aged; Algorithms; Cardiovascular Diseases,
  mortality; England, epidemiology; Epidemiologic Studies; Female; Humans;
  Male; Middle Aged; Prognosis; Sex Distribution; Wales, epidemiology}
    \strng{namehash}{HCJ+1}
    \strng{fullhash}{HCJCCVYRJMRSABP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    To develop and validate version two of the QRISK cardiovascular disease
  risk algorithm (QRISK2) to provide accurate estimates of cardiovascular risk
  in patients from different ethnic groups in England and Wales and to compare
  its performance with the modified version of Framingham score recommended by
  the National Institute for Health and Clinical Excellence (NICE). Prospective
  open cohort study with routinely collected data from general practice, 1
  January 1993 to 31 March 2008. 531 practices in England and Wales
  contributing to the national QRESEARCH database. 2.3 million patients aged
  35-74 (over 16 million person years) with 140,000 cardiovascular events.
  Overall population (derivation and validation cohorts) comprised 2.22 million
  people who were white or whose ethnic group was not recorded, 22,013 south
  Asian, 11,595 black African, 10,402 black Caribbean, and 19,792 from Chinese
  or other Asian or other ethnic groups. First (incident) diagnosis of
  cardiovascular disease (coronary heart disease, stroke, and transient
  ischaemic attack) recorded in general practice records or linked Office for
  National Statistics death certificates. Risk factors included self assigned
  ethnicity, age, sex, smoking status, systolic blood pressure, ratio of total
  serum cholesterol:high density lipoprotein cholesterol, body mass index,
  family history of coronary heart disease in first degree relative under 60
  years, Townsend deprivation score, treated hypertension, type 2 diabetes,
  renal disease, atrial fibrillation, and rheumatoid arthritis. The validation
  statistics indicated that QRISK2 had improved discrimination and calibration
  compared with the modified Framingham score. The QRISK2 algorithm explained
  43% of the variation in women and 38% in men compared with 39% and 35%,
  respectively, by the modified Framingham score. Of the 112,156 patients
  classified as high risk (that is, >or=20% risk over 10 years) by the modified
  Framingham score, 46,094 (41.1%) would be reclassified at low risk with
  QRISK2. The 10 year observed risk among these reclassified patients was 16.6%
  (95% confidence interval 16.1% to 17.0%)-that is, below the 20% treatment
  threshold. Of the 78 024 patients classified at high risk on QRISK2, 11,962
  (15.3%) would be reclassified at low risk by the modified Framingham score.
  The 10 year observed risk among these patients was 23.3% (22.2% to
  24.4%)-that is, above the 20% threshold. In the validation cohort, the annual
  incidence rate of cardiovascular events among those with a QRISK2 score of
  >or=20% was 30.6 per 1000 person years (29.8 to 31.5) for women and 32.5 per
  1000 person years (31.9 to 33.1) for men. The corresponding figures for the
  modified Framingham equation were 25.7 per 1000 person years (25.0 to 26.3)
  for women and 26.4 (26.0 to 26.8) for men). At the 20% threshold, the
  population identified by QRISK2 was at higher risk of a CV event than the
  population identified by the Framingham score. Incorporating ethnicity,
  deprivation, and other clinical conditions into the QRISK2 algorithm for risk
  of cardiovascular disease improves the accuracy of identification of those at
  high risk in a nationally representative population. At the 20% threshold,
  QRISK2 is likely to be a more efficient and equitable tool for treatment
  decisions for the primary prevention of cardiovascular disease. As the
  validation was performed in a similar population to the population from which
  the algorithm was derived, it potentially has a "home advantage." Further
  validation in other populations is therefore advised.%
    }
    \verb{doi}
    \verb 10.1136/bmj.39609.449676.25
    \endverb
    \field{issn}{1756-1833}
    \field{issue}{7659}
    \field{pages}{1475\bibrangedash 1482}
    \field{title}{Predicting cardiovascular risk in England and Wales:
  prospective derivation and validation of QRISK2.}
    \field{volume}{336}
    \verb{file}
    \verb :PDFs/hippisley-cox2008.pdf:PDF
    \endverb
    \field{journaltitle}{BMJ (Clinical research ed.)}
    \field{month}{06}
    \field{year}{2008}
  \endentry

  \entry{Bibbins-Domingo2016}{article}{}
    \name{author}{2}{}{%
      {{hash=BDK}{%
         family={Bibbins-Domingo},
         familyi={B\bibinithyphendelim D\bibinitperiod},
         given={Kirsten},
         giveni={K\bibinitperiod},
      }}%
      {{hash=FUPST}{%
         family={Force},
         familyi={F\bibinitperiod},
         given={U.S. Preventive Services\bibnamedelima Task},
         giveni={U\bibinitperiod\bibinitdelim P\bibinitperiod\bibinitdelim
  S\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
    }
    \keyw{Adult; Anticarcinogenic Agents, adverse effects, therapeutic use;
  Aspirin, adverse effects, therapeutic use; Cardiovascular Diseases,
  prevention & control; Colorectal Neoplasms, prevention & control;
  Fibrinolytic Agents, adverse effects, therapeutic use; Hemorrhage, chemically
  induced; Humans; Primary Prevention; Risk Assessment}
    \strng{namehash}{BDKFUPST1}
    \strng{fullhash}{BDKFUPST1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Update of the 2009 USPSTF recommendation on aspirin use to prevent
  cardiovascular disease (CVD) events and the 2007 recommendation on aspirin
  and nonsteroidal anti-inflammatory drug use to prevent colorectal cancer
  (CRC). The USPSTF reviewed 5 additional studies of aspirin for the primary
  prevention of CVD and several additional analyses of CRC follow-up data. The
  USPSTF also relied on commissioned systematic reviews of all-cause mortality
  and total cancer incidence and mortality and a comprehensive review of harms.
  The USPSTF then used a microsimulation model to systematically estimate the
  balance of benefits and harms. This recommendation applies to adults aged 40
  years or older without known CVD and without increased bleeding risk. The
  USPSTF recommends initiating low-dose aspirin use for the primary prevention
  of CVD and CRC in adults aged 50 to 59 years who have a 10% or greater
  10-year CVD risk, are not at increased risk for bleeding, have a life
  expectancy of at least 10 years, and are willing to take low-dose aspirin
  daily for at least 10 years. (B recommendation) The decision to initiate
  low-dose aspirin use for the primary prevention of CVD and CRC in adults aged
  60 to 69 years who have a 10% or greater 10-year CVD risk should be an
  individual one. Persons who are not at increased risk for bleeding, have a
  life expectancy of at least 10 years, and are willing to take low-dose
  aspirin daily for at least 10 years are more likely to benefit. Persons who
  place a higher value on the potential benefits than the potential harms may
  choose to initiate low-dose aspirin. (C recommendation) The current evidence
  is insufficient to assess the balance of benefits and harms of initiating
  aspirin use for the primary prevention of CVD and CRC in adults younger than
  50 years. (I statement) The current evidence is insufficient to assess the
  balance of benefits and harms of initiating aspirin use for the primary
  prevention of CVD and CRC in adults aged 70 years or older. (I statement).%
    }
    \verb{doi}
    \verb 10.7326/M16-0577
    \endverb
    \field{issn}{1539-3704}
    \field{issue}{12}
    \field{pages}{836\bibrangedash 845}
    \field{title}{Aspirin Use for the Primary Prevention of Cardiovascular
  Disease and Colorectal Cancer: U.S. Preventive Services Task Force
  Recommendation Statement.}
    \field{volume}{164}
    \verb{file}
    \verb :PDFs/bibbins2016.pdf:PDF
    \endverb
    \field{journaltitle}{Annals of internal medicine}
    \field{month}{06}
    \field{year}{2016}
  \endentry

  \entry{Kanis2008}{article}{}
    \name{author}{5}{}{%
      {{hash=KJA}{%
         family={Kanis},
         familyi={K\bibinitperiod},
         given={J\bibnamedelima A},
         giveni={J\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=JO}{%
         family={Johnell},
         familyi={J\bibinitperiod},
         given={O},
         giveni={O},
      }}%
      {{hash=OA}{%
         family={Oden},
         familyi={O\bibinitperiod},
         given={A},
         giveni={A},
      }}%
      {{hash=JH}{%
         family={Johansson},
         familyi={J\bibinitperiod},
         given={H},
         giveni={H},
      }}%
      {{hash=ME}{%
         family={McCloskey},
         familyi={M\bibinitperiod},
         given={E},
         giveni={E},
      }}%
    }
    \keyw{Aged; Aged, 80 and over; Body Mass Index; Epidemiologic Methods;
  Female; Hip Fractures, epidemiology, etiology; Humans; Male; Middle Aged;
  Osteoporosis, complications, epidemiology; Research Design, statistics &
  numerical data; Time Factors; United Kingdom, epidemiology}
    \strng{namehash}{KJA+1}
    \strng{fullhash}{KJAJOOAJHME1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    A fracture risk assessment tool (FRAX) is developed based on the use of
  clinical risk factors with or without bone mineral density tests applied to
  the UK. The aim of this study was to apply an assessment tool for the
  prediction of fracture in men and women with the use of clinical risk factors
  (CRFs) for fracture with and without the use of femoral neck bone mineral
  density (BMD). The clinical risk factors, identified from previous
  meta-analyses, comprised body mass index (BMI, as a continuous variable), a
  prior history of fracture, a parental history of hip fracture, use of oral
  glucocorticoids, rheumatoid arthritis and other secondary causes of
  osteoporosis, current smoking, and alcohol intake 3 or more units daily. Four
  models were constructed to compute fracture probabilities based on the
  epidemiology of fracture in the UK. The models comprised the ten-year
  probability of hip fracture, with and without femoral neck BMD, and the
  ten-year probability of a major osteoporotic fracture, with and without BMD.
  For each model fracture and death hazards were computed as continuous
  functions. Each clinical risk factor contributed to fracture probability. In
  the absence of BMD, hip fracture probability in women with a fixed BMI (25
  kg/m(2)) ranged from 0.2% at the age of 50 years for women without CRF's to
  22% at the age of 80 years with a parental history of hip fracture
  (approximately 100-fold range). In men, the probabilities were lower, as was
  the range (0.1 to 11% in the examples above). For a major osteoporotic
  fracture the probabilities ranged from 3.5% to 31% in women, and from 2.8% to
  15% in men in the example above. The presence of one or more risk factors
  increased probabilities in an incremental manner. The differences in
  probabilities between men and women were comparable at any given T-score and
  age, except in the elderly where probabilities were higher in women than in
  men due to the higher mortality of the latter. The models provide a framework
  which enhances the assessment of fracture risk in both men and women by the
  integration of clinical risk factors alone and/or in combination with BMD.%
    }
    \verb{doi}
    \verb 10.1007/s00198-007-0543-5
    \endverb
    \field{issn}{0937-941X}
    \field{issue}{4}
    \field{pages}{385\bibrangedash 397}
    \field{title}{FRAX and the assessment of fracture probability in men and
  women from the UK.}
    \field{volume}{19}
    \verb{file}
    \verb :PDFs/kanis2008.pdf:PDF
    \endverb
    \field{journaltitle}{Osteoporosis international : a journal established as
  result of cooperation between the European Foundation for Osteoporosis and
  the National Osteoporosis Foundation of the USA}
    \field{month}{04}
    \field{year}{2008}
  \endentry

  \entry{Kansagara2011}{article}{}
    \name{author}{7}{}{%
      {{hash=KD}{%
         family={Kansagara},
         familyi={K\bibinitperiod},
         given={Devan},
         giveni={D\bibinitperiod},
      }}%
      {{hash=EH}{%
         family={Englander},
         familyi={E\bibinitperiod},
         given={Honora},
         giveni={H\bibinitperiod},
      }}%
      {{hash=SA}{%
         family={Salanitro},
         familyi={S\bibinitperiod},
         given={Amanda},
         giveni={A\bibinitperiod},
      }}%
      {{hash=KD}{%
         family={Kagen},
         familyi={K\bibinitperiod},
         given={David},
         giveni={D\bibinitperiod},
      }}%
      {{hash=TC}{%
         family={Theobald},
         familyi={T\bibinitperiod},
         given={Cecelia},
         giveni={C\bibinitperiod},
      }}%
      {{hash=FM}{%
         family={Freeman},
         familyi={F\bibinitperiod},
         given={Michele},
         giveni={M\bibinitperiod},
      }}%
      {{hash=KS}{%
         family={Kripalani},
         familyi={K\bibinitperiod},
         given={Sunil},
         giveni={S\bibinitperiod},
      }}%
    }
    \keyw{Forecasting; Hospitalization; Humans; Models, Statistical; Outcome
  Assessment (Health Care); Patient Readmission; Risk Adjustment; Risk
  Assessment}
    \strng{namehash}{KD+1}
    \strng{fullhash}{KDEHSAKDTCFMKS1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Predicting hospital readmission risk is of great interest to identify which
  patients would benefit most from care transition interventions, as well as to
  risk-adjust readmission rates for the purposes of hospital comparison. To
  summarize validated readmission risk prediction models, describe their
  performance, and assess suitability for clinical or administrative use. The
  databases of MEDLINE, CINAHL, and the Cochrane Library were searched from
  inception through March 2011, the EMBASE database was searched through August
  2011, and hand searches were performed of the retrieved reference lists. Dual
  review was conducted to identify studies published in the English language of
  prediction models tested with medical patients in both derivation and
  validation cohorts. Data were extracted on the population, setting, sample
  size, follow-up interval, readmission rate, model discrimination and
  calibration, type of data used, and timing of data collection. Of 7843
  citations reviewed, 30 studies of 26 unique models met the inclusion
  criteria. The most common outcome used was 30-day readmission; only 1 model
  specifically addressed preventable readmissions. Fourteen models that relied
  on retrospective administrative data could be potentially used to risk-adjust
  readmission rates for hospital comparison; of these, 9 were tested in large
  US populations and had poor discriminative ability (c statistic range:
  0.55-0.65). Seven models could potentially be used to identify high-risk
  patients for intervention early during a hospitalization (c statistic range:
  0.56-0.72), and 5 could be used at hospital discharge (c statistic range:
  0.68-0.83). Six studies compared different models in the same population and
  2 of these found that functional and social variables improved model
  discrimination. Although most models incorporated variables for medical
  comorbidity and use of prior medical services, few examined variables
  associated with overall health and function, illness severity, or social
  determinants of health. Most current readmission risk prediction models that
  were designed for either comparative or clinical purposes perform poorly.
  Although in certain settings such models may prove useful, efforts to improve
  their performance are needed as use becomes more widespread.%
    }
    \verb{doi}
    \verb 10.1001/jama.2011.1515
    \endverb
    \field{issn}{1538-3598}
    \field{issue}{15}
    \field{pages}{1688\bibrangedash 1698}
    \field{title}{Risk prediction models for hospital readmission: a systematic
  review.}
    \field{volume}{306}
    \verb{file}
    \verb :PDFs/kansagara2011.pdf:PDF
    \endverb
    \field{journaltitle}{JAMA}
    \field{month}{10}
    \field{year}{2011}
  \endentry

  \entry{Usher-Smith2016}{article}{}
    \name{author}{5}{}{%
      {{hash=USJA}{%
         family={Usher-Smith},
         familyi={U\bibinithyphendelim S\bibinitperiod},
         given={Juliet\bibnamedelima A},
         giveni={J\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=WFM}{%
         family={Walter},
         familyi={W\bibinitperiod},
         given={Fiona\bibnamedelima M},
         giveni={F\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=EJD}{%
         family={Emery},
         familyi={E\bibinitperiod},
         given={Jon\bibnamedelima D},
         giveni={J\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=WAK}{%
         family={Win},
         familyi={W\bibinitperiod},
         given={Aung\bibnamedelima K},
         giveni={A\bibinitperiod\bibinitdelim K\bibinitperiod},
      }}%
      {{hash=GSJ}{%
         family={Griffin},
         familyi={G\bibinitperiod},
         given={Simon\bibnamedelima J},
         giveni={S\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
    }
    \keyw{Area Under Curve; Biomarkers, Tumor, metabolism; Body Mass Index;
  Colorectal Neoplasms, diagnosis, epidemiology; Early Detection of Cancer,
  methods; Humans; Incidence; Mass Screening; Models, Statistical; ROC Curve;
  Reproducibility of Results; Risk Assessment, methods; Risk Factors;
  Sensitivity and Specificity}
    \strng{namehash}{USJA+1}
    \strng{fullhash}{USJAWFMEJDWAKGSJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Colorectal cancer is the second leading cause of cancer-related death in
  Europe and the United States. Survival is strongly related to stage at
  diagnosis and population-based screening reduces colorectal cancer incidence
  and mortality. Stratifying the population by risk offers the potential to
  improve the efficiency of screening. In this systematic review we searched
  Medline, EMBASE, and the Cochrane Library for primary research studies
  reporting or validating models to predict future risk of primary colorectal
  cancer for asymptomatic individuals. A total of 12,808 papers were identified
  from the literature search and nine through citation searching. Fifty-two
  risk models were included. Where reported (n = 37), half the models had
  acceptable-to-good discrimination (the area under the receiver operating
  characteristic curve, AUROC >0.7) in the derivation sample. Calibration was
  less commonly assessed (n = 21), but overall acceptable. In external
  validation studies, 10 models showed acceptable discrimination (AUROC
  0.71-0.78). These include two with only three variables (age, gender, and
  BMI; age, gender, and family history of colorectal cancer). A small number of
  prediction models developed from case-control studies of genetic biomarkers
  also show some promise but require further external validation using
  population-based samples. Further research should focus on the feasibility
  and impact of incorporating such models into stratified screening
  programmes.%
    }
    \verb{doi}
    \verb 10.1158/1940-6207.CAPR-15-0274
    \endverb
    \field{issn}{1940-6215}
    \field{issue}{1}
    \field{pages}{13\bibrangedash 26}
    \field{title}{Risk Prediction Models for Colorectal Cancer: A Systematic
  Review.}
    \field{volume}{9}
    \verb{file}
    \verb :PDFs/usher-smith2016.pdf:PDF
    \endverb
    \field{journaltitle}{Cancer prevention research (Philadelphia, Pa.)}
    \field{month}{01}
    \field{year}{2016}
  \endentry

  \entry{Moons2009}{article}{}
    \name{author}{5}{}{%
      {{hash=MKGM}{%
         family={Moons},
         familyi={M\bibinitperiod},
         given={Karel G\bibnamedelima M},
         giveni={K\bibinitperiod\bibinitdelim G\bibinitperiod\bibinitdelim
  M\bibinitperiod},
      }}%
      {{hash=RP}{%
         family={Royston},
         familyi={R\bibinitperiod},
         given={Patrick},
         giveni={P\bibinitperiod},
      }}%
      {{hash=VY}{%
         family={Vergouwe},
         familyi={V\bibinitperiod},
         given={Yvonne},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=GDE}{%
         family={Grobbee},
         familyi={G\bibinitperiod},
         given={Diederick\bibnamedelima E},
         giveni={D\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=ADG}{%
         family={Altman},
         familyi={A\bibinitperiod},
         given={Douglas\bibnamedelima G},
         giveni={D\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
    }
    \keyw{Biomedical Research, methods; Causality; Models, Statistical;
  Multivariate Analysis; Prognosis; Research Design}
    \strng{namehash}{MKGM+1}
    \strng{fullhash}{MKGMRPVYGDEADG1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1136/bmj.b375
    \endverb
    \field{issn}{1756-1833}
    \field{pages}{b375}
    \field{title}{Prognosis and prognostic research: what, why, and how?}
    \field{volume}{338}
    \verb{file}
    \verb :PDFs/moons2009.html:URL
    \endverb
    \field{journaltitle}{BMJ (Clinical research ed.)}
    \field{month}{02}
    \field{year}{2009}
  \endentry

  \entry{DAgostino2001}{article}{}
    \name{author}{5}{}{%
      {{hash=DRB}{%
         family={D'Agostino},
         familyi={D\bibinitperiod},
         given={R\bibnamedelima B},
         giveni={R\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=GS}{%
         family={Grundy},
         familyi={G\bibinitperiod},
         given={S},
         giveni={S},
      }}%
      {{hash=SLM}{%
         family={Sullivan},
         familyi={S\bibinitperiod},
         given={L\bibnamedelima M},
         giveni={L\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=WP}{%
         family={Wilson},
         familyi={W\bibinitperiod},
         given={P},
         giveni={P},
      }}%
      {{hash=GCRP}{%
         family={Group},
         familyi={G\bibinitperiod},
         given={CHD Risk\bibnamedelima Prediction},
         giveni={C\bibinitperiod\bibinitdelim R\bibinitperiod\bibinitdelim
  P\bibinitperiod},
      }}%
    }
    \keyw{African Americans; Asian Americans; Coronary Disease, epidemiology,
  ethnology; Data Interpretation, Statistical; European Continental Ancestry
  Group; Female; Hispanic Americans; Humans; Indians, North American; Male;
  Multicenter Studies as Topic; Proportional Hazards Models; Research Design;
  Risk Assessment; Risk Factors; Socioeconomic Factors; United States,
  epidemiology}
    \strng{namehash}{DRB+1}
    \strng{fullhash}{DRBGSSLMWPGCRP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    The Framingham Heart Study produced sex-specific coronary heart disease
  (CHD) prediction functions for assessing risk of developing incident CHD in a
  white middle-class population. Concern exists regarding whether these
  functions can be generalized to other populations. To test the validity and
  transportability of the Framingham CHD prediction functions per a National
  Heart, Lung, and Blood Institute workshop organized for this purpose.
  Sex-specific CHD functions were derived from Framingham data for prediction
  of coronary death and myocardial infarction. These functions were applied to
  6 prospectively studied, ethnically diverse cohorts (n = 23 424), including
  whites, blacks, Native Americans, Japanese American men, and Hispanic men:
  the Atherosclerosis Risk in Communities Study (1987-1988), Physicians' Health
  Study (1982), Honolulu Heart Program (1980-1982), Puerto Rico Heart Health
  Program (1965-1968), Strong Heart Study (1989-1991), and Cardiovascular
  Health Study (1989-1990). The performance, or ability to accurately predict
  CHD risk, of the Framingham functions compared with the performance of risk
  functions developed specifically from the individual cohorts' data.
  Comparisons included evaluation of the equality of relative risks for
  standard CHD risk factors, discrimination, and calibration. For white men and
  women and for black men and women the Framingham functions performed
  reasonably well for prediction of CHD events within 5 years of follow-up.
  Among Japanese American and Hispanic men and Native American women, the
  Framingham functions systematically overestimated the risk of 5-year CHD
  events. After recalibration, taking into account different prevalences of
  risk factors and underlying rates of developing CHD, the Framingham functions
  worked well in these populations. The sex-specific Framingham CHD prediction
  functions perform well among whites and blacks in different settings and can
  be applied to other ethnic groups after recalibration for differing
  prevalences of risk factors and underlying rates of CHD events.%
    }
    \field{issn}{0098-7484}
    \field{issue}{2}
    \field{pages}{180\bibrangedash 187}
    \field{title}{Validation of the Framingham coronary heart disease
  prediction scores: results of a multiple ethnic groups investigation.}
    \field{volume}{286}
    \verb{file}
    \verb :PDFs/dagostino2001.pdf:PDF
    \endverb
    \field{journaltitle}{JAMA}
    \field{month}{07}
    \field{year}{2001}
  \endentry

  \entry{Bastuji-Garin2002}{article}{}
    \name{author}{10}{}{%
      {{hash=BGS}{%
         family={Bastuji-Garin},
         familyi={B\bibinithyphendelim G\bibinitperiod},
         given={Sylvie},
         giveni={S\bibinitperiod},
      }}%
      {{hash=DA}{%
         family={Deverly},
         familyi={D\bibinitperiod},
         given={Anne},
         giveni={A\bibinitperiod},
      }}%
      {{hash=MD}{%
         family={Moyse},
         familyi={M\bibinitperiod},
         given={Dominique},
         giveni={D\bibinitperiod},
      }}%
      {{hash=CA}{%
         family={Castaigne},
         familyi={C\bibinitperiod},
         given={Alain},
         giveni={A\bibinitperiod},
      }}%
      {{hash=MG}{%
         family={Mancia},
         familyi={M\bibinitperiod},
         given={Giuseppe},
         giveni={G\bibinitperiod},
      }}%
      {{hash=dLPW}{%
         prefix={de},
         prefixi={d\bibinitperiod},
         family={Leeuw},
         familyi={L\bibinitperiod},
         given={Peter\bibnamedelima W},
         giveni={P\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
      {{hash=RLM}{%
         family={Ruilope},
         familyi={R\bibinitperiod},
         given={Luis\bibnamedelima M},
         giveni={L\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=RT}{%
         family={Rosenthal},
         familyi={R\bibinitperiod},
         given={Talma},
         giveni={T\bibinitperiod},
      }}%
      {{hash=CG}{%
         family={Chatellier},
         familyi={C\bibinitperiod},
         given={Gilles},
         giveni={G\bibinitperiod},
      }}%
      {{hash=aaGiHTSGI}{%
         prefix={as\bibnamedelima a Goal\bibnamedelima in},
         prefixi={a\bibinitperiod\bibinitdelim a\bibinitperiod\bibinitdelim
  G\bibinitperiod\bibinitdelim i\bibinitperiod},
         family={Hypertension Treatment Study\bibnamedelima Group},
         familyi={H\bibinitperiod\bibinitdelim T\bibinitperiod\bibinitdelim
  S\bibinitperiod\bibinitdelim G\bibinitperiod},
         given={Intervention},
         giveni={I\bibinitperiod},
      }}%
    }
    \keyw{Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents,
  therapeutic use; Blood Pressure, physiology; Cholesterol, blood; Coronary
  Disease, epidemiology; Double-Blind Method; Europe, epidemiology; Female;
  Follow-Up Studies; Humans; Hypertension, drug therapy, epidemiology;
  Incidence; Israel, epidemiology; Male; Middle Aged; Predictive Value of
  Tests; Proportional Hazards Models; ROC Curve; Random Allocation; Risk
  Factors; Sex Factors; Stroke, epidemiology; Systole, physiology}
    \strng{namehash}{BGS+1}
    \strng{fullhash}{BGSDAMDCAMGLPWdRLMRTCGHTSGIaaGi1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Stratification of population groups according to cardiovascular risk level
  is recommended for primary prevention. To assess whether the Framingham
  models could accurately predict the absolute risk of coronary heart disease
  (CHD) and stroke in a large cohort of middle-aged European patients with
  hypertension, and rank individual patients according to actual risk. A
  prospective cohort study comparing the actual risk with that predicted by
  either the Framingham equations or models derived from the INSIGHT study.
  From the INSIGHT prospective trial, conducted in eight countries of Western
  Europe and Israel, we selected 4407 European patients younger than 75 years
  without previous cardiovascular events. None. Major cardiovascular events. In
  this population (45% men, mean age 64.1 years), 124 (2.8%) patients had CHD
  and 96 (2.2%) had strokes after a median follow-up of 3.7 years.
  Overestimation of absolute CHD risk by the Framingham equation was observed
  in all countries (from 2% in the UK to 7% in France), whereas predicted risk
  of stroke was close to the actual risk. However, patients in the highest risk
  quintile within each country had a threefold greater risk of a cardiovascular
  event than those in the lowest quintile. The Framingham models should not be
  used to predict absolute CHD risk in the European population as a whole.
  However, these models may be used within each country, provided that cut-off
  points defining high-risk patients have been determined within each country.%
    }
    \field{issn}{0263-6352}
    \field{issue}{10}
    \field{pages}{1973\bibrangedash 1980}
    \field{title}{The Framingham prediction rule is not valid in a European
  population of treated hypertensive patients.}
    \field{volume}{20}
    \verb{file}
    \verb :PDFs/bastuji-garin2002.pdf:PDF
    \endverb
    \field{journaltitle}{Journal of hypertension}
    \field{month}{10}
    \field{year}{2002}
  \endentry

  \entry{DeFilippis2015}{article}{}
    \name{author}{10}{}{%
      {{hash=DAP}{%
         family={DeFilippis},
         familyi={D\bibinitperiod},
         given={Andrew\bibnamedelima P},
         giveni={A\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=YR}{%
         family={Young},
         familyi={Y\bibinitperiod},
         given={Rebekah},
         giveni={R\bibinitperiod},
      }}%
      {{hash=CCJ}{%
         family={Carrubba},
         familyi={C\bibinitperiod},
         given={Christopher\bibnamedelima J},
         giveni={C\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=MJW}{%
         family={McEvoy},
         familyi={M\bibinitperiod},
         given={John\bibnamedelima W},
         giveni={J\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
      {{hash=BMJ}{%
         family={Budoff},
         familyi={B\bibinitperiod},
         given={Matthew\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=BRS}{%
         family={Blumenthal},
         familyi={B\bibinitperiod},
         given={Roger\bibnamedelima S},
         giveni={R\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=KRA}{%
         family={Kronmal},
         familyi={K\bibinitperiod},
         given={Richard\bibnamedelima A},
         giveni={R\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=MRL}{%
         family={McClelland},
         familyi={M\bibinitperiod},
         given={Robyn\bibnamedelima L},
         giveni={R\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=NK}{%
         family={Nasir},
         familyi={N\bibinitperiod},
         given={Khurram},
         giveni={K\bibinitperiod},
      }}%
      {{hash=BMJ}{%
         family={Blaha},
         familyi={B\bibinitperiod},
         given={Michael\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
    }
    \keyw{Aged; Aged, 80 and over; American Heart Association; Antihypertensive
  Agents, therapeutic use; Aspirin, therapeutic use; Calibration; Coronary
  Artery Disease, epidemiology, ethnology, prevention & control; Diabetes
  Complications; Female; Follow-Up Studies; Humans; Hypolipidemic Agents,
  therapeutic use; Male; Middle Aged; Myocardial Revascularization; Platelet
  Aggregation Inhibitors, therapeutic use; Practice Guidelines as Topic;
  Primary Prevention; Prospective Studies; Risk Assessment, methods, standards;
  United States, epidemiology; Voluntary Health Agencies}
    \strng{namehash}{DAP+1}
    \strng{fullhash}{DAPYRCCJMJWBMJBRSKRAMRLNKBMJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Accurate risk assessment of atherosclerotic cardiovascular disease (ASCVD)
  is essential to effectively balance the risks and benefits of therapy for
  primary prevention. To compare the calibration and discrimination of the new
  American Heart Association (AHA) and American College of Cardiology (ACC)
  ASCVD risk score with alternative risk scores and to explore preventive
  therapy as a cause of the reported risk overestimation using the
  AHA-ACC-ASCVD score. Prospective epidemiologic study of ASCVD. MESA
  (Multi-Ethnic Study of Atherosclerosis), a community-based, sex-balanced,
  multiethnic cohort. 4227 MESA participants aged 50 to 74 years and without
  diabetes at baseline. Observed and expected events for the AHA-ACC-ASCVD
  score were compared with 4 commonly used risk scores-and their respective end
  points-in MESA after a 10.2-year follow-up. The new AHA-ACC-ASCVD and 3 older
  Framingham-based risk scores overestimated cardiovascular events by 37% to
  154% in men and 8% to 67% in women. Overestimation was noted throughout the
  continuum of risk. In contrast, the Reynolds Risk Score overestimated risk by
  9% in men but underestimated risk by 21% in women. Aspirin, lipid-lowering or
  antihypertensive therapy, and interim revascularization did not explain the
  overestimation. Comparability of MESA with target populations for primary
  prevention and possibility of missed events in MESA. Of the 5 risk scores, 4,
  including the new AHA-ACC-ASCVD score, showed overestimation of risk (25% to
  115%) in a modern, multiethnic cohort without baseline clinical ASCVD. If
  validated, overestimation of ASCVD risk may have substantial implications for
  individual patients and the health care system. National Heart, Lung, and
  Blood Institute.%
    }
    \verb{doi}
    \verb 10.7326/M14-1281
    \endverb
    \field{issn}{1539-3704}
    \field{issue}{4}
    \field{pages}{266\bibrangedash 275}
    \field{title}{An analysis of calibration and discrimination among multiple
  cardiovascular risk scores in a modern multiethnic cohort.}
    \field{volume}{162}
    \verb{file}
    \verb :PDFs/defilippips2015.pdf:PDF
    \endverb
    \field{journaltitle}{Annals of internal medicine}
    \field{month}{02}
    \field{year}{2015}
  \endentry

  \entry{Dagan2017}{article}{}
    \name{author}{4}{}{%
      {{hash=DN}{%
         family={Dagan},
         familyi={D\bibinitperiod},
         given={Noa},
         giveni={N\bibinitperiod},
      }}%
      {{hash=CSC}{%
         family={Cohen-Stavi},
         familyi={C\bibinithyphendelim S\bibinitperiod},
         given={Chandra},
         giveni={C\bibinitperiod},
      }}%
      {{hash=LRM}{%
         family={Leventer-Roberts},
         familyi={L\bibinithyphendelim R\bibinitperiod},
         given={Maya},
         giveni={M\bibinitperiod},
      }}%
      {{hash=BRD}{%
         family={Balicer},
         familyi={B\bibinitperiod},
         given={Ran\bibnamedelima D},
         giveni={R\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
    }
    \keyw{Age Factors; Aged; Aged, 80 and over; Algorithms; Bone Density;
  Calibration; Electronic Health Records, statistics & numerical data; Female;
  Hip Fractures, epidemiology, etiology; Humans; Israel, epidemiology; Male;
  Middle Aged; Osteoporotic Fractures, epidemiology, etiology; Reproducibility
  of Results; Retrospective Studies; Risk Assessment, methods; Risk Factors}
    \strng{namehash}{DN+1}
    \strng{fullhash}{DNCSCLRMBRD1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
     To directly compare the performance and externally validate the three
  most studied prediction tools for osteoporotic fractures-QFracture, FRAX, and
  Garvan-using data from electronic health records.  Retrospective cohort
  study.  Payer provider healthcare organisation in Israel.  1 054 815
  members aged 50 to 90 years for comparison between tools and cohorts of
  different age ranges, corresponding to those in each tools' development
  study, for tool specific external validation.  First diagnosis of a major
  osteoporotic fracture (for QFracture and FRAX tools) and hip fractures (for
  all three tools) recorded in electronic health records from 2010 to 2014.
  Observed fracture rates were compared to probabilities predicted
  retrospectively as of 2010.  The observed five year hip fracture rate was
  2.7% and the rate for major osteoporotic fractures was 7.7%. The areas under
  the receiver operating curve (AUC) for hip fracture prediction were 82.7% for
  QFracture, 81.5% for FRAX, and 77.8% for Garvan. For major osteoporotic
  fractures, AUCs were 71.2% for QFracture and 71.4% for FRAX. All the tools
  underestimated the fracture risk, but the average observed to predicted
  ratios and the calibration slopes of FRAX were closest to 1. Tool specific
  validation analyses yielded hip fracture prediction AUCs of 88.0% for
  QFracture (among those aged 30-100 years), 81.5% for FRAX (50-90 years), and
  71.2% for Garvan (60-95 years).  Both QFracture and FRAX had high
  discriminatory power for hip fracture prediction, with QFracture performing
  slightly better. This performance gap was more pronounced in previous
  studies, likely because of broader age inclusion criteria for QFracture
  validations. The simpler FRAX performed almost as well as QFracture for hip
  fracture prediction, and may have advantages if some of the input data
  required for QFracture are not available. However, both tools require
  calibration before implementation.%
    }
    \verb{doi}
    \verb 10.1136/bmj.i6755
    \endverb
    \field{issn}{1756-1833}
    \field{pages}{i6755}
    \field{title}{External validation and comparison of three prediction tools
  for risk of osteoporotic fractures using data from population based
  electronic health records: retrospective cohort study.}
    \field{volume}{356}
    \verb{file}
    \verb :PDFs/Dagan2017.pdf:PDF
    \endverb
    \field{journaltitle}{BMJ (Clinical research ed.)}
    \field{month}{01}
    \field{year}{2017}
  \endentry

  \entry{Bitzur2015}{article}{}
    \name{author}{14}{}{%
      {{hash=BR}{%
         family={Bitzur},
         familyi={B\bibinitperiod},
         given={Rafael},
         giveni={R\bibinitperiod},
      }}%
      {{hash=RY}{%
         family={Rozenman},
         familyi={R\bibinitperiod},
         given={Yoseph},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=VS}{%
         family={Vinker},
         familyi={V\bibinitperiod},
         given={Shlomo},
         giveni={S\bibinitperiod},
      }}%
      {{hash=DD}{%
         family={Dikerl},
         familyi={D\bibinitperiod},
         given={Dror},
         giveni={D\bibinitperiod},
      }}%
      {{hash=SJ}{%
         family={Shemesh},
         familyi={S\bibinitperiod},
         given={Joseph},
         giveni={J\bibinitperiod},
      }}%
      {{hash=LA}{%
         family={Lahad},
         familyi={L\bibinitperiod},
         given={Amnon},
         giveni={A\bibinitperiod},
      }}%
      {{hash=GD}{%
         family={Gavishl},
         familyi={G\bibinitperiod},
         given={Dov},
         giveni={D\bibinitperiod},
      }}%
      {{hash=HD}{%
         family={Harats},
         familyi={H\bibinitperiod},
         given={Dror},
         giveni={D\bibinitperiod},
      }}%
      {{hash=KH}{%
         family={KnobLer},
         familyi={K\bibinitperiod},
         given={Hilla},
         giveni={H\bibinitperiod},
      }}%
      {{hash=SfRP}{%
         prefix={Society\bibnamedelima for},
         prefixi={S\bibinitperiod\bibinitdelim f\bibinitperiod},
         family={Research},
         familyi={R\bibinitperiod},
         given={Prevention},
         giveni={P\bibinitperiod},
      }}%
      {{hash=ToAI}{%
         prefix={Treatment\bibnamedelima of},
         prefixi={T\bibinitperiod\bibinitdelim o\bibinitperiod},
         family={Atherosclerosis},
         familyi={A\bibinitperiod},
         given={Israel},
         giveni={I\bibinitperiod},
      }}%
      {{hash=SIH}{%
         family={Society},
         familyi={S\bibinitperiod},
         given={Israel\bibnamedelima Heart},
         giveni={I\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=oFPIA}{%
         prefix={of},
         prefixi={o\bibinitperiod},
         family={Family\bibnamedelima Physicians},
         familyi={F\bibinitperiod\bibinitdelim P\bibinitperiod},
         given={Israel\bibnamedelima Association},
         giveni={I\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=oIMIS}{%
         prefix={of},
         prefixi={o\bibinitperiod},
         family={Internal\bibnamedelima Medicine},
         familyi={I\bibinitperiod\bibinitdelim M\bibinitperiod},
         given={Israel\bibnamedelima Society},
         giveni={I\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
    }
    \keyw{Cardiovascular Diseases, diagnosis, prevention & control, psychology;
  Cholesterol, LDL, blood; Health Behavior; Humans; Hydroxymethylglutaryl-CoA
  Reductase Inhibitors, pharmacology; Hyperlipidemias, blood, drug therapy;
  Israel; Preventive Health Services, organization & administration, trends;
  Secondary Prevention, methods, trends}
    \strng{namehash}{BR+1}
    \strng{fullhash}{BRRYVSDDSJLAGDHDKHRPSfAIToSIHFPIAoIMISo1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Atherosclerosis is one of the leading causes of morbidity and mortality in
  the world, including in Israel. This document updates the clinical
  recommendations of the Israeli medical societies (The Society for Research,
  Prevention and Treatment of Atherosclerosis, The Israel Heart Society, The
  Israel Association of Family Physicians, The Israel Society of Internal
  Medicine) from 2012. The need for an update stems from new studies and from
  the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce
  Atherosclerotic Cardiovascular Risk in Adults. These recommendations take
  into account the guidelines of leading medical organizations in the world, as
  well as the specific circumstances and needs of the medical system in
  Israel.%
    }
    \field{issn}{0017-7768}
    \field{issue}{5}
    \field{pages}{330\bibrangedash 3, 337\bibrangedash 8}
    \field{title}{[ISRAELI GUIDELINES FOR THE TREATMENT OF HYPERLIPIDEMIA -
  2014 UPDATE].}
    \field{volume}{154}
    \verb{file}
    \verb :PDFs/bitzur2015.pdf:PDF
    \endverb
    \field{journaltitle}{Harefuah}
    \field{month}{05}
    \field{year}{2015}
  \endentry

  \entry{Jeremiah2015}{article}{}
    \name{author}{4}{}{%
      {{hash=JMP}{%
         family={Jeremiah},
         familyi={J\bibinitperiod},
         given={Michael\bibnamedelima P},
         giveni={M\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=UBK}{%
         family={Unwin},
         familyi={U\bibinitperiod},
         given={Brian\bibnamedelima K},
         giveni={B\bibinitperiod\bibinitdelim K\bibinitperiod},
      }}%
      {{hash=GMH}{%
         family={Greenawald},
         familyi={G\bibinitperiod},
         given={Mark\bibnamedelima H},
         giveni={M\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=CVE}{%
         family={Casiano},
         familyi={C\bibinitperiod},
         given={Vincent\bibnamedelima E},
         giveni={V\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
    }
    \keyw{Aged; Aged, 80 and over; Bone Density, drug effects; Bone Density
  Conservation Agents, therapeutic use; Diphosphonates, therapeutic use;
  Female; Humans; Male; Middle Aged; Osteoporosis, diagnosis, drug therapy;
  Osteoporotic Fractures, prevention & control}
    \strng{namehash}{JMP+1}
    \strng{fullhash}{JMPUBKGMHCVE1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Osteoporosis-related fractures affect approximately one in two white women
  and one in five white men in their lifetime. The impact of fractures includes
  loss of function, significant costs, and increased mortality. The U.S.
  Preventive Services Task Force recommends using dual energy x-ray
  absorptiometry to screen all women 65 years and older, and younger women who
  have an increased fracture risk as determined by the World Health
  Organization's FRAX Fracture Risk Assessment Tool. Although guidelines are
  lacking for rescreening women who have normal bone mineral density on initial
  screening, intervals of at least four years appear safe. The U.S. Preventive
  Services Task Force found insufficient evidence to recommend screening for
  osteoporosis in men; other organizations recommend screening all men 70 years
  and older. In patients with newly diagnosed osteoporosis, suggested
  laboratory tests to identify secondary causes include serum 25-hydroxyvitamin
  D, calcium, creatinine, and thyroid-stimulating hormone. First-line treatment
  to prevent fractures consists of fall prevention, smoking cessation,
  moderation of alcohol intake, and bisphosphonate therapy. Clinicians should
  consider discontinuing bisphosphonate therapy after five years in women
  without a personal history of vertebral fractures. Raloxifene, teriparatide,
  and denosumab are alternative effective treatments for certain subsets of
  patients and for those who are unable to take or whose condition does not
  respond to bisphosphonates. The need for follow-up bone mineral density
  testing in patients receiving treatment for osteoporosis is uncertain.%
    }
    \field{issn}{1532-0650}
    \field{issue}{4}
    \field{pages}{261\bibrangedash 268}
    \field{title}{Diagnosis and Management of Osteoporosis.}
    \field{volume}{92}
    \verb{file}
    \verb :PDFs/Jeremiah2015.pdf:PDF
    \endverb
    \field{journaltitle}{American family physician}
    \field{month}{08}
    \field{year}{2015}
  \endentry

  \entry{Wells2001}{article}{}
    \name{author}{10}{}{%
      {{hash=WPS}{%
         family={Wells},
         familyi={W\bibinitperiod},
         given={P\bibnamedelima S},
         giveni={P\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
      {{hash=ADR}{%
         family={Anderson},
         familyi={A\bibinitperiod},
         given={D\bibnamedelima R},
         giveni={D\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=RM}{%
         family={Rodger},
         familyi={R\bibinitperiod},
         given={M},
         giveni={M},
      }}%
      {{hash=SI}{%
         family={Stiell},
         familyi={S\bibinitperiod},
         given={I},
         giveni={I},
      }}%
      {{hash=DJF}{%
         family={Dreyer},
         familyi={D\bibinitperiod},
         given={J\bibnamedelima F},
         giveni={J\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=BD}{%
         family={Barnes},
         familyi={B\bibinitperiod},
         given={D},
         giveni={D},
      }}%
      {{hash=FM}{%
         family={Forgie},
         familyi={F\bibinitperiod},
         given={M},
         giveni={M},
      }}%
      {{hash=KG}{%
         family={Kovacs},
         familyi={K\bibinitperiod},
         given={G},
         giveni={G},
      }}%
      {{hash=WJ}{%
         family={Ward},
         familyi={W\bibinitperiod},
         given={J},
         giveni={J},
      }}%
      {{hash=KMJ}{%
         family={Kovacs},
         familyi={K\bibinitperiod},
         given={M\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
    }
    \keyw{Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Canada;
  Clinical Protocols; Decision Trees; Emergency Service, Hospital;
  Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation
  Products, analysis; Follow-Up Studies; Humans; Male; Middle Aged;
  Probability; Prospective Studies; Pulmonary Embolism, diagnosis;
  Reproducibility of Results}
    \strng{namehash}{WPS+1}
    \strng{fullhash}{WPSADRRMSIDJFBDFMKGWJKMJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    The limitations of the current diagnostic standard, ventilation-perfusion
  lung scanning, complicate the management of patients with suspected pulmonary
  embolism. We previously demonstrated that determining the pretest probability
  can assist with management and that the high negative predictive value of
  certain D -dimer assays may simplify the diagnostic process. To determine the
  safety of using a simple clinical model combined with D -dimer assay to
  manage patients presenting to the emergency department with suspected
  pulmonary embolism. Prospective cohort study. Emergency departments at four
  tertiary care hospitals in Canada. 930 consecutive patients with suspected
  pulmonary embolism. Physicians first used a clinical model to determine
  patients' pretest probability of pulmonary embolism and then performed a D
  -dimer test. Patients with low pretest probability and a negative D -dimer
  result had no further tests and were considered to have a diagnosis of
  pulmonary embolism excluded. All other patients underwent
  ventilation-perfusion lung scanning. If the scan was nondiagnostic, bilateral
  deep venous ultrasonography was done. Whether further testing (by serial
  ultrasonography or angiography) was done depended on the patients' pretest
  probability and the lung scanning results. Patients received a diagnosis of
  pulmonary embolism if they had a high-probability ventilation-perfusion scan,
  an abnormal result on ultrasonography or pulmonary angiography, or a venous
  thromboembolic event during follow-up. Patients for whom the diagnosis was
  considered excluded were followed up for 3 months for the development of
  thromboembolic events. The pretest probability of pulmonary embolism was low,
  moderate, and high in 527, 339, and 64 patients (1.3%, 16.2%, and 37.5% had
  pulmonary embolism), respectively. Of 849 patients in whom a diagnosis of
  pulmonary-embolism had initially been excluded, 5 (0.6% [95% CI, 0.2% to
  1.4%]) developed pulmonary embolism or deep venous thrombosis during
  follow-up. However, 4 of these patients had not undergone the proper
  diagnostic testing protocol. In 7 of the patients who received a diagnosis of
  pulmonary embolism, the physician had performed more diagnostic tests than
  were called for by the algorithm. In 759 of the 849 patients in whom
  pulmonary embolism was not found on initial evaluation, the diagnostic
  protocol was followed correctly. Only 1 (0.1% [CI, 0.0% to 0.7%]) of these
  759 patients developed thromboembolic events during follow-up. Of the 437
  patients with a negative D -dimer result and low clinical probability, only 1
  developed pulmonary embolism during follow-up; thus, the negative predictive
  value for the combined strategy of using the clinical model with D -dimer
  testing in these patients was 99.5% (CI, 99.1% to 100%). Managing patients
  for suspected pulmonary embolism on the basis of pretest probability and D
  -dimer result is safe and decreases the need for diagnostic imaging.%
    }
    \field{issn}{0003-4819}
    \field{issue}{2}
    \field{pages}{98\bibrangedash 107}
    \field{title}{Excluding pulmonary embolism at the bedside without
  diagnostic imaging: management of patients with suspected pulmonary embolism
  presenting to the emergency department by using a simple clinical model and
  d-dimer.}
    \field{volume}{135}
    \verb{file}
    \verb :PDFs/Wells2001.pdf:PDF
    \endverb
    \field{journaltitle}{Annals of internal medicine}
    \field{month}{07}
    \field{year}{2001}
  \endentry

  \entry{Konrad2010}{article}{}
    \name{author}{9}{}{%
      {{hash=KTR}{%
         family={Konrad},
         familyi={K\bibinitperiod},
         given={Thomas\bibnamedelima R},
         giveni={T\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=LCL}{%
         family={Link},
         familyi={L\bibinitperiod},
         given={Carol\bibnamedelima L},
         giveni={C\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=SRJ}{%
         family={Shackelton},
         familyi={S\bibinitperiod},
         given={Rebecca\bibnamedelima J},
         giveni={R\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=MLD}{%
         family={Marceau},
         familyi={M\bibinitperiod},
         given={Lisa\bibnamedelima D},
         giveni={L\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=vdKO}{%
         prefix={von\bibnamedelima dem},
         prefixi={v\bibinitperiod\bibinitdelim d\bibinitperiod},
         family={Knesebeck},
         familyi={K\bibinitperiod},
         given={Olaf},
         giveni={O\bibinitperiod},
      }}%
      {{hash=SJ}{%
         family={Siegrist},
         familyi={S\bibinitperiod},
         given={Johannes},
         giveni={J\bibinitperiod},
      }}%
      {{hash=AS}{%
         family={Arber},
         familyi={A\bibinitperiod},
         given={Sara},
         giveni={S\bibinitperiod},
      }}%
      {{hash=AA}{%
         family={Adams},
         familyi={A\bibinitperiod},
         given={Ann},
         giveni={A\bibinitperiod},
      }}%
      {{hash=MJB}{%
         family={McKinlay},
         familyi={M\bibinitperiod},
         given={John\bibnamedelima B},
         giveni={J\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
    }
    \keyw{Adult; Appointments and Schedules; Family Practice, organization &
  administration; Female; Germany; Health Care Rationing; Humans; Male; Middle
  Aged; Office Visits; Practice Patterns, Physicians'; Professional Autonomy;
  Quality of Health Care; Time Management; United Kingdom; United States}
    \strng{namehash}{KTR+1}
    \strng{fullhash}{KTRLCLSRJMLDKOvdSJASAAMJB1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    As physicians are pressured to deliver an increasing number of preventive
  services, follow guidelines, engage in evidence-based practice, and deliver
  patient-centered care in managerially driven organizations, they struggle
  with how much control they have over their time. A secondary analysis was
  conducted with data from 3 parallel studies of clinical decision making in
  Germany, the United Kingdom, and the United States with 128 physicians per
  country. Physicians reported how much time they were allocated and how much
  time they needed for high-quality care for new patient appointments, routine
  consultations, and complete physicals. They also reported how much control
  they had over their time in the office and spending adequate time with
  patients. German, British, and American physicians were allocated (on
  average) 16/11/32 minutes for a new patient appointment, 6/10/18 minutes for
  a routine visit, and 12/20/36 minutes for a complete physical, but felt that
  they needed more time. Over half of German and American physicians felt that
  they always or usually had control over the hours they were required to be in
  their office or spending sufficient time with their patients while less than
  half of British physicians felt this way. German physicians had the least
  time allocated and needed for most types of appointment. American physicians
  had the most time allocated and needed for each type of appointment. However,
  British physicians felt they had the least control over time in their office
  and spending sufficient time with patients.%
    }
    \verb{doi}
    \verb 10.1097/MLR.0b013e3181c12e6a
    \endverb
    \field{issn}{1537-1948}
    \field{issue}{2}
    \field{pages}{95\bibrangedash 100}
    \field{title}{It's about time: physicians' perceptions of time constraints
  in primary care medical practice in three national healthcare systems.}
    \field{volume}{48}
    \verb{file}
    \verb :PDFs/konrad2010.pdf:PDF
    \endverb
    \field{journaltitle}{Medical care}
    \field{month}{02}
    \field{year}{2010}
  \endentry

  \entry{Wolf1991}{article}{}
    \name{author}{4}{}{%
      {{hash=WPA}{%
         family={Wolf},
         familyi={W\bibinitperiod},
         given={P\bibnamedelima A},
         giveni={P\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=DRB}{%
         family={D'Agostino},
         familyi={D\bibinitperiod},
         given={R\bibnamedelima B},
         giveni={R\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=BAJ}{%
         family={Belanger},
         familyi={B\bibinitperiod},
         given={A\bibnamedelima J},
         giveni={A\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=KWB}{%
         family={Kannel},
         familyi={K\bibinitperiod},
         given={W\bibnamedelima B},
         giveni={W\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
    }
    \keyw{Adult; Aged; Aged, 80 and over; Blood Pressure; Cerebrovascular
  Disorders, etiology; Female; Follow-Up Studies; Humans; Male; Massachusetts;
  Middle Aged; Probability; Risk Factors; Sex Characteristics}
    \strng{namehash}{WPA+1}
    \strng{fullhash}{WPADRBBAJKWB1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    A health risk appraisal function has been developed for the prediction of
  stroke using the Framingham Study cohort. The stroke risk factors included in
  the profile are age, systolic blood pressure, the use of antihypertensive
  therapy, diabetes mellitus, cigarette smoking, prior cardiovascular disease
  (coronary heart disease, cardiac failure, or intermittent claudication),
  atrial fibrillation, and left ventricular hypertrophy by electrocardiogram.
  Based on 472 stroke events occurring during 10 years' follow-up from biennial
  examinations 9 and 14, stroke probabilities were computed using the Cox
  proportional hazards model for each sex based on a point system. On the basis
  of the risk factors in the profile, which can be readily determined on
  routine physical examination in a physician's office, stroke risk can be
  estimated. An individual's risk can be related to the average risk of stroke
  for persons of the same age and sex. The information that one's risk of
  stroke is several times higher than average may provide the impetus for risk
  factor modification. It may also help to identify persons at substantially
  increased stroke risk resulting from borderline levels of multiple risk
  factors such as those with mild or borderline hypertension and facilitate
  multifactorial risk factor modification.%
    }
    \field{issn}{0039-2499}
    \field{issue}{3}
    \field{pages}{312\bibrangedash 318}
    \field{title}{Probability of stroke: a risk profile from the Framingham
  Study.}
    \field{volume}{22}
    \verb{file}
    \verb :PDFs/wolf1991.pdf:PDF
    \endverb
    \field{journaltitle}{Stroke}
    \field{month}{03}
    \field{year}{1991}
  \endentry

  \entry{DAgostino1994}{article}{}
    \name{author}{4}{}{%
      {{hash=DRB}{%
         family={D'Agostino},
         familyi={D\bibinitperiod},
         given={R\bibnamedelima B},
         giveni={R\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=WPA}{%
         family={Wolf},
         familyi={W\bibinitperiod},
         given={P\bibnamedelima A},
         giveni={P\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=BAJ}{%
         family={Belanger},
         familyi={B\bibinitperiod},
         given={A\bibnamedelima J},
         giveni={A\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=KWB}{%
         family={Kannel},
         familyi={K\bibinitperiod},
         given={W\bibnamedelima B},
         giveni={W\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
    }
    \keyw{Aged; Aged, 80 and over; Antihypertensive Agents, therapeutic use;
  Blood Pressure, drug effects; Cerebrovascular Disorders, etiology; Cohort
  Studies; Female; Humans; Male; Middle Aged; Probability; Proportional Hazards
  Models; Risk Factors; Sex Factors}
    \strng{namehash}{DRB+1}
    \strng{fullhash}{DRBWPABAJKWB1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    We sought to modify existing sex-specific health risk appraisal functions
  (profile functions) for the prediction of first stroke that better assess the
  effects of the use of antihypertensive medication. Health risk appraisal
  functions were previously developed from the Framingham Study cohort. These
  functions were Cox proportional hazards regression models relating age,
  systolic blood pressure, diabetes mellitus, cigarette smoking, prior
  cardiovascular disease, atrial fibrillation, left ventricular hypertrophy by
  electrocardiogram, and the use of antihypertensive medication to the
  occurrence of stroke. Closer examination of the data indicated that
  antihypertensive therapy effect is present only for systolic blood pressures
  between 110 and 200 mm Hg. Adjustments to the regressions to better fit the
  observed data were developed and tested for statistical significance and
  goodness-of-fit of the model residuals. Modified functions more consistent
  with the data were developed, and, from these, tables to evaluate 10-year
  risk of first stroke were computed. The stroke profile can be used for
  evaluation of the risk of stroke and suggestion of risk factor modification
  to reduce risk. The effect of antihypertensive therapy in the evaluation of
  stroke risk can now be better evaluated.%
    }
    \field{issn}{0039-2499}
    \field{issue}{1}
    \field{pages}{40\bibrangedash 43}
    \field{title}{Stroke risk profile: adjustment for antihypertensive
  medication. The Framingham Study.}
    \field{volume}{25}
    \verb{file}
    \verb :PDFs/dagostino1994.pdf:PDF
    \endverb
    \field{journaltitle}{Stroke}
    \field{month}{01}
    \field{year}{1994}
  \endentry

  \entry{Hippisley-Cox2013}{article}{}
    \name{author}{3}{}{%
      {{hash=HCJ}{%
         family={Hippisley-Cox},
         familyi={H\bibinithyphendelim C\bibinitperiod},
         given={Julia},
         giveni={J\bibinitperiod},
      }}%
      {{hash=CC}{%
         family={Coupland},
         familyi={C\bibinitperiod},
         given={Carol},
         giveni={C\bibinitperiod},
      }}%
      {{hash=BP}{%
         family={Brindle},
         familyi={B\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
    }
    \keyw{Age Factors; Aged; Aged, 80 and over; Algorithms; Arthritis,
  Rheumatoid, epidemiology; Atrial Fibrillation, epidemiology; Blood Pressure;
  Body Mass Index; Cholesterol, blood; Cholesterol, HDL, blood; Continental
  Population Groups; Coronary Disease, epidemiology, genetics; Diabetes
  Mellitus, epidemiology; Female; Heart Failure, epidemiology; Heart Valve
  Diseases, epidemiology; Humans; Hypertension, epidemiology; Incidence;
  Ischemic Attack, Transient, epidemiology; Kidney Diseases, epidemiology;
  Male; Middle Aged; Primary Health Care; Prospective Studies; Regression
  Analysis; Risk Assessment, methods; Risk Factors; Sex Factors; Smoking,
  epidemiology; Stroke, epidemiology; United Kingdom, epidemiology}
    \strng{namehash}{HCJCCBP1}
    \strng{fullhash}{HCJCCBP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    To develop and validate a risk algorithm (QStroke) to estimate risk of
  stroke or transient ischaemic attack in patients without prior stroke or
  transient ischaemic attack at baseline; to compare (a) QStroke with CHADS2
  and CHA2DS2VASc scores in patients with atrial fibrillation and (b) the
  performance of QStroke with the Framingham stroke score in the full
  population free of stroke or transient ischaemic attack. Prospective open
  cohort study using routinely collected data from general practice during the
  study period 1 January 1998 to 1 August 2012. 451 general practices in
  England and Wales contributing to the national QResearch database to develop
  the algorithm and 225 different QResearch practices to validate the
  algorithm. 3.5 million patients aged 25-84 years with 24.8 million person
  years in the derivation cohort who experienced 77,578 stroke events. For the
  validation cohort, we identified 1.9 million patients aged 25-84 years with
  12.7 million person years who experienced 38,404 stroke events. We excluded
  patients with a prior diagnosis of stroke or transient ischaemic attack and
  those prescribed oral anticoagulants at study entry. Incident diagnosis of
  stroke or transient ischaemic attack recorded in general practice records or
  linked death certificates during follow-up. Self assigned ethnicity, age,
  sex, smoking status, systolic blood pressure, ratio of total serum
  cholesterol to high density lipoprotein cholesterol concentrations, body mass
  index, family history of coronary heart disease in first degree relative
  under 60 years, Townsend deprivation score, treated hypertension, type 1
  diabetes, type 2 diabetes, renal disease, rheumatoid arthritis, coronary
  heart disease, congestive cardiac failure, valvular heart disease, and atrial
  fibrillation The QStroke algorithm explained 57% of the variation in women
  and 55% in men without a prior stroke. The D statistic for QStroke was 2.4 in
  women and 2.3 in men. QStroke had improved performance on all measures of
  discrimination and calibration compared with the Framingham score in patients
  without a prior stroke. Among patients with atrial fibrillation, levels of
  discrimination were lower, but QStroke had some improved performance on all
  measures of discrimination compared with CHADS2 and CHA2DS2VASc. QStroke
  provides a valid measure of absolute stroke risk in the general population of
  patients free of stroke or transient ischaemic attack as shown by its
  performance in a separate validation cohort. QStroke also shows some
  improvement on current risk scoring methods, CHADS2 and CHA2DS2VASc, for the
  subset of patients with atrial fibrillation for whom anticoagulation may be
  required. Further research is needed to evaluate the cost effectiveness of
  using these algorithms in primary care.%
    }
    \verb{doi}
    \verb 10.1136/bmj.f2573
    \endverb
    \field{issn}{1756-1833}
    \field{pages}{f2573}
    \field{title}{Derivation and validation of QStroke score for predicting
  risk of ischaemic stroke in primary care and comparison with other risk
  scores: a prospective open cohort study.}
    \field{volume}{346}
    \verb{file}
    \verb :PDFs/hippisley-cox2013.pdf:PDF
    \endverb
    \field{journaltitle}{BMJ (Clinical research ed.)}
    \field{month}{05}
    \field{year}{2013}
  \endentry

  \entry{Ng2017}{online}{}
    \name{author}{1}{}{%
      {{hash=NA}{%
         family={Ng},
         familyi={N\bibinitperiod},
         given={Andrew},
         giveni={A\bibinitperiod},
      }}%
    }
    \strng{namehash}{NA1}
    \strng{fullhash}{NA1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{title}{AI is the new electricity}
    \verb{url}
    \verb https://www.gsb.stanford.edu/insights/andrew-ng-why-ai-new-electricit
    \verb y
    \endverb
    \field{year}{2017}
    \warn{\item Invalid format of field 'date' \item Invalid format of field
  'date'}
  \endentry

  \entry{Rajkomar2018}{article}{}
    \name{author}{34}{}{%
      {{hash=RA}{%
         family={Rajkomar},
         familyi={R\bibinitperiod},
         given={Alvin},
         giveni={A\bibinitperiod},
      }}%
      {{hash=OE}{%
         family={Oren},
         familyi={O\bibinitperiod},
         given={Eyal},
         giveni={E\bibinitperiod},
      }}%
      {{hash=CK}{%
         family={Chen},
         familyi={C\bibinitperiod},
         given={Kai},
         giveni={K\bibinitperiod},
      }}%
      {{hash=DAM}{%
         family={Dai},
         familyi={D\bibinitperiod},
         given={Andrew\bibnamedelima M.},
         giveni={A\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=HN}{%
         family={Hajaj},
         familyi={H\bibinitperiod},
         given={Nissan},
         giveni={N\bibinitperiod},
      }}%
      {{hash=LPJ}{%
         family={Liu},
         familyi={L\bibinitperiod},
         given={Peter\bibnamedelima J.},
         giveni={P\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=LX}{%
         family={Liu},
         familyi={L\bibinitperiod},
         given={Xiaobing},
         giveni={X\bibinitperiod},
      }}%
      {{hash=SM}{%
         family={Sun},
         familyi={S\bibinitperiod},
         given={Mimi},
         giveni={M\bibinitperiod},
      }}%
      {{hash=SP}{%
         family={Sundberg},
         familyi={S\bibinitperiod},
         given={Patrik},
         giveni={P\bibinitperiod},
      }}%
      {{hash=YH}{%
         family={Yee},
         familyi={Y\bibinitperiod},
         given={Hector},
         giveni={H\bibinitperiod},
      }}%
      {{hash=ZK}{%
         family={Zhang},
         familyi={Z\bibinitperiod},
         given={Kun},
         giveni={K\bibinitperiod},
      }}%
      {{hash=DGE}{%
         family={Duggan},
         familyi={D\bibinitperiod},
         given={Gavin\bibnamedelima E.},
         giveni={G\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=FG}{%
         family={Flores},
         familyi={F\bibinitperiod},
         given={Gerardo},
         giveni={G\bibinitperiod},
      }}%
      {{hash=HM}{%
         family={Hardt},
         familyi={H\bibinitperiod},
         given={Michaela},
         giveni={M\bibinitperiod},
      }}%
      {{hash=IJ}{%
         family={Irvine},
         familyi={I\bibinitperiod},
         given={Jamie},
         giveni={J\bibinitperiod},
      }}%
      {{hash=LQ}{%
         family={Le},
         familyi={L\bibinitperiod},
         given={Quoc},
         giveni={Q\bibinitperiod},
      }}%
      {{hash=LK}{%
         family={Litsch},
         familyi={L\bibinitperiod},
         given={Kurt},
         giveni={K\bibinitperiod},
      }}%
      {{hash=MJ}{%
         family={Marcus},
         familyi={M\bibinitperiod},
         given={Jake},
         giveni={J\bibinitperiod},
      }}%
      {{hash=MA}{%
         family={Mossin},
         familyi={M\bibinitperiod},
         given={Alexander},
         giveni={A\bibinitperiod},
      }}%
      {{hash=TJ}{%
         family={Tansuwan},
         familyi={T\bibinitperiod},
         given={Justin},
         giveni={J\bibinitperiod},
      }}%
      {{hash=WD}{%
         family={Wang},
         familyi={W\bibinitperiod},
         given={De},
         giveni={D\bibinitperiod},
      }}%
      {{hash=WJ}{%
         family={Wexler},
         familyi={W\bibinitperiod},
         given={James},
         giveni={J\bibinitperiod},
      }}%
      {{hash=WJ}{%
         family={Wilson},
         familyi={W\bibinitperiod},
         given={Jimbo},
         giveni={J\bibinitperiod},
      }}%
      {{hash=LD}{%
         family={Ludwig},
         familyi={L\bibinitperiod},
         given={Dana},
         giveni={D\bibinitperiod},
      }}%
      {{hash=VSL}{%
         family={Volchenboum},
         familyi={V\bibinitperiod},
         given={Samuel\bibnamedelima L.},
         giveni={S\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=CK}{%
         family={Chou},
         familyi={C\bibinitperiod},
         given={Katherine},
         giveni={K\bibinitperiod},
      }}%
      {{hash=PM}{%
         family={Pearson},
         familyi={P\bibinitperiod},
         given={Michael},
         giveni={M\bibinitperiod},
      }}%
      {{hash=MS}{%
         family={Madabushi},
         familyi={M\bibinitperiod},
         given={Srinivasan},
         giveni={S\bibinitperiod},
      }}%
      {{hash=SNH}{%
         family={Shah},
         familyi={S\bibinitperiod},
         given={Nigam\bibnamedelima H.},
         giveni={N\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
      {{hash=BAJ}{%
         family={Butte},
         familyi={B\bibinitperiod},
         given={Atul\bibnamedelima J.},
         giveni={A\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=HM}{%
         family={Howell},
         familyi={H\bibinitperiod},
         given={Michael},
         giveni={M\bibinitperiod},
      }}%
      {{hash=CC}{%
         family={Cui},
         familyi={C\bibinitperiod},
         given={Claire},
         giveni={C\bibinitperiod},
      }}%
      {{hash=CG}{%
         family={Corrado},
         familyi={C\bibinitperiod},
         given={Greg},
         giveni={G\bibinitperiod},
      }}%
      {{hash=DJ}{%
         family={Dean},
         familyi={D\bibinitperiod},
         given={Jeff},
         giveni={J\bibinitperiod},
      }}%
    }
    \keyw{cs.CY, cs.LG}
    \strng{namehash}{RA+1}
  \strng{fullhash}{RAOECKDAMHNLPJLXSMSPYHZKDGEFGHMIJLQLKMJMATJWDWJWJLDVSLCKPMMSSNHBAJHMCCCGDJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Predictive modeling with electronic health record (EHR) data is anticipated
  to drive personalized medicine and improve healthcare quality. Constructing
  predictive statistical models typically requires extraction of curated
  predictor variables from normalized EHR data, a labor-intensive process that
  discards the vast majority of information in each patient's record. We
  propose a representation of patients' entire, raw EHR records based on the
  Fast Healthcare Interoperability Resources (FHIR) format. We demonstrate that
  deep learning methods using this representation are capable of accurately
  predicting multiple medical events from multiple centers without
  site-specific data harmonization. We validated our approach using
  de-identified EHR data from two U.S. academic medical centers with 216,221
  adult patients hospitalized for at least 24 hours. In the sequential format
  we propose, this volume of EHR data unrolled into a total of 46,864,534,945
  data points, including clinical notes. Deep learning models achieved high
  accuracy for tasks such as predicting in-hospital mortality (AUROC across
  sites 0.93-0.94), 30-day unplanned readmission (AUROC 0.75-0.76), prolonged
  length of stay (AUROC 0.85-0.86), and all of a patient's final discharge
  diagnoses (frequency-weighted AUROC 0.90). These models outperformed
  state-of-the-art traditional predictive models in all cases. We also present
  a case-study of a neural-network attribution system, which illustrates how
  clinicians can gain some transparency into the predictions. We believe that
  this approach can be used to create accurate and scalable predictions for a
  variety of clinical scenarios, complete with explanations that directly
  highlight evidence in the patient's chart.%
    }
    \verb{eprint}
    \verb 1801.07860v2
    \endverb
    \field{title}{Scalable and accurate deep learning for electronic health
  records}
    \verb{file}
    \verb :PDFs/Rajkomar2018 - Scalable and Accurate Deep Learning for Electron
    \verb ic Health Records.pdf:PDF
    \endverb
    \field{journaltitle}{arxiv}
    \field{eprinttype}{arXiv}
    \field{eprintclass}{cs.CY}
    \field{day}{24}
    \field{month}{01}
    \field{year}{2018}
  \endentry

  \entry{Hripcsak2011}{article}{}
    \name{author}{5}{}{%
      {{hash=HG}{%
         family={Hripcsak},
         familyi={H\bibinitperiod},
         given={George},
         giveni={G\bibinitperiod},
      }}%
      {{hash=KC}{%
         family={Knirsch},
         familyi={K\bibinitperiod},
         given={Charles},
         giveni={C\bibinitperiod},
      }}%
      {{hash=ZL}{%
         family={Zhou},
         familyi={Z\bibinitperiod},
         given={Li},
         giveni={L\bibinitperiod},
      }}%
      {{hash=WA}{%
         family={Wilcox},
         familyi={W\bibinitperiod},
         given={Adam},
         giveni={A\bibinitperiod},
      }}%
      {{hash=MG}{%
         family={Melton},
         familyi={M\bibinitperiod},
         given={Genevieve},
         giveni={G\bibinitperiod},
      }}%
    }
    \strng{namehash}{HG+1}
    \strng{fullhash}{HGKCZLWAMG1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Large-scale electronic health record research introduces biases compared to
  traditional manually curated retrospective research. We used data from a
  community-acquired pneumonia study for which we had a gold standard to
  illustrate such biases. The challenges include data inaccuracy,
  incompleteness, and complexity, and they can produce in distorted results. We
  found that a naïve approach approximated the gold standard, but errors on a
  minority of cases shifted mortality substantially. Manual review revealed
  errors in both selecting and characterizing the cohort, and narrowing the
  cohort improved the result. Nevertheless, a significantly narrowed cohort
  might contain its own biases that would be difficult to estimate.%
    }
    \verb{doi}
    \verb 10.5210/disco.v6i0.3581
    \endverb
    \field{issn}{1747-5333}
    \field{pages}{48\bibrangedash 52}
    \field{title}{Bias associated with mining electronic health records.}
    \field{volume}{6}
    \verb{file}
    \verb :PDFs/Hripcsak2011.pdf:PDF
    \endverb
    \field{journaltitle}{Journal of biomedical discovery and collaboration}
    \field{month}{06}
    \field{year}{2011}
  \endentry

  \entry{Jensen2012}{article}{}
    \name{author}{3}{}{%
      {{hash=JPB}{%
         family={Jensen},
         familyi={J\bibinitperiod},
         given={Peter\bibnamedelima B},
         giveni={P\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=JLJ}{%
         family={Jensen},
         familyi={J\bibinitperiod},
         given={Lars\bibnamedelima J},
         giveni={L\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=BS}{%
         family={Brunak},
         familyi={B\bibinitperiod},
         given={Søren},
         giveni={S\bibinitperiod},
      }}%
    }
    \keyw{Biomedical Research, methods, standards; Electronic Health Records,
  statistics & numerical data, utilization; Genetic Association Studies,
  methods; Humans; Information Dissemination, methods; Medical Records Systems,
  Computerized, statistics & numerical data, utilization; Patient Care,
  methods, standards; Primary Health Care, methods, standards; Public Health,
  methods, standards}
    \strng{namehash}{JPBJLJBS1}
    \strng{fullhash}{JPBJLJBS1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Clinical data describing the phenotypes and treatment of patients
  represents an underused data source that has much greater research potential
  than is currently realized. Mining of electronic health records (EHRs) has
  the potential for establishing new patient-stratification principles and for
  revealing unknown disease correlations. Integrating EHR data with genetic
  data will also give a finer understanding of genotype-phenotype
  relationships. However, a broad range of ethical, legal and technical reasons
  currently hinder the systematic deposition of these data in EHRs and their
  mining. Here, we consider the potential for furthering medical research and
  clinical care using EHR data and the challenges that must be overcome before
  this is a reality.%
    }
    \verb{doi}
    \verb 10.1038/nrg3208
    \endverb
    \field{issn}{1471-0064}
    \field{issue}{6}
    \field{pages}{395\bibrangedash 405}
    \field{title}{Mining electronic health records: towards better research
  applications and clinical care.}
    \field{volume}{13}
    \verb{file}
    \verb :PDFs/Jensen2012.pdf:PDF
    \endverb
    \field{journaltitle}{Nature reviews. Genetics}
    \field{month}{05}
    \field{year}{2012}
  \endentry

  \entry{Reges2018}{article}{}
    \name{author}{8}{}{%
      {{hash=RO}{%
         family={Reges},
         familyi={R\bibinitperiod},
         given={Orna},
         giveni={O\bibinitperiod},
      }}%
      {{hash=GP}{%
         family={Greenland},
         familyi={G\bibinitperiod},
         given={Philip},
         giveni={P\bibinitperiod},
      }}%
      {{hash=DD}{%
         family={Dicker},
         familyi={D\bibinitperiod},
         given={Dror},
         giveni={D\bibinitperiod},
      }}%
      {{hash=LM}{%
         family={Leibowitz},
         familyi={L\bibinitperiod},
         given={Morton},
         giveni={M\bibinitperiod},
      }}%
      {{hash=HM}{%
         family={Hoshen},
         familyi={H\bibinitperiod},
         given={Moshe},
         giveni={M\bibinitperiod},
      }}%
      {{hash=GI}{%
         family={Gofer},
         familyi={G\bibinitperiod},
         given={Ilan},
         giveni={I\bibinitperiod},
      }}%
      {{hash=RTLJ}{%
         family={Rasmussen-Torvik},
         familyi={R\bibinithyphendelim T\bibinitperiod},
         given={Laura\bibnamedelima J},
         giveni={L\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=BRD}{%
         family={Balicer},
         familyi={B\bibinitperiod},
         given={Ran\bibnamedelima D},
         giveni={R\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
    }
    \keyw{Adult; Female; Gastrectomy, methods, mortality; Gastric Bypass,
  mortality; Gastroplasty, mortality; Humans; Kaplan-Meier Estimate;
  Laparoscopy; Male; Middle Aged; Obesity, Morbid, mortality, surgery, therapy;
  Proportional Hazards Models; Retrospective Studies; Weight Loss}
    \strng{namehash}{RO+1}
    \strng{fullhash}{ROGPDDLMHMGIRTLJBRD1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Bariatric surgery is an effective and safe approach for weight loss and
  short-term improvement in metabolic disorders such as diabetes. However,
  studies have been limited in most settings by lack of a nonsurgical group,
  losses to follow-up, missing data, and small sample sizes in clinical trials
  and observational studies. To assess the association of 3 common types of
  bariatric surgery compared with nonsurgical treatment with mortality and
  other clinical outcomes among obese patients. Retrospective cohort study in a
  large Israeli integrated health fund covering 54% of Israeli citizens with
  less than 1% turnover of members annually. Obese adult patients who underwent
  bariatric surgery between January 1, 2005, and December 31, 2014, were
  selected and compared with obese nonsurgical patients matched on age, sex,
  body mass index (BMI), and diabetes, with a final follow-up date of December
  31, 2015. A total of 33 540 patients were included in this study. Bariatric
  surgery (laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic
  sleeve gastrectomy) or usual care obesity management only (provided by a
  primary care physician and which may include dietary counseling and behavior
  modification). The primary outcome, all-cause mortality, matched and adjusted
  for BMI prior to surgery, age, sex, socioeconomic status, diabetes,
  hyperlipidemia, hypertension, cardiovascular disease, and smoking. The study
  population included 8385 patients who underwent bariatric surgery (median
  age, 46 [IQR, 37-54] years; 5490 [65.5%] women; baseline median BMI, 40.6
  [IQR, 38.5-43.7]; laparoscopic banding [n = 3635], gastric bypass
  [n = 1388], laparoscopic sleeve gastrectomy [n = 3362], and 25 155
  nonsurgical matched patients (median age, 46 [IQR, 37-54] years; 16 470
  [65.5%] women; baseline median BMI, 40.5 [IQR, 37.0-43.5]). The availability
  of follow-up data was 100% for all-cause mortality. There were 105 deaths
  (1.3%) among surgical patients during a median follow-up of 4.3 (IQR,
  2.8-6.6) years (including 61 [1.7%] who underwent laparoscopic banding, 18
  [1.3%] gastric bypass, and 26 [0.8%] sleeve gastrectomy), and 583 deaths
  (2.3%) among nonsurgical patients during a median follow-up of 4.0 (IQR,
  2.6-6.2) years. The absolute difference was 2.51 (95% CI, 1.86-3.15) fewer
  deaths/1000 person-years in the surgical vs nonsurgical group. Adjusted
  hazard ratios (HRs) for mortality among nonsurgical vs surgical patients were
  2.02 (95% CI, 1.63-2.52) for the entire study population; by surgical type,
  HRs were 2.01 (95% CI, 1.50-2.69) for laparoscopic banding, 2.65 (95% CI,
  1.55-4.52) for gastric bypass, and 1.60 (95% CI, 1.02-2.51) for laparoscopic
  sleeve gastrectomy. Among obese patients in a large integrated health fund in
  Israel, bariatric surgery using laparoscopic banding, gastric bypass, or
  laparoscopic sleeve gastrectomy, compared with usual care nonsurgical obesity
  management, was associated with lower all-cause mortality over a median
  follow-up of approximately 4.5 years. The evidence of this association adds
  to the limited literature describing beneficial outcomes of these 3 types of
  bariatric surgery compared with usual care obesity management alone.%
    }
    \verb{doi}
    \verb 10.1001/jama.2017.20513
    \endverb
    \field{issn}{1538-3598}
    \field{issue}{3}
    \field{pages}{279\bibrangedash 290}
    \field{title}{Association of Bariatric Surgery Using Laparoscopic Banding,
  Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care
  Obesity Management With All-Cause Mortality.}
    \field{volume}{319}
    \verb{file}
    \verb :PDFs/reges2018.pdf:PDF
    \endverb
    \field{journaltitle}{JAMA}
    \field{month}{01}
    \field{year}{2018}
  \endentry

  \entry{Rennert2001}{article}{}
    \name{author}{2}{}{%
      {{hash=RG}{%
         family={Rennert},
         familyi={R\bibinitperiod},
         given={G},
         giveni={G},
      }}%
      {{hash=PY}{%
         family={Peterburg},
         familyi={P\bibinitperiod},
         given={Y},
         giveni={Y},
      }}%
    }
    \keyw{Adolescent; Adult; Age Distribution; Aged; Chronic Disease,
  epidemiology; Female; Health Maintenance Organizations; Humans; Israel,
  epidemiology; Male; Middle Aged; Prevalence; Primary Health Care; Registries;
  Sex Distribution}
    \strng{namehash}{RGPY1}
    \strng{fullhash}{RGPY1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Knowledge of the prevalence of chronic disease in the population is
  essential for health planners and providers. To present the results of a
  concentrated effort by the largest health maintenance organization in Israel
  (Clalit Health Services) in order to develop a comprehensive register of
  chronic diseases. In 1998, all 2,704 primary care physicians in Israel's
  largest health provider were requested to report on all patients with
  selected chronic diseases. In addition, all the filled prescriptions for
  medications relevant to the investigated diseases and all relevant
  hospitalization events were added to the database. Prevalence rates were
  calculated based on the reporting practices only (1,653 physicians
  responsible for a total of 1,409,725 adults). Hypertension (10.2/100),
  diabetes (6.1/100), hyperlipidemia (5.7/100), peptic ulcer (4.7/100) and
  ischemic heart disease (4.3/100) were the most prevalent. Females had
  significantly higher rates of hypothyroidism, psychoses, neuroses and
  malignancies, and lower rates of ischemic heart disease, chronic obstructive
  pulmonary disease, heart failure and asthma. Arabs had higher rates of
  diabetes mellitus and lower rates of ischemic heart disease, hypertension and
  hyperlipidemia than Jews. About 20% of the adult population had one or more
  of the selected chronic diseases. Differences in rates noted between
  physicians, not explainable by population characteristics, may reflect
  differences in the quality and delivery of health services. Rate differences
  between demographic subgroups call for further studies on the etiology,
  susceptibility and natural history of these diseases.%
    }
    \field{issn}{1565-1088}
    \field{issue}{6}
    \field{pages}{404\bibrangedash 408}
    \field{title}{Prevalence of selected chronic diseases in Israel.}
    \field{volume}{3}
    \verb{file}
    \verb :PDFs/Rennert2001.pdf:PDF
    \endverb
    \field{journaltitle}{The Israel Medical Association journal : IMAJ}
    \field{month}{06}
    \field{year}{2001}
  \endentry

  \entry{Lam2015}{article}{}
    \name{author}{2}{}{%
      {{hash=LWY}{%
         family={Lam},
         familyi={L\bibinitperiod},
         given={Wai\bibnamedelima Yin},
         giveni={W\bibinitperiod\bibinitdelim Y\bibinitperiod},
      }}%
      {{hash=FP}{%
         family={Fresco},
         familyi={F\bibinitperiod},
         given={Paula},
         giveni={P\bibinitperiod},
      }}%
    }
    \keyw{Chronic Disease, drug therapy, economics; Health Care Costs; Humans;
  Medication Adherence}
    \strng{namehash}{LWYFP1}
    \strng{fullhash}{LWYFP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    WHO reported that adherence among patients with chronic diseases averages
  only 50% in developed countries. This is recognized as a significant public
  health issue, since medication nonadherence leads to poor health outcomes and
  increased healthcare costs. Improving medication adherence is, therefore,
  crucial and revealed on many studies, suggesting interventions can improve
  medication adherence. One significant aspect of the strategies to improve
  medication adherence is to understand its magnitude. However, there is a lack
  of general guidance for researchers and healthcare professionals to choose
  the appropriate tools that can explore the extent of medication adherence and
  the reasons behind this problem in order to orchestrate subsequent
  interventions. This paper reviews both subjective and objective medication
  adherence measures, including direct measures, those involving secondary
  database analysis, electronic medication packaging (EMP) devices, pill count,
  and clinician assessments and self-report. Subjective measures generally
  provide explanations for patient's nonadherence whereas objective measures
  contribute to a more precise record of patient's medication-taking behavior.
  While choosing a suitable approach, researchers and healthcare professionals
  should balance the reliability and practicality, especially cost
  effectiveness, for their purpose. Meanwhile, because a perfect measure does
  not exist, a multimeasure approach seems to be the best solution currently.%
    }
    \verb{doi}
    \verb 10.1155/2015/217047
    \endverb
    \field{issn}{2314-6141}
    \field{pages}{217047}
    \field{title}{Medication Adherence Measures: An Overview.}
    \field{volume}{2015}
    \verb{file}
    \verb :PDFs/Lam2015.pdf:PDF
    \endverb
    \field{journaltitle}{BioMed research international}
    \field{year}{2015}
  \endentry

  \entry{Tibshirani2011}{article}{}
    \name{author}{1}{}{%
      {{hash=TR}{%
         family={Tibshirani},
         familyi={T\bibinitperiod},
         given={Robert},
         giveni={R\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{TR1}
    \strng{fullhash}{TR1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1111/j.1467-9868.2011.00771.x
    \endverb
    \field{number}{3}
    \field{pages}{273\bibrangedash 282}
    \field{title}{Regression shrinkage and selection via the lasso: a
  retrospective}
    \field{volume}{73}
    \verb{file}
    \verb :PDFs/tibshirani2011.pdf:PDF
    \endverb
    \field{journaltitle}{Journal of the Royal Statistical Society: Series B
  (Statistical Methodology)}
    \field{year}{2011}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Freund1997}{article}{}
    \name{author}{2}{}{%
      {{hash=FY}{%
         family={Freund},
         familyi={F\bibinitperiod},
         given={Yoav},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=SRE}{%
         family={Schapire},
         familyi={S\bibinitperiod},
         given={Robert\bibnamedelima E},
         giveni={R\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Elsevier {BV}}%
    }
    \strng{namehash}{FYSRE1}
    \strng{fullhash}{FYSRE1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1006/jcss.1997.1504
    \endverb
    \field{number}{1}
    \field{pages}{119\bibrangedash 139}
    \field{title}{A Decision-Theoretic Generalization of On-Line Learning and
  an Application to Boosting}
    \field{volume}{55}
    \verb{file}
    \verb :PDFs/freund1997.pdf:PDF
    \endverb
    \field{journaltitle}{Journal of Computer and System Sciences}
    \field{year}{1997}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Shannon1948}{article}{}
    \name{author}{1}{}{%
      {{hash=SCE}{%
         family={Shannon},
         familyi={S\bibinitperiod},
         given={C.\bibnamedelima E.},
         giveni={C\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
    }
    \list{publisher}{2}{%
      {Institute of Electrical}%
      {Electronics Engineers ({IEEE})}%
    }
    \strng{namehash}{SCE1}
    \strng{fullhash}{SCE1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1002/j.1538-7305.1948.tb01338.x
    \endverb
    \field{number}{3}
    \field{pages}{379\bibrangedash 423}
    \field{title}{A Mathematical Theory of Communication}
    \field{volume}{27}
    \verb{file}
    \verb :PDFs/shannon1948.pdf:PDF
    \endverb
    \field{journaltitle}{Bell System Technical Journal}
    \field{year}{1948}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Bergstra2012}{article}{}
    \name{author}{2}{}{%
      {{hash=BJ}{%
         family={Bergstra},
         familyi={B\bibinitperiod},
         given={James},
         giveni={J\bibinitperiod},
      }}%
      {{hash=BY}{%
         family={Bengio},
         familyi={B\bibinitperiod},
         given={Yoshua},
         giveni={Y\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {JMLR.org}%
    }
    \keyw{deep learning, global optimization, model selection, neural networks,
  response surface modeling}
    \strng{namehash}{BJBY1}
    \strng{fullhash}{BJBY1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{issn}{1532-4435}
    \field{pages}{281\bibrangedash 305}
    \field{title}{Random Search for Hyper-parameter Optimization}
    \verb{url}
    \verb http://dl.acm.org/citation.cfm?id=2188385.2188395
    \endverb
    \field{volume}{13}
    \field{journaltitle}{J. Mach. Learn. Res.}
    \field{month}{02}
    \field{year}{2012}
  \endentry

  \entry{Houwelingen2000}{article}{}
    \name{author}{1}{}{%
      {{hash=vHHC}{%
         prefix={van},
         prefixi={v\bibinitperiod},
         family={Houwelingen},
         familyi={H\bibinitperiod},
         given={H\bibnamedelima C},
         giveni={H\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
    }
    \keyw{Calibration; Humans; Lymphoma, Non-Hodgkin, mortality, therapy;
  Models, Statistical; Prognosis; Proportional Hazards Models; Survival
  Analysis}
    \strng{namehash}{HHCv1}
    \strng{fullhash}{HHCv1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    The problem of assessing the validity and value of prognostic survival
  models presented in the literature for a particular population for which some
  data has been collected is discussed. Methods are sketched to perform
  validation through 'calibration', that is by embedding the literature model
  in a larger calibration model. This general approach is exemplified for
  x-year survival probabilities, Cox regression and general non-proportional
  hazards models. Some comments are made on basic structural changes to the
  model, described as 'revision'. Finally, general methods are discussed to
  combine models from different sources. The methods are illustrated with a
  model for non-Hodgkin's lymphoma validated on a Dutch data set.%
    }
    \field{issn}{0277-6715}
    \field{issue}{24}
    \field{pages}{3401\bibrangedash 3415}
    \field{title}{Validation, calibration, revision and combination of
  prognostic survival models.}
    \field{volume}{19}
    \verb{file}
    \verb :PDFs/Van-houwelingen2000.pdf:PDF
    \endverb
    \field{journaltitle}{Statistics in medicine}
    \field{month}{12}
    \field{year}{2000}
  \endentry

  \entry{Rubin1987}{book}{}
    \name{editor}{1}{}{%
      {{hash=RDB}{%
         family={Rubin},
         familyi={R\bibinitperiod},
         given={Donald\bibnamedelima B.},
         giveni={D\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {John Wiley {\&} Sons, Inc.}%
    }
    \strng{namehash}{RDB1}
    \strng{fullhash}{RDB1}
    \field{labelnamesource}{editor}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1002/9780470316696
    \endverb
    \field{title}{Multiple Imputation for Nonresponse in Surveys}
    \verb{file}
    \verb :PDFs/Rubin1987.pdf:PDF
    \endverb
    \field{year}{1987}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Buuren2011}{article}{}
    \name{author}{2}{}{%
      {{hash=vBS}{%
         prefix={van},
         prefixi={v\bibinitperiod},
         family={Buuren},
         familyi={B\bibinitperiod},
         given={Stef},
         giveni={S\bibinitperiod},
      }}%
      {{hash=GOK}{%
         family={Groothuis-Oudshoorn},
         familyi={G\bibinithyphendelim O\bibinitperiod},
         given={Karin},
         giveni={K\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Foundation for Open Access Statistic}%
    }
    \strng{namehash}{BSvGOK1}
    \strng{fullhash}{BSvGOK1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.18637/jss.v045.i03
    \endverb
    \field{number}{3}
    \field{title}{mice: Multivariate Imputation by Chained Equations {inR}}
    \field{volume}{45}
    \verb{file}
    \verb :PDFs/van-buuren2011.pdf:PDF
    \endverb
    \field{journaltitle}{Journal of Statistical Software}
    \field{year}{2011}
  \endentry

  \entry{BradleyEfron1994}{book}{}
    \name{author}{1}{}{%
      {{hash=BERT}{%
         family={Bradley\bibnamedelima Efron},
         familyi={B\bibinitperiod\bibinitdelim E\bibinitperiod},
         given={Robert\bibnamedelima Tibshirani},
         giveni={R\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Taylor \& Francis Ltd}%
    }
    \strng{namehash}{BERT1}
    \strng{fullhash}{BERT1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{isbn}{0412042312}
    \field{pagetotal}{456}
    \field{title}{An Introduction to the Bootstrap}
    \verb{url}
    \verb https://www.ebook.de/de/product/3596896/bradley_efron_robert_tibshira
    \verb ni_an_introduction_to_the_bootstrap.html
    \endverb
    \field{day}{15}
    \field{month}{05}
    \field{year}{1994}
    \warn{\item Can't use 'date' + 'year'}
  \endentry

  \entry{Schomaker2016}{article}{}
    \name{author}{2}{}{%
      {{hash=SM}{%
         family={Schomaker},
         familyi={S\bibinitperiod},
         given={Michael},
         giveni={M\bibinitperiod},
      }}%
      {{hash=HC}{%
         family={Heumann},
         familyi={H\bibinitperiod},
         given={Christian},
         giveni={C\bibinitperiod},
      }}%
    }
    \keyw{stat.ME}
    \strng{namehash}{SMHC1}
    \strng{fullhash}{SMHC1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Many modern estimators require bootstrapping to calculate confidence
  intervals because either no analytic standard error is available or the
  distribution of the parameter of interest is non-symmetric. It remains
  however unclear how to obtain valid bootstrap inference when dealing with
  multiple imputation to address missing data. We present four methods which
  are intuitively appealing, easy to implement, and combine bootstrap
  estimation with multiple imputation. We show that three of the four
  approaches yield valid inference, but that the performance of the methods
  varies with respect to the number of imputed data sets and the extent of
  missingness. Simulation studies reveal the behavior of our approaches in
  finite samples. A topical analysis from HIV treatment research, which
  determines the optimal timing of antiretroviral treatment initiation in young
  children, demonstrates the practical implications of the four methods in a
  sophisticated and realistic setting. This analysis suffers from missing data
  and uses the $g$-formula for inference, a method for which no standard errors
  are available.%
    }
    \verb{doi}
    \verb 10.1002/sim.7654
    \endverb
    \verb{eprint}
    \verb http://arxiv.org/abs/1602.07933v6
    \endverb
    \field{title}{Bootstrap Inference when Using Multiple Imputation}
    \verb{file}
    \verb :http\://arxiv.org/pdf/1602.07933v6:PDF
    \endverb
    \field{eprinttype}{arXiv}
    \field{eprintclass}{stat.ME}
    \field{day}{25}
    \field{month}{02}
    \field{year}{2016}
  \endentry

  \entry{Pencina2008}{article}{}
    \name{author}{4}{}{%
      {{hash=PMJ}{%
         family={Pencina},
         familyi={P\bibinitperiod},
         given={Michael\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=DRB}{%
         family={D'Agostino},
         familyi={D\bibinitperiod},
         given={Ralph\bibnamedelima B},
         giveni={R\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=DRB}{%
         family={D'Agostino},
         familyi={D\bibinitperiod},
         given={Ralph\bibnamedelima B},
         giveni={R\bibinitperiod\bibinitdelim B\bibinitperiod},
      }}%
      {{hash=VRS}{%
         family={Vasan},
         familyi={V\bibinitperiod},
         given={Ramachandran\bibnamedelima S},
         giveni={R\bibinitperiod\bibinitdelim S\bibinitperiod},
      }}%
    }
    \keyw{Area Under Curve; Cardiovascular Diseases, etiology; Humans; Models,
  Statistical; ROC Curve; Risk Assessment, classification, statistics &
  numerical data; Risk Factors; United States}
    \strng{namehash}{PMJ+1}
    \strng{fullhash}{PMJDRBDRBVRS1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{abstract}{%
    Identification of key factors associated with the risk of developing
  cardiovascular disease and quantification of this risk using multivariable
  prediction algorithms are among the major advances made in preventive
  cardiology and cardiovascular epidemiology in the 20th century. The ongoing
  discovery of new risk markers by scientists presents opportunities and
  challenges for statisticians and clinicians to evaluate these biomarkers and
  to develop new risk formulations that incorporate them. One of the key
  questions is how best to assess and quantify the improvement in risk
  prediction offered by these new models. Demonstration of a statistically
  significant association of a new biomarker with cardiovascular risk is not
  enough. Some researchers have advanced that the improvement in the area under
  the receiver-operating-characteristic curve (AUC) should be the main
  criterion, whereas others argue that better measures of performance of
  prediction models are needed. In this paper, we address this question by
  introducing two new measures, one based on integrated sensitivity and
  specificity and the other on reclassification tables. These new measures
  offer incremental information over the AUC. We discuss the properties of
  these new measures and contrast them with the AUC. We also develop simple
  asymptotic tests of significance. We illustrate the use of these measures
  with an example from the Framingham Heart Study. We propose that scientists
  consider these types of measures in addition to the AUC when assessing the
  performance of newer biomarkers.%
    }
    \verb{doi}
    \verb 10.1002/sim.2929
    \endverb
    \field{issn}{0277-6715}
    \field{issue}{2}
    \field{pages}{157\bibrangedash 72; discussion 207\bibrangedash 12}
    \field{title}{Evaluating the added predictive ability of a new marker: from
  area under the ROC curve to reclassification and beyond.}
    \field{volume}{27}
    \verb{file}
    \verb :PDFs/pencina2008.pdf:PDF
    \endverb
    \field{journaltitle}{Statistics in medicine}
    \field{month}{01}
    \field{year}{2008}
  \endentry

  \entry{Vickers2016}{article}{}
    \name{author}{3}{}{%
      {{hash=VAJ}{%
         family={Vickers},
         familyi={V\bibinitperiod},
         given={Andrew\bibnamedelima J},
         giveni={A\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=VCB}{%
         family={Van\bibnamedelima Calster},
         familyi={V\bibinitperiod\bibinitdelim C\bibinitperiod},
         given={Ben},
         giveni={B\bibinitperiod},
      }}%
      {{hash=SEW}{%
         family={Steyerberg},
         familyi={S\bibinitperiod},
         given={Ewout\bibnamedelima W},
         giveni={E\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
    }
    \keyw{Biomarkers; Decision Support Techniques; Diagnostic Tests, Routine,
  methods; Humans; Models, Statistical; Predictive Value of Tests; ROC Curve}
    \strng{namehash}{VAJVCBSEW1}
    \strng{fullhash}{VAJVCBSEW1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1136/bmj.i6
    \endverb
    \field{issn}{1756-1833}
    \field{pages}{i6}
    \field{title}{Net benefit approaches to the evaluation of prediction
  models, molecular markers, and diagnostic tests.}
    \field{volume}{352}
    \verb{file}
    \verb :PDFs/vickers2016.pdf:PDF
    \endverb
    \field{journaltitle}{BMJ (Clinical research ed.)}
    \field{month}{01}
    \field{year}{2016}
  \endentry

  \entry{Steyerberg2008}{book}{}
    \name{author}{1}{}{%
      {{hash=SEW}{%
         family={Steyerberg},
         familyi={S\bibinitperiod},
         given={Ewout\bibnamedelima W.},
         giveni={E\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Springer}%
    }
    \strng{namehash}{SEW1}
    \strng{fullhash}{SEW1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{isbn}{978-0387772431}
    \field{title}{Clinical Prediction Models: A Practical Approach to
  Development, Validation, and Updating (Statistics for Biology and Health)}
    \verb{url}
    \verb https://www.amazon.com/Clinical-Prediction-Models-Development-Validat
    \verb ion/dp/038777243X?SubscriptionId=0JYN1NVW651KCA56C102&tag=techkie-20&
    \verb linkCode=xm2&camp=2025&creative=165953&creativeASIN=038777243X
    \endverb
    \verb{file}
    \verb :PDFs/steyerberg2009.pdf:PDF
    \endverb
    \field{year}{2008}
  \endentry

  \entry{FrankE.Harrell2015}{book}{}
    \name{author}{1}{}{%
      {{hash=HFE}{%
         family={Harrell},
         familyi={H\bibinitperiod},
         given={Frank\bibnamedelima E.},
         giveni={F\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Springer International Publishing}%
    }
    \strng{namehash}{HFE1}
    \strng{fullhash}{HFE1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \verb{doi}
    \verb 10.1007/978-3-319-19425-7
    \endverb
    \field{title}{Regression Modeling Strategies}
    \verb{file}
    \verb :PDFs/harrell2015.pdf:PDF
    \endverb
    \field{year}{2015}
  \endentry

  \entry{Cohen1988}{book}{}
    \name{author}{1}{}{%
      {{hash=CJ}{%
         family={Cohen},
         familyi={C\bibinitperiod},
         given={Jacob},
         giveni={J\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Routledge}%
    }
    \strng{namehash}{CJ1}
    \strng{fullhash}{CJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{isbn}{978-0805802832}
    \field{title}{Statistical Power Analysis for the Behavioral Sciences (2nd
  Edition)}
    \verb{url}
    \verb https://www.amazon.com/Statistical-Power-Analysis-Behavioral-Sciences
    \verb /dp/0805802835?SubscriptionId=0JYN1NVW651KCA56C102&tag=techkie-20&lin
    \verb kCode=xm2&camp=2025&creative=165953&creativeASIN=0805802835
    \endverb
    \field{year}{1988}
  \endentry
\enddatalist
\endinput
